Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3009466	s-valpr	umol/l (umol/l)	5479	26549	0.07%
3009466	s-valpr	— (—)	2152	5597	100.00%	Distribution not available
3009466	s-valpr	% (—)	32	33	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Generalized epilepsy, strict definition

214

32.87

317.33

4.2

6.2

388.60

375.31

umol/l

0.32

196

Mental retardation, wide definition

297

234

15.26

315.45

6.1

5.2

414.54

375.01

umol/l

3.06

280

214

Mental retardation

289

221

15.85

312.74

6.1

5.2

416.14

372.88

umol/l

3.47

272

203

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1447

2272

6.72

307.65

6.3

4.8

371.41

362.79

umol/l

1.11

1269

1942

Epilepsy

2341

1067

25.42

307.65

4.2

5.9

371.21

367.71

umol/l

0.30

2070

911

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1712

4121

2.98

307.65

5.9

4.9

372.62

369.75

umol/l

0.30

1505

3589

Concussion

820

1474

4.92

307.65

5.3

6.1

366.84

383.72

umol/l

2.01

727

1269

General symptoms and signs

1998

2729

3.74

307.65

5.4

5.1

366.78

374.54

umol/l

1.17

1774

2334

Kela-code for severe mental illness

3252

1079

36.06

307.65

6.9

3.2

386.81

352.44

umol/l

10.46

2915

915

All pneumoniae

1740

4177

2.93

307.65

5.9

4.9

373.72

370.38

umol/l

0.37

1531

3640

Focal epilepsy, strict definition

1368

646

24.93

307.65

3.7

5.7

367.42

364.67

umol/l

0.17

1199

549

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

838

821

11.32

307.65

6.4

5.4

384.75

372.76

umol/l

0.97

735

726

Influenza and pneumonia

1797

4199

2.86

307.65

5.9

4.9

372.96

371.05

umol/l

0.19

1582

3650

Focal epilepsy

1575

712

26.28

307.65

4.0

5.6

372.22

362.21

umol/l

0.93

1390

605

Any mental disorder

2819

1080

13.54

307.65

5.7

2.7

370.02

357.48

umol/l

1.77

2471

892

Anxiety disorders, excluding more controls

2076

923

15.50

307.65

5.7

2.7

371.04

362.77

umol/l

0.81

1834

765

All anxiety disorders

1731

2393

6.06

307.65

5.7

5.3

368.89

377.16

umol/l

1.16

1528

2117

Anxiety (asthma-related co-morbidities)

1714

1123

12.59

307.65

5.7

3.5

368.94

363.50

umol/l

0.47

1512

961

Use of disulfiram, acamprosate or naltrexone

460

503

10.34

307.65

7.9

5.6

377.82

371.69

umol/l

0.31

423

438

Hypothyroidism, levothyroxine purchases

492

188

15.44

307.65

6.6

2.7

392.72

387.77

umol/l

0.15

433

152

Use of biperiden

512

244

27.61

307.65

7.4

5.4

401.54

358.53

umol/l

4.47

468

210

Alcohol abuse, main dg, excluding more controls

410

192

22.64

307.65

6.5

2.7

370.94

339.68

umol/l

1.65

365

159

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1256

286

47.87

307.65

6.3

2.6

379.60

366.23

umol/l

0.69

1108

245

Nonorganic sleeping disorders, excluding more controls

454

196

24.38

307.65

6.2

2.6

383.67

341.90

umol/l

3.31

404

172

Schizoaffective disorder

1056

257

60.63

307.65

8.0

4.6

392.99

355.52

umol/l

4.01

967

224

Disorders of adult personality and behaviour

1441

1330

11.92

307.65

6.4

5.3

379.38

373.09

umol/l

0.59

1282

1151

Schizophrenia

1423

571

30.52

307.65

7.4

4.0

390.89

361.12

umol/l

4.55

1297

495

Parkinson's disease, excluding more controls

197

76.31

307.65

6.1

1.3

373.24

302.50

umol/l

—

178

Hypothyroidism (congenital or acquired)

496

193

15.14

307.65

6.6

2.7

393.13

390.96

umol/l

0.06

437

157

Alzheimer disease, excluding more controls

308

142.30

307.65

3.2

1.5

320.95

285.88

umol/l

—

242

Hyperkinetic disorders, excluding more controls

233

28.26

307.65

4.7

3.2

361.83

365.55

umol/l

0.07

206

Substance abuse, excluding more controls

1827

793

21.32

307.65

6.2

2.7

369.61

352.70

umol/l

2.09

1596

645

Use of hypnotics and sedatives

2288

3217

4.22

307.65

6.0

4.5

379.24

361.91

umol/l

4.82

2026

2756

Emotionally unstable personality disorder

719

486

16.78

307.65

6.4

5.2

380.97

368.33

umol/l

0.90

634

415

Bipolar affective disorders

2167

466

60.35

307.65

6.6

4.6

381.27

363.36

umol/l

1.79

1919

403

Mood disorders, excluding more controls

3155

1027

19.67

307.65

6.1

2.7

373.98

356.92

umol/l

2.89

2792

845

Persistent mood disorders

476

514

9.71

307.65

6.2

4.2

366.73

360.48

umol/l

0.32

422

444

Alcohol use disorder, ICD-based

1362

2101

6.86

307.65

6.3

4.8

372.31

364.57

umol/l

0.90

1196

1787

1585

3140

3.23

307.65

6.0

4.8

374.17

371.28

umol/l

0.28

1392

2735

Other anxiety disorders

1356

1783

7.06

307.65

5.7

5.2

368.58

374.40

umol/l

0.55

1187

1578

Episodal and paroxysmal disorders

2215

2695

4.31

307.65

4.6

5.8

369.63

373.50

umol/l

0.45

1949

2321

General examination and investigation of persons without complaint and reported diagnosis

1419

1840

4.20

307.65

5.9

4.6

375.84

364.51

umol/l

1.64

1277

1573

Alcohol dependence

951

1211

8.40

307.65

6.7

4.7

371.79

364.56

umol/l

0.59

848

1025

Personality disorders, excluding more controls

1346

280

53.25

307.65

6.4

2.7

377.74

361.50

umol/l

0.89

1193

237

Substance use, excluding alcohol

805

872

10.01

307.65

6.6

5.0

374.93

370.55

umol/l

0.26

713

759

Convulsions, not elsewhere classified

1331

915

15.97

307.65

4.9

5.1

369.73

373.80

umol/l

0.28

1193

771

Status epilepticus

294

40.56

307.65

5.1

6.7

371.99

374.36

umol/l

0.05

269

Suicide or other Intentional self-harm

1145

1216

10.30

307.65

6.4

5.1

384.14

368.24

umol/l

2.04

1012

1066

Unspecified mental disorder

3318

1223

31.84

307.65

6.9

3.3

385.93

352.11

umol/l

10.92

2976

1031

Mental and behavioural disorders due to psychoactive substance use

1853

2853

6.43

307.65

6.2

4.7

369.58

365.34

umol/l

0.47

1619

2451

Other reaction to severe stress, and adjustment disorders

753

1537

5.05

307.65

5.4

367.44

377.43

umol/l

0.95

662

1359

Acute and transient psychotic disorders

915

394

27.94

307.65

7.6

4.2

390.16

350.43

umol/l

5.57

828

340

Organic, including symptomatic, mental disorders

1121

1245

6.78

307.65

4.8

4.5

352.80

352.45

umol/l

0.02

950

1045

Mood [affective] disorders

3329

2496

9.20

307.65

6.1

4.0

374.50

363.65

umol/l

2.31

2946

2135

Specific personality disorders

1225

1045

12.99

307.65

6.4

5.2

380.55

371.18

umol/l

0.89

1092

902

Benzodiazepine use

3244

2823

8.58

307.65

5.9

4.3

376.67

357.53

umol/l

6.51

2854

2404

Any dementia, excluding more controls

644

430

10.79

307.65

4.0

2.7

330.50

331.34

umol/l

0.03

519

354

Neurotic, stress-related and somatoform disorders

2184

3248

4.94

307.65

5.7

5.1

371.37

374.30

umol/l

0.34

1930

2830

Non-selective monoamine reuptake inhibitors

790

1046

7.58

307.65

5.6

4.3

360.91

366.72

umol/l

0.41

687

890

Other and unspecified nonorganic psychotic disorders

1617

713

27.15

307.65

7.1

4.2

388.24

359.82

umol/l

4.95

1471

617

Other symptoms and signs involving cognitive functions and awareness

1073

1675

6.27

307.65

5.0

4.6

354.88

359.87

umol/l

0.40

920

1408

Symptoms and signs involving cognition, perception, emotional state and behaviour

1835

3662

3.59

307.65

5.5

5.0

365.27

369.02

umol/l

0.43

1598

3179

Anxiety disorders

2205

3270

4.94

307.65

5.7

5.0

371.38

373.41

umol/l

0.22

1948

2850

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1256

1360

10.00

307.65

6.3

5.1

379.60

370.93

umol/l

0.86

1108

1192

Schizophrenia, schizotypal and delusional disorders

2514

1211

24.37

307.65

7.1

4.1

386.90

359.52

umol/l

7.24

2287

1037

1592

2810

5.42

307.65

6.2

4.8

370.09

362.16

umol/l

1.06

1395

2400

Other antidepressants

2151

1984

5.81

307.65

5.2

4.5

361.37

367.01

umol/l

0.67

1863

1692

Selective serotonin reuptake inhibitors

2182

2019

5.84

307.65

5.6

4.4

367.18

368.62

umol/l

0.13

1896

1724

Other degenerative diseases of the nervous system

488

398

9.59

307.65

3.9

5.6

329.26

368.20

umol/l

4.35

394

327

Substance abuse

1827

2815

6.52

307.65

6.2

4.7

369.61

364.62

umol/l

0.58

1596

2416

Schizophrenia or delusion

2511

1203

24.52

307.65

7.1

4.0

386.86

359.52

umol/l

7.19

2285

1027

Focal epilepsy, mode (most common among epilepsy diagnosis)

1285

616

24.51

307.65

3.7

5.6

369.27

363.77

umol/l

0.37

1127

520

1679

2851

5.50

307.65

6.3

4.7

370.80

362.65

umol/l

1.14

1474

2436

Persons encountering health services in other circumstances

881

1802

5.06

307.65

6.6

4.5

373.29

368.71

umol/l

0.37

770

1558

Hypothyroidism and >3 levothyroxin purchases

492

188

15.44

307.65

6.6

2.7

392.72

387.77

umol/l

0.15

433

152

Poisoning by medicine

1081

1035

11.53

307.65

6.7

5.0

381.59

371.83

umol/l

0.87

958

897

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

426

403

12.13

307.65

6.9

5.7

381.88

379.08

umol/l

0.10

382

357

Neurological diseases

1520

1859

4.19

307.65

4.9

6.0

370.60

381.77

umol/l

1.52

1363

1597

Pneumonia, organism unspecified

1586

3817

3.07

307.65

5.9

4.9

371.65

369.68

umol/l

0.18

1384

3320

Depression

2423

2386

7.25

307.65

5.7

4.1

370.07

365.67

umol/l

0.52

2132

2048

Dementia

707

845

5.96

307.65

4.0

3.9

335.65

342.08

umol/l

0.43

574

707

Depression medications

783

220

18.50

307.65

5.6

2.7

373.40

384.60

umol/l

0.46

689

181

Malaise and fatigue

1033

1462

6.08

307.65

5.8

4.8

364.12

367.35

umol/l

0.24

911

1217

Dementia, including avohilmo

743

956

5.53

307.65

4.0

337.97

342.37

umol/l

0.28

607

803

Delirium, not induced by alcohol and other psychoactive substances

353

328

11.57

307.65

5.4

4.5

354.95

350.66

umol/l

0.17

313

285

Mental and behavioural disorders due to alcohol

1552

2464

6.44

307.65

6.2

4.7

370.72

363.40

umol/l

0.90

1359

2107

Intracranial trauma

1075

1527

5.39

307.65

5.2

6.1

364.75

384.54

umol/l

3.08

937

1313

Poisoning by drugs, medicaments and biological substances

1171

1151

11.19

307.65

6.7

5.0

379.58

370.21

umol/l

0.88

1039

998

Generalized epilepsy

421

162

33.83

307.65

4.9

5.9

395.41

372.05

umol/l

1.08

387

136

Any dementia

669

804

6.06

307.65

3.9

3.8

328.54

337.81

umol/l

0.69

533

677

Mood disorders

3339

2490

9.24

307.65

6.1

4.0

374.29

363.77

umol/l

2.19

2955

2128

Personality disorders

1346

1262

11.73

307.65

6.4

5.3

377.74

374.05

umol/l

0.28

1193

1096

Condition for Implicit Sepsis (Organ dysfunction codes)

1542

3268

3.51

307.65

5.2

5.0

358.27

371.17

umol/l

2.47

1345

2824

Generalized epilepsy, mode (most common among epilepsy diagnosis)

289

115

32.15

307.65

4.5

5.9

385.78

363.30

umol/l

0.83

262

101

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1585

3140

3.23

307.65

6.0

4.8

374.17

371.28

umol/l

0.28

1392

2735

Pneumonias (Asthma/COPD co-morbidities)

1730

4175

2.92

307.65

5.9

4.9

373.60

369.98

umol/l

0.41

1520

3638

Other and unspecified mood [affective] disorders

393

144

30.94

307.65

6.4

5.5

373.53

378.64

umol/l

0.15

338

130

Alcohol use disorder, Swedish definition

1593

2663

5.81

307.65

6.3

4.7

371.39

361.16

umol/l

1.59

1402

2268

Psychiatric diseases

2762

976

14.68

307.65

5.7

2.7

370.48

356.97

umol/l

1.84

2424

798

Schizophrenia or delusion, excluding more controls

2511

397

74.09

307.65

7.1

2.8

386.86

358.65

umol/l

3.15

2285

332

Mental disorders, not otherwise specified

307

176

18.98

307.65

6.9

3.6

381.58

353.12

umol/l

1.53

283

156

Other specified and unspecified personality disorders

507

388

14.83

307.65

6.6

5.3

377.89

369.62

umol/l

0.41

452

341

Any reimbursement code in KELA

1120

485

11.85

307.65

5.8

3.0

373.21

341.59

umol/l

2.84

991

381

Mixed and other personality disorders

391

348

12.54

307.65

6.6

5.5

370.41

368.30

umol/l

0.08

338

303

Implicit Sepsis

1336

2915

3.65

307.65

5.2

4.9

352.56

365.78

umol/l

2.30

1157

2500

Manic episode

423

102.34

307.65

8.1

5.7

409.38

365.39

umol/l

1.76

387

Persistent delusional disorders

302

252

13.18

305.75

6.7

4.2

374.03

349.65

umol/l

1.44

276

217

Persons encountering health services in other circumstances, wide

1976

3813

2.73

304.69

6.0

4.5

370.59

367.79

umol/l

0.31

1729

3290

Acute alcohol intoxication

593

1106

5.58

302.16

6.1

4.6

365.78

361.43

umol/l

0.25

526

938

Speech and linguistic disorders, excluding more controls

217

25.71

296.55

5.5

3.3

380.65

388.16

umol/l

0.16

201

KRA_PSY_EATING, excluding more controls

174

40.21

285.09

6.0

3.8

369.10

334.00

umol/l

0.71

144

Injuries to the head

1789

4428

2.67

284.48

5.3

5.0

364.05

370.27

umol/l

0.85

1558

3839

Implicit bacterial Sepsis

717

1480

4.58

283.98

5.4

4.4

353.99

351.73

umol/l

0.14

623

1232

Behavioural syndromes associated with physiological disturbances and physical factors

717

1693

4.38

274.80

6.1

5.2

379.89

371.65

umol/l

0.71

634

1472

Mental and behavioural disorders due to sedatives or hypnotics

329

368

10.00

272.79

6.6

5.7

371.03

382.86

umol/l

0.50

289

321

Bacterial Sepsis

773

1708

4.14

266.92

5.4

4.5

356.17

355.93

umol/l

0.01

675

1434

Extrapyramidal and movement disorders

692

1658

4.31

260.25

6.2

4.4

385.00

355.31

umol/l

5.48

626

1376

Constipation

1377

3487

2.88

257.56

6.1

4.6

373.41

365.34

umol/l

1.16

1222

2982

Syncope and collapse

670

1381

4.39

251.12

4.6

4.7

352.69

362.21

umol/l

0.79

563

1145

Traumatic subdural haemorrhage

240

183

13.42

249.46

4.7

5.3

340.77

362.20

umol/l

0.91

198

144

Intracranial injury

986

2976

3.27

247.44

5.0

4.9

361.97

366.77

umol/l

0.40

852

2554

Symptoms and signs involving the nervous and musculoskeletal systems

979

3075

3.26

245.52

5.3

4.9

376.39

362.73

umol/l

1.89

876

2625

Generalized anxiety disorder

361

510

7.39

242.93

5.2

5.5

363.87

374.04

umol/l

0.46

324

450

Other disorders of fluid, electrolyte and acid-base balance

580

1243

4.65

237.63

5.6

4.4

370.35

355.93

umol/l

1.36

507

1031

Other mental disorders due to brain damage and dysfunction and to physical disease

295

341

9.20

236.12

5.8

4.6

355.63

356.26

umol/l

0.02

252

293

Hypo-osmolality and hyponatraemia

398

642

6.48

235.51

5.5

4.4

386.62

351.71

umol/l

4.00

352

536

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

292

346

9.31

230.91

7.6

5.6

386.27

369.04

umol/l

0.75

271

300

Panic disorder

349

510

7.14

227.70

5.3

5.6

371.86

376.64

umol/l

0.16

301

450

Secondary parkinsonism

179

103

21.09

225.24

7.2

4.5

386.51

359.03

umol/l

0.98

166

Secondary parkinsonism+Parkinsonism in other disease

180

106

20.50

223.86

7.2

4.4

385.69

358.23

umol/l

0.99

167

Anaemias

309

205

10.22

219.05

5.6

3.2

366.78

408.01

umol/l

2.37

277

171

Problems related to lifestyle

316

439

7.65

216.83

5.7

4.9

375.31

371.52

umol/l

0.14

275

383

Phobic anxiety disorders

331

483

7.17

216.30

5.9

5.7

373.99

378.19

umol/l

0.14

298

434

Emotional disorders starting during childhood or adolecense, excluding more controls

137

36.62

215.12

5.4

2.7

375.79

380.00

umol/l

0.05

126

Neurological diseases, wide definition

600

604

5.09

211.07

5.4

6.4

372.87

404.31

umol/l

4.00

542

523

Mild mental retardation

183

133

16.73

204.21

6.3

5.4

406.27

376.24

umol/l

1.30

172

121

Sleep disorders

493

1102

4.65

203.43

6.2

5.3

383.42

368.24

umol/l

1.42

440

960

Fever of other and unknown origin

738

2023

3.44

199.78

5.6

5.1

373.84

370.47

umol/l

0.23

644

1712

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

508

1051

4.58

199.32

5.6

5.7

373.53

385.83

umol/l

0.94

455

935

Schizotypal disorder

151

22.88

198.91

7.5

5.3

403.02

360.32

umol/l

1.88

134

Degenerative diseases of the nervous system

509

825

4.77

198.49

3.7

310.06

333.41

umol/l

2.52

404

680

Mental and behavioural disorders due to cannabinoids

208

194

12.64

198.29

6.7

5.0

378.94

379.21

umol/l

0.01

185

169

Acute alcohol intoxication, ICD10

484

1095

4.61

196.99

6.2

5.2

368.61

364.68

umol/l

0.20

425

959

Headache

873

2388

3.10

194.77

4.9

5.2

354.35

377.16

umol/l

3.95

762

2043

Nonorganic sleeping disorders

454

1006

4.71

189.60

6.2

5.4

383.67

369.38

umol/l

1.22

404

877

Sequelae of cerebrovascular disease

537

1155

4.18

188.11

3.7

4.5

344.36

344.63

umol/l

0.01

455

965

Oedema, not elsewhere classified

446

976

4.65

186.36

6.0

4.6

366.46

370.12

umol/l

0.16

393

800

Medical observation and evaluation for suspected diseases and conditions

1043

1841

2.94

183.20

5.5

4.6

369.43

364.40

umol/l

0.43

895

1574

Other bacterial diseases

1381

4000

2.42

183.07

5.7

4.9

364.88

368.45

umol/l

0.35

1192

3478

Alcohol abuse, main dg

410

866

4.97

181.97

6.5

5.4

370.94

366.38

umol/l

0.21

365

760

Parkinson's disease, strict definition, excluding more controls

108

46.94

181.49

5.4

1.3

366.33

302.50

umol/l

—

100

Insomnia

394

816

5.05

178.83

6.3

5.4

384.32

366.32

umol/l

1.58

355

703

Fall on same level

1683

4263

2.23

175.97

5.4

5.1

368.71

371.99

umol/l

0.35

1463

3712

Unspecific neurodegenerative disorder

532

906

4.14

169.80

3.3

3.8

325.00

330.41

umol/l

0.32

426

747

Cerebrovascular diseases

993

2654

2.72

168.44

4.1

5.1

348.96

364.52

umol/l

2.46

843

2274

Depression or dysthymia

504

623

4.57

167.87

3.1

2.7

339.96

365.26

umol/l

2.18

412

501

Obsessive-compulsive disorder

204

233

9.33

165.01

6.1

5.2

381.59

385.00

umol/l

0.09

180

202

Open wound of head

805

2795

2.89

164.49

5.5

5.0

370.92

366.87

umol/l

0.29

710

2401

Monoamine oxidase A inhibitors

215

266

8.38

162.17

5.6

4.9

366.22

369.06

umol/l

0.08

183

235

Disorders of psychological development

356

674

5.16

160.44

5.7

5.5

396.69

382.89

umol/l

0.83

327

602

Recurrent or chronic depression

312

373

6.11

156.58

2.9

327.16

377.69

umol/l

4.57

253

308

Other and unspecified mental retardation

132

19.27

156.08

5.9

5.0

442.47

366.33

umol/l

4.46

124

Stroke, including SAH

825

2207

2.81

149.88

3.9

5.0

348.30

358.43

umol/l

1.08

696

1878

Dizziness and giddiness

936

2971

2.59

149.21

5.4

4.9

362.79

365.43

umol/l

0.21

814

2554

Implicit viral Sepsis

352

773

4.71

148.35

5.0

4.7

354.28

362.10

umol/l

0.39

311

653

Viral Sepsis

352

774

4.70

148.11

5.0

4.7

354.28

362.08

umol/l

0.39

311

654

Bacterial infection, other or unspecified

726

2285

2.92

148.10

5.8

4.5

356.37

356.23

umol/l

0.01

622

1943

Bacterial pneumonia, not elsewhere classified

565

1530

3.33

143.61

6.0

4.4

376.62

357.98

umol/l

1.97

500

1291

Dissociative [conversion] disorders

138

111

13.51

142.72

6.6

5.5

382.36

385.26

umol/l

0.05

121

Stroke, excluding SAH

773

2060

2.83

142.67

3.9

4.8

346.12

354.93

umol/l

0.85

654

1744

Bacterial pneumoniae

583

1633

3.22

140.33

6.1

4.5

375.28

359.56

umol/l

1.55

517

1387

Viral hepatitis, IBD co-morbidity

166

179

9.82

140.15

5.7

7.7

354.38

422.12

umol/l

5.48

144

153

Other symptoms and signs involving the nervous and musculoskeletal systems

631

2136

3.01

139.47

4.8

5.0

375.35

364.35

umol/l

0.94

561

1830

Antihypertensive medication - note that there are other indications

970

2080

2.59

138.19

5.8

5.2

368.20

379.91

umol/l

1.38

857

1808

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1419

3788

2.16

138.09

6.0

4.5

370.28

368.10

umol/l

0.20

1256

3273

Alzheimer disease, including avohilmo

436

800

4.02

136.44

3.1

3.7

312.45

328.57

umol/l

1.27

343

658

Acute tubulo-interstitial nephritis

827

2857

2.61

135.88

5.6

4.6

360.88

361.94

umol/l

0.07

725

2418

Early onset COPD, excluding more controls

343

801

4.40

133.40

5.9

4.7

362.00

368.10

umol/l

0.29

301

665

Parasetamol

1142

2497

2.36

132.33

5.2

5.1

360.25

377.25

umol/l

2.81

999

2165

Pneumonitis due to solids and liquids

216

340

6.73

132.09

5.9

4.7

353.21

349.86

umol/l

0.11

190

295

Other symptoms and signs involving general sensations and perceptions

143

138

11.37

131.64

6.9

4.9

366.05

364.42

umol/l

0.04

132

118

Other functional intestinal disorders

676

2329

2.82

130.74

6.3

4.6

375.48

365.66

umol/l

0.96

608

1977

Alzheimer disease

388

712

4.20

130.43

3.1

3.6

306.51

326.19

umol/l

1.56

302

575

Other disorders of urethra and urinary system

876

2643

2.52

129.07

5.8

4.6

373.07

363.60

umol/l

1.06

769

2261

Unspecified dementia

184

212

8.08

128.91

4.5

3.4

344.56

335.97

umol/l

0.26

148

177

severe traumatic brain injury, does not include concussion

391

1042

3.87

127.30

4.9

4.6

346.49

352.28

umol/l

0.29

330

875

COPD/asthma/ILD related infections

1344

3144

2.16

126.81

5.6

4.8

366.61

371.23

umol/l

0.50

1177

2738

COPD/asthma related infections

1344

3144

2.16

126.81

5.6

4.8

366.61

371.23

umol/l

0.50

1177

2738

Superficial injury of head

388

1032

3.86

126.48

5.7

4.9

373.59

368.53

umol/l

0.26

333

893

Renal tubulo-interstitial diseases

1108

3850

2.23

125.87

5.6

4.8

358.88

367.69

umol/l

1.13

975

3303

Mental and behavioural disorders due to use of other stimulants, including caffeine

152

172

10.03

125.44

6.9

5.4

388.20

381.68

umol/l

0.13

131

147

Post-traumatic stress disorder

174

232

7.82

123.42

5.6

5.9

367.65

385.18

umol/l

0.66

156

203

Nontraumatic intracranial haemmorrhage

309

709

4.48

123.03

3.7

4.7

346.39

348.68

umol/l

0.09

256

605

Dementia in other diseases classified elsewhere

130

123

11.39

120.92

5.8

3.7

351.26

354.98

umol/l

0.08

104

108

Abnormal involuntary movements

275

586

4.89

120.67

6.3

5.1

379.26

358.04

umol/l

1.25

250

509

Falls/tendency to fall

1482

3682

2.04

119.97

5.3

5.2

367.09

373.64

umol/l

0.86

1297

3199

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

487

1536

3.21

119.36

5.9

5.4

387.33

375.35

umol/l

0.97

425

1349

Endocrine, nutritional and metabolic diseases

1158

2665

2.23

118.72

5.9

4.6

371.11

374.27

umol/l

0.27

1034

2296

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

521

757

3.49

118.60

5.6

5.3

370.80

377.47

umol/l

0.39

461

642

Schizoid personality disorder

105

16.64

118.57

6.1

5.2

372.95

347.92

umol/l

0.64

STROKE

793

2189

2.55

117.71

4.4

5.2

362.08

372.40

umol/l

1.06

685

1875

Examination and observation for other reasons

773

1818

2.62

116.70

5.2

4.6

364.07

363.69

umol/l

0.02

698

1556

Heart failure, not strict

939

2810

2.33

115.26

5.8

4.7

365.50

364.21

umol/l

0.10

836

2391

Dementia in Alzheimer disease

220

325

5.93

114.37

2.8

3.4

311.22

326.71

umol/l

0.65

159

265

Hypothyroidism, strict autoimmune, 3 medication purchases required

1067

3343

2.20

114.17

6.1

4.6

378.82

362.42

umol/l

2.93

944

2857

Intracerebral haemorrhage

217

395

5.68

113.69

3.7

4.6

340.33

335.52

umol/l

0.16

182

340

Non-invasive ventilation

219

369

5.66

113.35

5.3

3.1

362.86

353.64

umol/l

0.31

198

288

Hypothyreosis and Thyroxine purchase for inclusion criteria

1156

3634

2.12

112.08

6.3

4.6

381.18

361.08

umol/l

4.42

1018

3107

Hypothyroidism, strict autoimmune

996

2960

2.25

111.92

6.3

4.7

379.08

361.70

umol/l

3.01

878

2548

COPD (mode)

410

935

3.55

111.48

5.5

4.3

348.43

354.59

umol/l

0.34

357

778

Other extrapyramidal and movement disorders in other diseases

356

977

3.75

111.08

6.1

4.7

390.38

357.15

umol/l

3.75

319

823

Hypothyroidism, other/unspecified

1129

3533

2.13

110.82

6.3

4.7

380.56

360.27

umol/l

4.40

996

3022

Unspecified fall

689

2763

2.52

107.63

4.9

5.0

356.07

367.03

umol/l

1.16

590

2381

Intentional self-harm by sharp object

122

126

10.87

107.55

6.2

5.7

378.85

359.63

umol/l

0.53

105

112

Alcohol withdrawal state with delirium

197

348

6.03

107.53

6.1

5.5

356.92

361.29

umol/l

0.15

168

309

Care involving use of rehabilitation procedures

861

3635

2.28

107.26

5.0

5.1

374.28

368.88

umol/l

0.47

786

3132

Alzheimer’s disease, wide definition

303

617

4.20

105.59

3.1

3.6

305.02

324.74

umol/l

1.31

241

495

Hypothyroidism, drug reimbursement

149

115

9.40

104.77

6.5

2.7

392.27

387.34

umol/l

0.10

133

Other diseases of urinary system

1250

3498

2.03

103.89

5.5

4.8

372.89

364.69

umol/l

1.06

1071

3020

Cystitis

1011

2856

2.19

103.74

5.6

4.6

370.25

364.38

umol/l

0.57

876

2440

Other neurotic disorders

136

168

8.62

103.42

6.9

4.8

397.71

361.01

umol/l

1.69

126

145

Other headache syndromes

465

1568

3.01

103.36

4.5

5.9

340.56

374.66

umol/l

5.44

402

1356

Erysipelas

697

2628

2.45

101.91

5.8

4.7

363.55

359.74

umol/l

0.24

599

2234

Other CVD (FINNGEN)

220

327

5.49

101.49

5.2

4.8

363.23

358.34

umol/l

0.15

182

265

Other and unspecified myopathies

203

390

5.48

100.89

5.7

4.8

352.39

349.03

umol/l

0.11

175

341

Sleep disorders (combined)

1262

4231

1.98

100.86

5.6

5.0

368.33

368.51

umol/l

0.01

1104

3684

Cerebrovascular diseases (FINNGEN)

511

1262

2.95

100.40

4.5

5.4

362.03

384.41

umol/l

2.55

453

1081

Exposure to unspecified factor

1249

5014

1.95

100.12

5.0

5.1

360.99

371.22

umol/l

1.45

1078

4364

Vascular dementia

134

161

8.30

99.14

3.5

3.4

321.28

325.32

umol/l

0.09

105

134

Mental and behavioural disorders due to opioids

147

211

7.60

98.79

5.1

5.4

355.05

386.15

umol/l

0.85

119

182

Symptoms and signs concerning food and fluid intake

169

279

6.25

97.90

5.4

4.8

382.65

355.65

umol/l

1.30

148

232

Focal brain injury

126

151

8.67

97.68

4.9

6.0

352.82

380.10

umol/l

0.83

107

125

Bronchitis

1339

4640

1.91

97.27

5.6

4.9

368.66

367.51

umol/l

0.10

1158

4026

Ischaemic Stroke, excluding all haemorrhages

650

1972

2.53

96.95

3.9

4.8

342.80

353.04

umol/l

0.96

549

1661

Bacterial pneumonia (organism specified)

594

2127

2.58

96.63

6.0

4.5

375.30

354.23

umol/l

2.66

525

1792

Psychotic depression

17.13

96.35

3.6

342.12

358.26

umol/l

0.23

Paranoid personality disorder

15.59

96.23

6.4

5.2

379.29

355.79

umol/l

0.55

Explicit Sepsis

510

1810

2.74

94.60

5.5

4.6

358.44

357.65

umol/l

0.04

436

1528

Somnolence, stupor and coma

127

162

8.37

94.13

7.8

5.1

387.80

356.11

umol/l

1.25

118

140

N06DA Anticholinesterases

367

896

3.38

93.31

3.1

3.7

315.80

325.82

umol/l

0.60

293

725

Use of anticholinesterases

367

896

3.38

93.31

3.1

3.7

315.80

325.82

umol/l

0.60

293

725

Memory loss

164

279

6.12

92.53

3.9

4.5

325.13

356.30

umol/l

1.55

141

237

Alzheimer’s disease (Late onset)

264

555

4.16

91.88

3.0

3.4

303.47

321.05

umol/l

0.98

209

442

Persons encountering health services for specific procedures and health care

1374

4611

1.86

91.34

5.1

5.2

367.99

369.91

umol/l

0.17

1214

3991

Emotional disorders and disorders of social functioning with onset specific to childhood

154

246

6.54

91.26

5.7

5.2

375.57

394.42

umol/l

0.74

141

218

External causes of morbidity and mortality

811

1768

2.32

90.46

5.2

4.7

365.19

375.41

umol/l

1.05

705

1526

Use of other anti-dementia drugs

299

711

3.74

90.19

3.0

3.4

305.96

318.18

umol/l

0.69

238

562

Use of memantine

299

711

3.74

90.19

3.0

3.4

305.96

318.18

umol/l

0.69

238

562

Other problems related to primary support group, including family circumstances

254

622

4.13

89.64

5.9

5.5

394.77

385.74

umol/l

0.39

221

554

Undefined dementia

186

329

5.35

89.04

4.5

3.4

344.03

321.25

umol/l

1.08

150

272

Hypotension

249

622

4.12

88.88

4.9

4.1

359.05

340.78

umol/l

1.02

206

519

Symptoms and signs involving emotional state

110

128

9.38

88.23

7.3

5.5

378.79

380.10

umol/l

0.03

100

113

Disorders of the thyroid gland

1137

3849

1.95

87.64

6.2

4.7

382.08

360.32

umol/l

5.19

997

3292

Lung diseases due to external agents

241

595

4.18

87.53

5.8

4.6

350.16

348.04

umol/l

0.07

214

502

Other septicaemia

455

1636

2.77

86.67

5.6

4.3

358.94

351.91

umol/l

0.45

387

1379

Septicaemia

494

1817

2.65

86.04

5.6

4.4

360.06

353.49

umol/l

0.44

421

1534

Dissocial personality disorder

12.68

85.99

8.4

5.3

411.26

359.08

umol/l

1.13

Migraine

506

1644

2.65

85.75

4.3

6.0

343.42

380.25

umol/l

6.07

436

1423

Other external causes of accidental injury

1024

2516

2.06

85.63

5.2

5.0

360.76

376.87

umol/l

2.60

890

2187

Metabolic disorders

1159

3774

1.93

85.32

5.5

5.1

365.96

370.63

umol/l

0.49

1028

3263

Bleeding

983

3585

2.02

85.23

4.6

5.1

353.27

365.83

umol/l

1.81

842

3088

Early onset COPD

343

1089

3.23

85.22

5.9

4.7

362.00

361.27

umol/l

0.03

301

921

Circumscribed brain atrophy

15.02

84.84

5.6

4.1

314.74

352.06

umol/l

0.96

Other CVD

269

744

3.71

83.00

4.8

4.3

353.21

344.80

umol/l

0.37

223

620

Infections, IBD-co-morbidities

208

317

4.87

82.88

5.8

6.2

359.27

400.67

umol/l

3.20

188

274

Assault

291

858

3.51

81.92

6.5

5.5

377.18

373.03

umol/l

0.15

258

758

Persons encountering health services for examination and investigation

808

1842

2.22

81.62

5.2

4.6

370.68

364.24

umol/l

0.54

703

1575

Intestinal infectious diseases

1164

4902

1.87

81.60

5.3

5.1

365.34

369.71

umol/l

0.46

1024

4243

Diseases of the myoneural junction and muscle

224

554

4.19

81.38

5.8

4.9

352.99

355.05

umol/l

0.07

193

481

Social phobias

164

316

5.37

80.92

5.7

5.5

366.87

384.43

umol/l

0.66

145

277

Personality and behavioural disorders due to brain disease, damage and dysfunction

14.75

80.83

4.7

4.8

361.03

356.42

umol/l

0.07

Pain, not elsewhere classified

305

934

3.32

80.09

4.7

5.1

355.85

374.54

umol/l

1.00

269

783

Accidents

1002

2516

2.01

79.13

5.3

5.0

361.83

376.87

umol/l

2.31

869

2187

Diseases of pulp and periapical tissues, including avohilmo

1287

3678

1.83

78.18

5.6

4.6

365.16

367.24

umol/l

0.18

1123

3152

Continuous positive airway pressure

190

353

4.72

77.89

6.5

3.4

353.04

370.60

umol/l

0.72

164

278

Certain infectious and parasitic diseases

1210

3268

1.87

77.45

5.4

4.9

365.28

372.69

umol/l

0.91

1066

2822

Dental pulpitis 4

1284

3690

1.82

76.61

5.6

4.7

365.14

367.60

umol/l

0.23

1121

3161

Other neurological diseases

806

3170

2.07

76.42

4.5

4.9

360.91

360.00

umol/l

0.06

696

2705

Dental pulpitis 1

1283

3691

1.82

76.35

5.6

4.7

365.18

367.53

umol/l

0.21

1120

3163

Dental pulpitis 1, only avohilmo

1311

3826

1.80

75.82

5.7

4.7

364.82

367.55

umol/l

0.26

1154

3273

Dental pulpitis 4, only avohilmo

1305

3818

1.80

74.84

5.7

4.7

364.58

367.66

umol/l

0.30

1146

3268

Other chronic obstructive pulmonary disease, including avohilmo

603

2212

2.30

74.82

5.6

4.5

352.22

352.03

umol/l

0.01

527

1850

Migraine without aura

247

692

3.63

74.64

4.1

5.9

335.40

382.04

umol/l

4.71

216

600

Other acute lower respiratory infections

694

3130

2.14

74.61

5.7

4.9

372.43

365.59

umol/l

0.61

621

2684

Visual disturbances and blindness

606

2725

2.25

74.50

4.5

5.0

366.04

364.73

umol/l

0.07

523

2345

Acute bronchitis

535

2235

2.38

74.30

5.6

4.8

370.44

361.06

umol/l

0.77

472

1896

Diarrhoea and gastroenteritis of presumed infectious origin

884

4156

1.95

73.23

5.3

5.1

365.66

369.14

umol/l

0.30

773

3601

Eating disorder

174

384

4.68

73.09

6.0

5.6

369.10

370.59

umol/l

0.03

144

330

Nausea and vomiting

367

1296

2.83

72.86

5.3

4.8

366.75

366.58

umol/l

0.01

324

1107

Speech and linguistic disorders

224

573

3.91

72.79

5.5

5.3

381.87

393.22

umol/l

0.48

208

520

Type 2 diabetes, definitions combined, including avohilmo

1131

3657

1.85

72.71

6.0

5.0

367.14

369.77

umol/l

0.24

999

3151

All influenza

336

1164

2.94

71.59

6.1

4.9

373.63

365.34

umol/l

0.45

294

997

Symptoms and signs involving the urinary system

882

3521

1.96

71.29

5.7

4.8

360.15

362.10

umol/l

0.15

756

3017

Type 2 diabetes

1176

3898

1.81

70.56

6.0

5.0

366.04

370.27

umol/l

0.45

1044

3359

1322

4007

1.76

70.20

5.4

4.9

363.94

369.93

umol/l

0.73

1148

3472

Dental caries

363

1311

2.79

70.16

6.0

4.8

378.79

373.04

umol/l

0.31

322

1131

Toxic effects of substances chiefly nonmedicinal as to source

226

627

3.73

69.87

5.2

5.4

391.88

366.04

umol/l

1.20

188

551

Other special examinations and investigations of persons without complaint or reported diagnosis

766

1842

2.12

69.84

4.9

4.6

361.13

364.24

umol/l

0.21

660

1575

Type 2 diabetes, definitions combined

1110

3649

1.83

69.62

6.0

5.0

367.92

369.49

umol/l

0.13

984

3139

Type 2 diabetes, strict (exclude DM1)

1110

3656

1.83

69.29

6.0

5.0

367.92

369.38

umol/l

0.12

984

3145

Other chronic obstructive pulmonary disease

502

1761

2.40

69.01

5.4

4.5

347.61

350.87

umol/l

0.19

436

1466

COPD

519

1832

2.37

68.97

5.4

4.5

349.05

351.95

umol/l

0.17

452

1527

Dependent personality disorder

11.15

68.96

6.3

5.7

362.19

369.15

umol/l

0.13

Emotional disorders starting during childhood or adolescence

138

262

5.51

68.87

5.4

5.1

376.72

387.15

umol/l

0.33

127

232

198

506

4.01

68.58

6.2

4.8

371.78

373.57

umol/l

0.06

178

433

Factors influencing health status and contact with health services

409

727

2.85

68.44

5.6

4.2

374.30

359.62

umol/l

1.12

364

620

Volume depletion

158

341

4.79

68.34

6.4

4.5

348.71

338.59

umol/l

0.31

135

287

COPD, hospital admission 2, with asthma infections

388

1245

2.70

68.25

5.7

4.2

350.28

345.81

umol/l

0.23

339

1028

COPD, hospital admissions 3, with asthma pneumonia sepsis

334

989

2.92

67.89

5.8

3.9

345.70

339.36

umol/l

0.33

294

809

Other pulmonary diagnosis

940

2448

1.94

67.18

5.4

4.9

361.94

375.34

umol/l

1.85

827

2127

Chronic viral hepatitis

156

341

4.85

67.04

5.7

6.4

354.26

383.80

umol/l

1.49

136

298

Injury, poisoning and certain other consequences of external causes

620

1374

2.28

66.90

5.1

4.7

363.04

378.27

umol/l

1.57

536

1178

Eating disorders

195

502

4.00

66.89

6.0

5.4

367.00

371.73

umol/l

0.13

162

431

COPD related to multimorbidity

433

1468

2.52

66.09

5.4

4.2

342.42

340.92

umol/l

0.07

374

1209

Covid-19 confirmed case

388

1511

2.61

66.03

5.9

4.9

382.39

360.62

umol/l

2.16

340

1286

Hyperkinetic disorders

236

690

3.49

65.86

4.6

6.0

361.68

388.61

umol/l

1.86

209

614

Disturbance of activity and attention

208

560

3.79

65.68

4.4

5.9

359.99

389.92

umol/l

1.91

185

494

Transport accidents

533

2107

2.27

65.30

5.1

353.64

378.44

umol/l

3.38

458

1828

Injuries to the thorax

551

2522

2.21

64.95

5.6

4.9

355.74

360.88

umol/l

0.34

478

2150

Use of donepezil

226

627

3.54

64.84

3.1

3.5

311.58

322.69

umol/l

0.50

177

501

Asthma, unspecified (mode)

572

2072

2.21

64.47

5.1

4.9

353.46

373.23

umol/l

2.47

505

1791

Asthma, unspecified (mode), excluding more controls

563

2009

2.22

64.20

5.1

4.9

354.36

374.30

umol/l

2.46

497

1740

COPD, early/later onset

503

1855

2.32

64.15

5.4

4.4

347.97

348.69

umol/l

0.04

437

1543

Excluding asthma or asthma-COPD overlap

926

2448

1.91

63.39

5.3

4.9

361.93

375.34

umol/l

1.85

817

2127

Dental caries 3

907

2439

1.92

63.05

5.4

4.4

361.40

365.93

umol/l

0.38

785

2062

Hydrocephalus

141

297

4.93

62.96

4.9

4.6

386.02

349.50

umol/l

1.82

125

258

Supplementary factors related to causes of morbidity and mortality classified elsewhere

419

1732

2.46

62.87

5.4

5.1

379.98

364.89

umol/l

0.92

359

1504

Speech disturbances, not elsewhere classified

160

374

4.44

62.78

4.3

4.9

362.76

351.61

umol/l

0.39

135

319

Type 2 diabetes, wide definition

887

3089

1.89

62.56

5.7

4.8

353.64

366.97

umol/l

1.96

779

2641

Other nutritional deficiencies

746

3780

1.95

62.34

6.1

5.1

359.01

374.23

umol/l

2.01

655

3286

Other eating disorders

116

208

5.83

62.16

6.5

5.7

348.92

370.98

umol/l

0.73

179

Dentinal caries

319

1156

2.80

61.97

6.2

4.9

380.46

370.81

umol/l

0.54

282

998

Dental caries 1

851

2256

1.94

61.66

5.5

4.4

362.79

363.83

umol/l

0.07

738

1903

Habit and impulse disorders

10.18

61.59

6.8

5.3

396.48

365.63

umol/l

0.77

Biguanides

1074

3758

1.78

61.51

5.8

5.0

362.00

368.48

umol/l

0.77

941

3229

Dental caries, including avohilmo

849

2253

1.94

61.37

5.4

4.4

362.23

363.70

umol/l

0.10

736

1900

Visual disturbances

545

2541

2.17

61.37

4.4

5.0

359.14

365.74

umol/l

0.45

468

2186

ILD differential diagnosis

917

2444

1.89

61.28

5.4

4.9

362.59

375.83

umol/l

1.80

810

2125

Other viral hepatitis

165

404

4.29

61.24

5.7

6.4

356.47

380.10

umol/l

1.15

143

351

COPD differential diagnosis

917

2445

1.89

61.22

5.4

4.9

362.39

375.90

umol/l

1.86

809

2126

Asthma

859

2415

1.92

61.14

4.9

355.88

375.45

umol/l

3.20

748

2098

COPD, hospital admissions

493

1849

2.29

60.86

5.4

4.3

347.85

348.46

umol/l

0.03

428

1541

Invasive ventilation

148

334

4.62

60.86

7.0

4.8

373.68

361.59

umol/l

0.28

126

292

Asthma, excluding more controls

842

2339

1.93

60.85

4.9

357.31

376.54

umol/l

3.05

734

2034

Injuries to the abdomen, lower back, lumbar spine and pelvis

477

2105

2.28

60.46

5.9

4.8

359.08

361.08

umol/l

0.11

414

1791

Asthma-related pneumonia

434

1853

2.37

60.28

5.2

4.7

354.97

359.32

umol/l

0.24

377

1564

Asthma-related pneumonia or sepsis

435

1860

2.37

60.20

5.2

4.7

355.48

359.21

umol/l

0.20

378

1569

Asthma, hospital admissions 3, pneumonia

435

1860

2.37

60.20

5.2

4.7

355.48

359.21

umol/l

0.20

378

1569

Other (not insulin) diabetes medications

1096

3793

1.76

60.18

5.9

5.0

364.77

368.93

umol/l

0.43

969

3262

Dental caries 3, only avohilmo

919

2525

1.88

60.04

5.4

4.5

360.92

366.61

umol/l

0.52

793

2137

Diabetes mellitus

1205

4252

1.70

59.43

5.9

5.0

365.15

371.29

umol/l

0.76

1067

3682

Traumatic subarachnoid haemorrhage

10.62

59.42

4.7

5.9

341.27

365.24

umol/l

0.44

Diabetes, varying definitions

1200

4242

1.70

59.09

6.0

5.0

365.42

371.04

umol/l

0.67

1063

3671

Diffuse brain injury

104

8.04

58.17

4.8

6.4

333.87

367.67

umol/l

0.86

Poisoning by medicine, drug-induced

10.74

58.16

7.0

5.9

399.03

367.77

umol/l

0.86

Fracture of skull and facial bones

296

1082

2.79

57.25

5.7

5.3

371.89

367.25

umol/l

0.19

262

940

Parkinson's disease, including avohilmo

207

617

3.44

57.19

6.1

4.0

370.71

342.53

umol/l

1.80

188

516

Cutaneous abscess, furuncle and carbuncle

352

1405

2.55

57.04

5.8

5.2

368.93

371.08

umol/l

0.08

311

1223

Infections of the skin and subcutaneous tissue

715

3758

1.92

56.92

5.6

5.2

367.29

372.11

umol/l

0.36

630

3270

Diseases of pulp and periapical tissues

417

1798

2.35

56.83

5.9

4.9

369.83

370.66

umol/l

0.04

362

1548

Alzheimer’s disease (Atypical or mixed)

110

206

5.47

55.77

2.6

3.3

299.43

332.57

umol/l

1.59

166

Acute upper respiratory infections of multiple and unspecified sites

888

3725

1.80

55.62

5.9

5.0

367.42

373.99

umol/l

0.67

769

3235

Fracture of rib(s), sternum and thoracic spine

363

1496

2.47

54.89

5.5

4.7

351.75

359.48

umol/l

0.45

312

1270

12.43

54.82

6.6

5.0

391.37

348.20

umol/l

1.09

Agoraphobia

109

7.64

54.68

5.2

5.6

385.37

388.20

umol/l

0.03

Obesity

696

3653

1.91

54.67

6.1

5.1

358.04

374.44

umol/l

2.14

614

3178

Cerebral palsy and other paralytic syndromes

195

577

3.48

54.66

5.3

5.2

397.92

365.41

umol/l

2.01

178

500

Other sleep disorders

145

349

4.25

54.55

6.3

5.8

377.95

371.49

umol/l

0.20

133

296

Obesity and other hyperalimentation

697

3661

1.90

54.50

6.1

5.1

358.09

374.38

umol/l

2.12

615

3185

Migraine with aura

241

809

3.02

54.34

3.9

6.0

337.49

379.11

umol/l

4.02

209

700

Viral hepatitis

169

460

3.83

54.05

5.6

6.1

356.10

376.80

umol/l

0.99

147

404

Parkinson's disease

197

591

3.41

53.90

6.1

4.0

373.24

340.53

umol/l

2.17

178

493

Dental pulpitis 2, only avohilmo

760

2036

1.92

53.74

5.3

4.4

361.92

364.34

umol/l

0.16

660

1715

Dental caries 1, only avohilmo

850

2362

1.85

53.72

5.4

4.4

360.37

364.76

umol/l

0.36

734

1996

Specific development disorders of speech and language

137

309

4.46

53.17

5.8

5.3

392.65

386.78

umol/l

0.16

127

282

Previous suicide attempt

13.62

52.59

7.4

5.6

379.93

373.82

umol/l

0.08

Dental pulpitis 2

740

1991

1.92

51.78

5.3

4.4

362.32

364.46

umol/l

0.14

642

1680

Dental caries 3 and operation codes

973

2869

1.75

51.30

5.4

4.5

358.15

366.44

umol/l

0.92

832

2439

Unknown and unspecified causes of morbidity

116

248

4.81

50.80

6.4

5.1

384.09

363.57

umol/l

0.79

107

210

Toxic effect of other and unspecified substances

10.21

50.56

5.1

5.4

373.08

369.29

umol/l

0.05

Abnormalities of gait and mobility

166

466

3.66

50.43

5.6

4.6

388.37

350.74

umol/l

2.49

149

398

179

5.57

50.05

6.6

3.8

376.77

346.59

umol/l

1.08

158

Asthma (mode)

808

2444

1.83

49.88

4.9

355.10

375.83

umol/l

3.42

704

2125

Pain in limb

922

3897

1.72

49.53

5.2

354.10

373.44

umol/l

3.23

793

3418

Normal-pressure hydrocephalus

165

5.83

49.39

5.0

3.6

392.36

343.97

umol/l

2.00

139

Injuries to the ankle and foot

820

4277

1.76

49.36

5.4

366.30

375.43

umol/l

0.94

715

3752

Diabetes medication

1162

4354

1.63

49.20

5.8

5.0

363.81

370.69

umol/l

0.88

1025

3766

Asthma, hospital admission 2, infections

669

3578

1.86

48.52

5.0

5.1

354.53

370.68

umol/l

2.07

576

3094

Asthma-related infections

669

3578

1.86

48.52

5.0

5.1

354.53

370.68

umol/l

2.07

576

3094

Mixed disorders of conduct and emotions

147

6.21

47.75

6.6

5.1

394.34

377.22

umol/l

0.41

129

Personal history of risk-factors, not elsewhere classified

10.23

47.46

7.5

5.5

378.02

367.26

umol/l

0.18

Low back pain

862

3868

1.73

47.40

5.2

353.91

371.73

umol/l

3.05

746

3355

Dental caries 1 and operation codes

917

2720

1.74

47.40

5.4

4.5

360.70

364.70

umol/l

0.33

780

2311

Alzheimer’s disease (Early onset)

132

6.29

46.68

3.1

4.4

317.03

352.32

umol/l

1.07

111

Hypokalaemia

152

424

3.67

46.59

4.8

5.0

342.27

357.56

umol/l

0.61

129

369

Type of accident

358

1583

2.30

46.22

5.2

5.1

375.55

364.75

umol/l

0.51

306

1373

Somatoform disorder

188

603

3.17

46.07

4.3

4.9

355.55

368.17

umol/l

0.43

163

530

Gingivitis and periodontal diseases

986

3033

1.69

45.89

5.7

4.8

373.49

365.80

umol/l

0.84

858

2606

Malignant neoplasm of brain

163

5.73

45.87

2.9

5.7

356.85

371.07

umol/l

0.36

144

Other diseases of intestines

1215

4469

1.59

45.84

5.6

5.0

365.19

371.79

umol/l

0.81

1075

3867

Pain in throat and chest

966

3544

1.68

45.48

5.6

5.1

365.54

372.74

umol/l

0.77

855

3080

Other soft tissue disorders, not elsewhere classified

1085

4149

1.63

45.44

5.2

5.3

354.77

373.13

umol/l

3.39

930

3635

Specific development disorders of scholastic skills

109

241

4.69

45.36

4.9

5.2

375.33

378.08

umol/l

0.06

104

220

Symptoms and signs involving the circulatory and respiratory systems

1193

3754

1.60

45.02

5.5

5.2

368.74

374.29

umol/l

0.64

1055

3267

Mental and behavioural disorders due to tobacco

138

370

3.85

44.99

6.5

5.4

365.31

370.63

umol/l

0.15

127

328

Abnormalities of breathing

1024

3714

1.65

44.94

5.4

5.1

371.96

373.34

umol/l

0.10

898

3234

Vascular dementia (undefined)

9.20

44.76

3.8

3.0

314.50

322.27

umol/l

0.12

Diagnoses used for exclusion with ILD

306

1286

2.42

44.43

5.5

4.7

349.07

358.16

umol/l

0.50

271

1102

Injuries to the hip and thigh

488

2253

2.00

43.91

4.3

4.7

343.26

356.22

umol/l

1.16

406

1905

Fracture of lower leg, including ankle

618

3373

1.84

43.87

5.4

5.3

370.11

370.71

umol/l

0.03

545

2914

Persons encountering health services for specific procedures, not carried out

136

368

3.82

43.79

6.3

5.5

358.47

367.03

umol/l

0.27

116

312

Poisoning by narcotics and psychodysleptics [hallucinogens]

8.47

43.67

5.6

5.5

382.84

356.01

umol/l

0.45

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

142

399

3.66

43.21

5.8

5.3

380.15

369.79

umol/l

0.32

128

337

Wide developmental disorders

203

5.03

43.14

6.2

5.4

390.23

375.77

umol/l

0.38

187

Sequelae of injuries of head

115

280

4.29

43.06

3.5

5.8

339.40

366.11

umol/l

0.95

251

Acute upper respiratory infections

1125

4462

1.59

43.05

5.5

4.9

362.44

369.66

umol/l

0.89

982

3859

Diseases of oral cavity, salivary glands and jaws

990

3083

1.66

42.93

5.5

4.8

364.84

366.93

umol/l

0.16

864

2650

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1055

4018

1.61

42.80

5.5

5.0

356.96

371.62

umol/l

2.67

927

3475

Asthma (only as main-diagnosis), excluding more controls

704

2339

1.81

42.66

4.9

355.32

376.54

umol/l

3.18

611

2034

Irregular menses

477

1943

2.01

42.51

5.7

5.3

376.69

382.80

umol/l

0.40

412

1713

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

111

266

4.36

42.45

3.2

5.3

352.02

365.42

umol/l

0.41

103

234

Asthma (only as main-diagnosis)

712

2415

1.79

42.15

4.9

354.21

375.45

umol/l

3.23

617

2098

Parodontitis

950

4311

1.64

42.14

5.7

5.0

373.94

365.12

umol/l

1.13

827

3737

Codes for special purposes

509

2657

1.94

42.14

5.7

5.1

377.92

367.74

umol/l

0.85

444

2297

Provisional assignment of new diseases of uncertain etiology

508

2654

1.93

41.95

5.7

5.1

377.85

367.72

umol/l

0.85

443

2296

Parodontitis or operation codes

950

4316

1.63

41.81

5.7

5.0

373.94

365.04

umol/l

1.15

827

3741

Parodontitis and operation codes

896

4247

1.65

41.69

5.8

5.0

376.40

365.51

umol/l

1.50

780

3679

Chronic periodontitis, including avohilmo

945

4312

1.63

41.67

5.7

5.0

374.65

365.18

umol/l

1.26

822

3738

Use of rivastigmine

149

443

3.42

41.25

3.0

3.5

323.36

331.19

umol/l

0.26

119

349

Fracture of shoulder and upper arm

408

1992

2.07

40.89

5.0

5.1

357.78

366.59

umol/l

0.57

363

1715

Other and unspecified drugs and medicaments

135

386

3.61

40.08

6.0

5.3

381.96

368.39

umol/l

0.44

121

336

Retention of urine

346

1336

2.21

39.97

5.5

4.3

363.76

348.40

umol/l

1.11

296

1120

Intentional self-harm by unspecified means

9.39

39.84

7.2

5.9

402.23

391.10

umol/l

0.17

Codeine

1080

3774

1.58

39.55

4.9

5.4

345.82

378.96

umol/l

11.12

943

3274

Smoking dependency

138

406

3.50

39.23

6.5

5.5

365.31

364.26

umol/l

0.03

127

361

Special screening examination for infectious and parasitic diseases

286

896

2.41

39.19

6.3

5.2

373.45

374.01

umol/l

0.02

245

777

Transient ischemic attack

461

1957

1.97

39.03

4.2

4.7

349.56

352.12

umol/l

0.14

391

1646

Polyuria

250

1020

2.49

38.84

5.7

4.5

354.71

355.14

umol/l

0.01

203

870

Disorders of ocular muscles, binocular movement, accommodation and refraction

525

2819

1.87

38.82

5.3

5.2

395.81

369.64

umol/l

3.20

463

2471

Problems related to social environment

110

6.31

38.30

5.5

5.2

417.69

366.02

umol/l

2.23

Malignant neoplasm of eye, brain and central nervous system

207

4.65

38.19

2.9

5.7

351.25

366.70

umol/l

0.42

182

Glucagon-like peptide-1 (GLP-1) analogues

529

2357

1.86

37.84

5.5

4.5

344.40

358.79

umol/l

1.55

461

1985

Statin medication

826

2796

1.67

37.54

5.8

5.4

372.13

376.03

umol/l

0.33

739

2427

Dental operations

671

1949

1.78

37.48

5.2

4.4

356.47

359.85

umol/l

0.22

569

1653

Other and unspecified effects of external causes

332

1555

2.16

37.30

5.7

5.3

356.70

371.18

umol/l

0.95

287

1351

Dental operations, only avohilmo

711

2100

1.75

37.28

5.2

4.5

356.34

358.21

umol/l

0.12

612

1780

Vocal cord dysfunction

214

4.30

37.15

5.4

3.2

347.13

363.12

umol/l

0.43

179

Fracture of lumbar spine and pelvis

238

968

2.49

37.13

5.5

4.5

352.69

352.05

umol/l

0.02

201

815

Hard cardiovascular diseases

764

2930

1.69

37.13

4.6

5.2

356.60

367.01

umol/l

1.16

669

2517

Aneurysms, operations, SAH

178

627

2.89

37.10

3.8

5.1

357.45

358.08

umol/l

0.02

147

544

Amenorrhoea

107

275

3.99

37.02

5.5

5.2

371.75

376.63

umol/l

0.11

236

Open wound of forearm

150

482

3.20

36.96

5.4

360.15

373.07

umol/l

0.52

129

422

Symptoms and signs involving the digestive system and abdomen

1161

3807

1.54

36.76

5.3

5.1

365.69

371.98

umol/l

0.71

1010

3289

Assault by bodily force

149

480

3.20

36.66

6.1

5.9

362.06

378.14

umol/l

0.67

135

419

Lower back pain or/and sciatica

1075

4880

1.54

36.38

5.1

353.37

369.05

umol/l

2.95

939

4213

Autism

134

5.64

36.35

6.5

5.6

400.32

355.21

umol/l

1.54

123

Diabetes, insulin treatment (Kela reimbursement)

1079

4305

1.54

36.22

5.5

5.1

356.72

371.69

umol/l

2.85

948

3726

Injuries to the elbow and forearm

738

4048

1.66

35.97

4.9

5.2

360.46

373.00

umol/l

1.31

628

3543

Vascular dementia (subcortical)

9.49

35.85

2.9

3.3

301.89

325.80

umol/l

0.43

Cardiovascular diseases (excluding rheumatic etc)

797

2792

1.66

35.82

5.7

5.5

370.79

385.37

umol/l

1.71

702

2457

Obesity, other/unspecified

368

1821

2.04

35.69

6.0

5.1

354.49

372.89

umol/l

1.44

330

1581

Viral pneumonia

160

544

3.00

35.64

7.2

4.9

403.12

364.59

umol/l

2.49

138

469

Abnormalities of heart beat

362

1770

2.05

35.30

5.2

4.8

359.87

362.77

umol/l

0.14

311

1501

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

122

357

3.52

35.03

3.1

5.2

344.49

363.66

umol/l

0.74

113

312

504

2764

1.83

34.92

5.1

5.3

358.26

373.36

umol/l

1.49

433

2406

Anankastic personality disorder

146

5.20

34.82

4.9

5.7

355.34

367.66

umol/l

0.28

126

Cardiovascular diseases

773

2545

1.67

34.80

5.5

372.80

385.86

umol/l

1.31

683

2237

Chronic lower respiratory diseases

1312

4839

1.47

34.73

5.2

5.1

360.07

373.13

umol/l

2.50

1147

4201

Assault by blunt object

7.47

34.54

7.2

6.5

409.76

366.75

umol/l

0.50

Maltreatment syndromes

112

315

3.69

34.28

6.0

5.6

363.56

378.00

umol/l

0.36

101

274

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

994

4657

1.54

34.07

5.1

364.38

368.88

umol/l

0.41

858

4050

Hyperosmolality and hypernatraemia

9.67

33.82

8.2

4.2

376.30

355.90

umol/l

0.30

Injuries to the wrist and hand

1042

4998

1.52

33.79

5.2

5.1

366.36

370.29

umol/l

0.37

892

4364

Disorders of thyroid, IBD co-morbidities

151

355

3.13

33.74

5.4

6.4

377.80

399.48

umol/l

0.95

126

309

Dysphagia

255

1120

2.31

33.59

5.1

4.6

364.17

359.11

umol/l

0.20

217

948

Event of undetermined intent

117

346

3.50

33.14

4.9

5.8

349.05

378.33

umol/l

1.11

101

309

Injuries to the knee and lower leg

1254

4910

1.47

33.10

5.1

364.88

369.63

umol/l

0.52

1087

4260

Obesity due to excess calories

474

2626

1.82

32.71

6.2

5.2

349.85

372.81

umol/l

2.99

418

2286

Neuromuscular dysfunction of bladder

120

363

3.38

32.64

4.5

5.1

359.97

352.65

umol/l

0.19

314

Exclusions for E4_PCOS_CONSORTIUM

748

2883

1.64

32.50

5.7

5.2

370.03

375.39

umol/l

0.37

637

2543

Other and unspecified injuries of head

256

3.91

32.48

5.2

350.45

360.72

umol/l

0.27

225

Disorders of speech understanding and production

225

4.14

32.47

5.7

5.0

373.62

388.84

umol/l

0.42

208

Leisure time condition

222

936

2.41

32.25

5.6

5.0

380.15

366.18

umol/l

0.69

187

813

Polycystic ovarian syndrome, consortium definition

644

2297

1.70

32.20

5.3

5.1

368.92

375.94

umol/l

0.52

542

2006

Obesity related asthma

355

1803

1.99

32.08

5.3

5.2

349.03

370.31

umol/l

2.07

313

1560

Aplastic and other anaemias

410

2070

1.89

31.82

4.7

4.3

351.69

349.57

umol/l

0.10

348

1725

Hypertension, essential

842

3046

1.59

31.67

5.3

5.5

358.55

378.49

umol/l

3.42

750

2638

Subarachnoid haemorrhage

122

380

3.28

31.62

3.8

5.1

365.37

350.25

umol/l

0.49

338

Cluster headache, wide

128

5.25

31.53

2.8

6.6

313.90

375.59

umol/l

2.18

110

Strabismus

307

1487

2.09

31.53

5.0

5.2

390.77

370.31

umol/l

1.24

271

1300

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

8.10

31.48

4.8

5.7

397.41

373.11

umol/l

0.36

Other anaemias

381

1924

1.93

31.27

4.8

4.3

353.77

347.33

umol/l

0.36

324

1598

Other and unspecified anaemias

379

1916

1.93

31.27

4.8

4.3

352.96

347.42

umol/l

0.29

322

1590

Fracture of femur

256

1053

2.25

31.21

4.3

4.4

341.23

344.68

umol/l

0.13

209

888

Exposure to other specified factors

786

4713

1.57

31.15

5.2

356.14

374.12

umol/l

2.38

684

4110

Follow-up examination after treatment for conditions other than malignant neoplasms

397

1348

1.94

31.02

5.5

4.6

359.38

363.09

umol/l

0.19

350

1145

Other strabismus

261

1198

2.20

30.76

5.1

5.2

401.20

369.44

umol/l

2.12

234

1052

Other bacterial intestinal infections

199

818

2.47

30.56

5.8

4.7

357.58

355.84

umol/l

0.06

178

696

COPD, hospital admissions 1, only main diagnosis

326

1381

2.03

30.36

5.3

4.2

349.28

343.43

umol/l

0.31

287

1142

Diseases of the respiratory system

662

1988

1.68

30.18

5.0

4.9

361.98

375.78

umol/l

1.54

575

1734

Acute alcohol intoxication ICD-9

122

5.28

30.14

6.4

4.2

364.01

348.77

umol/l

0.29

109

Opioids

1085

3861

1.48

29.55

4.9

5.4

346.79

379.56

umol/l

11.23

946

3349

Tramadol

823

3412

1.56

29.51

4.5

5.4

338.80

377.46

umol/l

11.70

695

2956

Cerebral cysts

265

3.70

29.42

4.9

5.8

370.47

373.10

umol/l

0.06

236

Hypertensive diseases (excluding secondary)

611

2122

1.69

29.27

5.8

5.7

364.41

384.87

umol/l

2.74

550

1864

Diplopia

157

590

2.71

29.12

5.2

5.0

371.60

356.57

umol/l

0.57

135

517

Cluster headache, strict

126

5.10

29.05

2.9

6.6

312.07

375.90

umol/l

2.19

109

Codeine or tramadol medication

1195

4600

1.45

28.94

4.9

5.2

345.07

372.75

umol/l

8.98

1037

3981

Superficial injury of hip and thigh

163

627

2.64

28.78

4.3

4.8

333.39

359.52

umol/l

1.47

142

548

Anorexia (incl.atypical)

250

3.73

28.72

6.3

5.2

363.42

370.26

umol/l

0.16

214

Agranulocytosis

142

511

2.84

28.67

6.8

5.2

395.55

364.29

umol/l

1.58

128

447

Visual field defects

117

378

3.17

28.66

3.8

5.1

346.88

352.55

umol/l

0.14

102

330

Autism spe

153

4.71

28.46

6.2

5.6

403.25

366.20

umol/l

1.14

141

Used for control exclusion in common control thyroid runs

1143

4010

1.45

27.81

5.6

4.9

370.94

367.35

umol/l

0.33

987

3490

Fracture of foot, except ankle

272

1329

2.07

27.52

5.7

5.3

366.48

371.53

umol/l

0.21

242

1160

Abdominal and pelvic pain

1099

3804

1.46

27.43

5.3

5.1

363.99

371.89

umol/l

0.94

960

3286

Sleep apnoea

925

4226

1.49

27.41

5.3

5.2

360.92

369.36

umol/l

1.04

800

3691

Migraine without aura and triptan purchases

197

850

2.35

27.23

3.7

5.9

332.16

381.98

umol/l

4.44

172

737

Enterocolitis due to Clostridium difficile

126

439

2.93

27.00

5.2

4.7

350.52

348.54

umol/l

0.05

110

374

Paralytic ileus and intestinal obstruction

255

1225

2.10

26.94

5.7

4.5

354.51

359.96

umol/l

0.24

228

1021

Bacterial intestinal infections, IBD co-morbidities

196

849

2.34

26.83

5.7

4.8

353.52

355.70

umol/l

0.08

174

728

Acute renal failure

211

944

2.27

26.77

5.1

4.6

336.67

352.61

umol/l

0.83

185

801

Exclusions for E4_PCOS_BROAD

210

938

2.27

26.75

6.5

5.1

374.79

375.55

umol/l

0.02

191

828

Sleep apnoea, including avohilmo

983

4365

1.47

26.71

5.4

5.2

360.09

370.99

umol/l

1.60

861

3804

Cramp and spasm

227

3.79

26.56

6.5

5.7

376.35

361.90

umol/l

0.37

197

Progressive vascular leukoencephalopathy

6.41

26.32

3.3

3.2

313.46

336.16

umol/l

0.41

Heart failure and antihypertensive medication

245

748

2.19

26.23

5.3

4.9

356.56

366.27

umol/l

0.48

223

630

Other/unspecified dorsalgia

393

2192

1.80

26.19

4.7

5.2

348.83

369.14

umol/l

2.06

341

1896

Symptoms and signs involving speech and voice

311

1626

1.93

25.93

4.3

4.9

347.31

365.77

umol/l

1.38

261

1387

Fall on and from stairs and steps

264

1306

2.05

25.85

5.2

4.9

365.44

363.01

umol/l

0.10

227

1123

Diseases of the skin and subcutaneous tissue

1112

3893

1.44

25.83

5.3

5.1

356.91

371.79

umol/l

2.65

976

3382

Complications of medical and surgical care

683

4199

1.55

25.75

5.3

4.9

353.36

365.28

umol/l

1.32

594

3617

Dorsalgia

1084

4100

1.44

25.56

4.9

5.2

351.60

373.02

umol/l

4.88

935

3554

Sleep disorders, other/unspecified

153

4.42

25.56

5.9

377.60

370.74

umol/l

0.12

138

Superficial injury of lower leg

261

1291

2.04

25.56

5.3

5.4

361.43

370.47

umol/l

0.43

225

1112

Chronic periapical parodontitis

210

961

2.21

25.22

4.9

4.7

367.29

365.84

umol/l

0.05

181

823

Intermittent heterotropia

314

3.24

25.12

5.2

410.10

375.99

umol/l

1.00

282

Visual impairment including blindness (binocular or monocular)

264

3.45

25.09

5.3

5.0

409.13

360.48

umol/l

1.93

231

Other or unspecified ileus, impaction or obstruction

190

837

2.30

25.00

5.8

4.6

350.66

356.77

umol/l

0.22

171

700

Heart failure,strict

432

1792

1.75

24.96

4.6

4.3

343.24

350.43

umol/l

0.48

371

1495

Disorders of other endocrine glands

426

2438

1.73

24.93

6.4

4.9

373.17

367.56

umol/l

0.34

370

2100

Renal failure

387

1999

1.78

24.78

5.4

4.3

338.70

347.21

umol/l

0.54

335

1664

8.89

24.75

9.0

4.6

379.39

363.51

umol/l

0.20

Bulimia nervosa (incl. atypical)

120

4.81

24.67

6.2

5.7

371.62

360.14

umol/l

0.12

103

Hypertension

835

3167

1.50

24.54

5.3

5.4

359.52

378.78

umol/l

3.22

742

2750

Hypertensive diseases

835

3168

1.50

24.53

5.3

5.4

359.52

378.82

umol/l

3.23

742

2751

Other disorders of teeth and supporting structures

206

948

2.20

24.40

5.2

4.7

371.02

362.66

umol/l

0.34

177

804

Special screening examination for other diseases and disorders

278

3.32

24.40

5.2

4.7

358.24

349.55

umol/l

0.19

241

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

211

3.72

24.35

4.1

4.5

348.39

343.90

umol/l

0.10

184

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

103

337

3.10

24.16

5.7

5.6

393.33

398.97

umol/l

0.15

302

Injuries to the shoulder and upper arm

824

4706

1.48

23.98

4.8

5.1

358.64

367.35

umol/l

0.94

723

4068

Benign neoplasm of meninges

116

413

2.87

23.97

3.7

5.2

348.95

361.92

umol/l

0.54

109

358

Hyperkinetic disorders (excl. ADHD)

119

4.87

23.88

5.1

5.6

381.63

397.63

umol/l

0.29

111

Decubitus ulcer and pressure area

229

3.59

23.88

5.0

4.4

331.10

353.94

umol/l

0.60

197

Subjective visual disturbances

237

1167

2.05

23.55

3.8

5.0

353.54

364.35

umol/l

0.52

205

1004

Other general symptoms and signs

156

4.15

23.51

6.5

5.2

355.67

375.14

umol/l

0.47

132

Other diseases of hard tissues of teeth

594

2816

1.58

23.42

5.4

4.9

368.81

371.28

umol/l

0.15

521

2443

All influenza (not pneumonia)

172

748

2.33

23.41

5.8

5.2

371.69

370.27

umol/l

0.04

146

641

Other diseases of the respiratory system

197

907

2.20

23.35

5.9

4.4

355.57

347.98

umol/l

0.34

171

760

Other respiratory disorders and diseases

197

907

2.20

23.35

5.9

4.4

355.57

347.98

umol/l

0.34

171

760

Genitourinary diseases

727

2387

1.54

23.27

5.3

5.2

367.59

377.63

umol/l

1.00

642

2095

Weight loss

120

445

2.75

22.99

4.9

364.90

361.46

umol/l

0.09

102

381

Pure hypercholesterolaemia

636

2760

1.55

22.85

4.9

348.62

365.81

umol/l

2.30

557

2355

Complications of surgical and medical care, not elsewhere classified

936

4706

1.43

22.85

5.0

5.1

348.57

369.05

umol/l

3.75

808

4077

Disorders of lipoprotein metabolism and other lipidaemias

736

3084

1.51

22.74

4.9

5.0

351.25

367.53

umol/l

2.35

645

2641

Autoimmune diseases

1157

4260

1.39

22.59

5.5

4.9

370.66

367.81

umol/l

0.25

992

3711

Benign neoplasm of meninges

116

427

2.77

22.54

3.7

5.0

348.95

366.49

umol/l

0.82

109

364

Benign neoplasm: Cerebral meninges

107

378

2.89

22.47

3.6

5.2

348.36

363.63

umol/l

0.63

102

329

Other and unspecified intracranial injuries

130

4.48

22.45

5.8

5.3

361.82

365.19

umol/l

0.05

116

Unspecified urinary incontinence

100

341

2.99

22.37

6.5

4.7

369.96

369.99

umol/l

0.00

292

Inflammatory diseases of the central nervous system

114

418

2.79

22.35

4.5

5.5

346.97

372.72

umol/l

1.15

370

Fall involving bed

103

4.94

22.17

5.7

4.1

406.75

350.74

umol/l

1.81

Migraine with aura and triptan purchases

171

764

2.27

21.89

3.8

5.9

332.30

382.36

umol/l

4.20

145

655

Benign neoplasm: Cerebral meninges

107

385

2.84

21.74

3.6

5.1

348.36

368.07

umol/l

0.91

102

330

Other diseases of blood and blood-forming organs, wide

221

1094

2.04

21.71

6.4

5.0

393.35

365.06

umol/l

2.02

193

942

Fall on same level involving ice and snow

537

3435

1.57

21.69

5.2

5.1

363.03

368.03

umol/l

0.35

475

2966

Other disorders starting during childhood or adolescence

335

2.99

21.61

5.6

5.1

394.76

391.12

umol/l

0.09

300

Venous thromboembolism

467

2809

1.62

21.48

5.3

4.7

351.82

357.96

umol/l

0.34

394

2380

Pain (limb, back, neck, head abdominally)

804

2741

1.48

21.46

5.1

359.66

376.80

umol/l

2.48

705

2367

Asthma (diagnoses ohter than nonallergic)

839

5018

1.44

21.38

4.9

5.1

353.86

370.57

umol/l

2.69

731

4344

Sequelae of injuries, of poisoning and of other consequences of external causes

257

1348

1.93

21.38

4.6

5.4

339.42

367.94

umol/l

2.53

211

1172

Dyspnoea

822

4380

1.44

21.20

5.2

5.0

360.75

364.88

umol/l

0.35

715

3772

Cellulitis

224

1131

2.00

20.85

5.2

5.1

364.13

366.63

umol/l

0.07

190

984

Later onset COPD, excluding more controls

148

486

2.40

20.56

4.5

3.4

320.30

332.93

umol/l

0.50

125

387

Extreme obesity with alveolar hypoventilation

175

3.78

20.55

6.4

5.0

379.36

365.68

umol/l

0.31

154

Other complications of surgical and medical care, not elsewhere classified

114

437

2.66

20.49

5.6

5.3

401.42

369.08

umol/l

0.98

100

377

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

233

1203

1.96

20.33

6.2

5.1

365.48

377.58

umol/l

0.72

214

1038

Toxic effect of ethanol

236

3.33

20.11

5.4

5.7

401.40

366.63

umol/l

1.10

206

COPD-related respiratory insufficiency

115

447

2.61

20.08

6.3

4.0

349.89

340.55

umol/l

0.25

101

368

Other and unspecified degenerative diseases of nervous system

5.93

19.92

5.0

4.2

310.46

343.53

umol/l

0.67

Tobacco use

254

3.20

19.71

5.9

5.6

352.72

365.19

umol/l

0.27

220

Blood alcohol or alcohol intoxication level

128

4.24

19.40

7.1

5.7

396.48

374.66

umol/l

0.43

114

Open wound of abdomen, lower back and pelvis

164

3.80

19.35

6.5

5.5

350.07

379.22

umol/l

0.80

147

Diseases of oesophagus, stomach and duodenum

1038

4612

1.37

19.33

4.9

5.2

347.96

371.29

umol/l

5.65

910

3998

Non-ischemic cardiomyopathy

264

1174

1.86

19.23

5.0

4.3

355.71

345.96

umol/l

0.50

225

969

Disorders of refraction and accommodation

264

1440

1.84

19.23

5.7

5.3

407.24

369.25

umol/l

4.02

234

1267

Tubulo-interstitial nephritis, not specified as acute or chronic

284

3.01

19.15

4.8

4.3

354.40

351.81

umol/l

0.06

239

Encephalitis

138

4.07

19.14

4.2

5.5

335.37

371.53

umol/l

1.01

119

Asthma, including avohilmo

1173

5085

1.35

19.07

5.0

5.1

358.71

371.79

umol/l

2.29

1025

4411

Other encephalitis

126

4.21

18.92

4.1

5.9

324.50

380.63

umol/l

2.18

108

Superficial injury of wrist and hand

214

1105

1.96

18.73

5.2

5.4

364.91

371.17

umol/l

0.25

185

969

Undetermined asthma

121

498

2.46

18.70

4.8

4.9

338.90

366.58

umol/l

1.55

102

418

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

380

2319

1.65

18.67

5.2

5.5

369.36

375.68

umol/l

0.32

329

2044

Undetermined asthma, excluding more controls

121

500

2.45

18.54

4.8

4.9

338.90

366.13

umol/l

1.51

102

417

Superficial injury of forearm

121

502

2.45

18.49

5.6

5.3

349.94

369.55

umol/l

0.67

447

Unspecified acute lower respiratory infection

168

801

2.13

18.38

6.5

5.3

388.51

366.67

umol/l

1.33

156

695

Gastrointestinal diseases

667

2266

1.48

18.24

5.5

5.0

362.12

382.25

umol/l

2.69

581

1973

5.07

18.20

6.8

5.2

406.03

377.47

umol/l

0.60

Diseases of external ear

311

1818

1.73

18.14

5.2

4.9

371.53

363.83

umol/l

0.43

268

1562

Any gastric operation

902

3250

1.40

18.13

5.2

358.52

381.81

umol/l

4.65

790

2851

GASTRO-related operations

902

3250

1.40

18.13

5.2

358.52

381.81

umol/l

4.65

790

2851

Diseases of the digestive system

399

2492

1.61

17.79

4.9

4.8

364.22

354.18

umol/l

0.67

345

2113

Brain meningioma, excluding all cancers (controls excluding all cancers)

218

3.25

17.74

3.4

5.0

342.55

366.67

umol/l

0.81

184

Superficial injury of abdomen, lower back and pelvis

163

779

2.12

17.74

5.9

5.1

369.95

366.17

umol/l

0.12

144

686

Brain meningioma

219

3.24

17.62

3.4

5.0

342.55

367.56

umol/l

0.87

187

Open wound of lower leg

150

696

2.18

17.61

5.1

360.36

365.62

umol/l

0.16

124

601

Other diseases of jaws

255

3.03

17.58

5.2

4.9

341.48

359.91

umol/l

0.53

215

Intestinal stricture

266

1510

1.78

17.24

5.5

4.6

353.59

358.33

umol/l

0.21

238

1273

Foreign body in alimentary tract

275

2.95

17.21

6.4

5.4

364.50

365.45

umol/l

0.02

245

Parodontitis or/and operation codes

707

2941

1.44

17.13

6.0

5.4

376.89

368.82

umol/l

0.77

621

2584

Unspecified privation

128

564

2.31

17.11

5.5

5.3

342.58

367.30

umol/l

1.06

110

491

Unspecified event, undetermined intent

132

3.94

17.00

5.3

6.0

314.37

377.04

umol/l

2.22

120

Viral and other specified intestinal infections

245

1333

1.81

16.90

5.2

5.4

367.09

370.50

umol/l

0.13

224

1179

Other symptoms and signs involving the urinary system

111

464

2.43

16.72

6.9

4.9

370.12

354.86

umol/l

0.57

103

399

Dental pulpitis 3

169

590

2.09

16.64

5.1

4.8

361.34

385.44

umol/l

1.26

145

523

Degeneration of the brain due to alcohol

4.67

16.51

5.4

5.3

336.13

363.60

umol/l

0.47

All-cause Heart Failure

450

2102

1.55

16.44

4.5

4.4

340.69

348.84

umol/l

0.59

382

1766

Divergent concomitant strabismus

393

2.54

16.19

5.4

5.6

383.56

368.13

umol/l

0.40

346

Sequelae of external causes of morbidity and mortality

227

1263

1.81

15.82

5.0

4.9

354.91

361.30

umol/l

0.26

196

1075

Suppurative and necrotic conditions of lower respiratory tract

245

2.97

15.74

7.3

5.1

378.66

356.69

umol/l

0.63

220

DVT of lower extremities and pulmonary embolism

340

2109

1.62

15.62

5.3

4.6

348.32

356.28

umol/l

0.45

288

1768

Direct fill therapy

153

752

2.06

15.53

6.4

5.2

391.71

372.61

umol/l

0.86

138

661

Other dorsopathies, not elsewhere classified

1039

4144

1.33

15.31

4.7

5.2

349.73

373.29

umol/l

5.71

893

3597

Mycoses

241

1380

1.76

15.25

5.4

4.9

344.41

360.62

umol/l

0.92

211

1182

Other maltreatment syndromes

213

3.11

15.22

6.0

5.7

373.39

373.69

umol/l

0.01

182

GI-bleeding

269

1588

1.71

15.22

4.6

4.5

354.12

348.56

umol/l

0.25

235

1334

Abnormal weight loss

399

2.47

15.20

4.4

4.9

352.67

359.87

umol/l

0.19

342

Heart failure, strict

453

2155

1.52

15.19

4.5

4.4

340.57

349.37

umol/l

0.67

386

1813

Osteopathies and chondropathies

473

3020

1.49

15.15

4.6

5.1

348.70

366.85

umol/l

1.90

406

2604

Hypothermia

4.65

15.12

6.2

5.0

363.64

364.57

umol/l

0.01

Dental pulpitis 3, only avohilmo

152

539

2.08

15.01

4.6

4.8

360.13

383.28

umol/l

1.08

130

483

Other and unspecified injuries of lower leg

348

2.57

15.00

5.6

5.4

354.56

380.93

umol/l

1.02

301

Injury of other and unspecified intrathoracic organs

314

2.67

14.95

6.6

5.1

368.52

359.71

umol/l

0.21

275

Open wound of wrist and hand

433

2851

1.51

14.85

5.6

5.4

370.42

369.97

umol/l

0.02

365

2496

Burns and corrosions

159

807

2.00

14.79

5.9

5.5

375.71

367.67

umol/l

0.29

151

712

Osteoporosis

190

972

1.88

14.79

4.4

4.6

334.37

353.24

umol/l

1.06

158

832

Other and unspecified iron deficiency

262

1548

1.70

14.78

4.7

4.6

352.22

358.19

umol/l

0.27

221

1302

Degeneration of nervous system due to alcohol

4.22

14.61

5.4

5.1

336.13

363.94

umol/l

0.48

Other heart diseases

494

2209

1.49

14.57

5.4

5.6

371.99

386.96

umol/l

1.45

441

1942

Other fall from one level to another

228

1304

1.76

14.51

5.4

5.1

361.44

366.79

umol/l

0.21

202

1128

Complications of procedures, not elsewhere classified

707

4465

1.37

14.19

4.9

5.1

344.93

369.07

umol/l

4.26

610

3867

Irritable bowel syndrome

242

1417

1.72

14.16

5.1

5.0

342.51

372.00

umol/l

2.58

209

1216

Other diseases of the digestive system

264

1583

1.68

14.14

4.7

4.4

351.88

348.61

umol/l

0.13

229

1327

Respiratory insufficiency

237

2.86

14.10

5.3

3.9

345.88

343.36

umol/l

0.05

185

Diseases of the eye and adnexa

892

3340

1.34

14.10

5.3

5.4

371.05

374.61

umol/l

0.28

772

2929

Evidence of alcohol involvement determined by level of intoxication

5.30

14.05

7.1

6.2

414.41

364.72

umol/l

0.84

Oxycodone

296

1768

1.63

14.04

4.0

4.8

317.30

365.22

umol/l

6.63

248

1482

Injuries involving multiple body regions

186

3.15

13.99

6.4

5.8

350.96

365.13

umol/l

0.28

165

Other diseases of pleura

360

2059

1.56

13.97

5.3

4.3

349.31

347.77

umol/l

0.07

319

1713

Drug-induced neutropenia

331

2.56

13.95

6.8

5.3

394.22

359.59

umol/l

1.31

287

Fracture at wrist and hand level

342

2192

1.57

13.93

5.1

5.4

365.09

372.14

umol/l

0.36

287

1922

Single delivery by forceps and vacuum extractor

759

0.29

13.78

4.1

6.0

345.45

388.10

umol/l

0.70

663

Nutritional anaemias

379

2425

1.53

13.68

4.5

4.6

351.71

356.64

umol/l

0.26

316

2035

Injuries to the neck

224

1306

1.73

13.38

4.6

5.3

354.59

364.02

umol/l

0.38

186

1134

Reimbursement for rheumatic diseases

220

3680

0.59

13.35

3.9

5.2

357.39

368.28

umol/l

0.57

186

3198

Hypoglycaemia, other or unspecified

363

2.44

13.30

5.4

5.3

371.79

365.36

umol/l

0.16

321

Dermatitis and eczema

1028

5222

1.29

13.25

4.8

5.2

368.06

369.05

umol/l

0.07

888

4543

Hemiplegia

241

2.79

13.23

5.2

5.6

356.44

358.68

umol/l

0.04

214

Endovascular or surgical operations to intracerebral aneurysms

247

2.76

13.18

3.3

5.8

353.00

369.79

umol/l

0.36

220

Superficial injury of thorax

149

771

1.95

13.15

5.3

5.0

357.01

362.80

umol/l

0.18

130

669

Other condition

147

758

1.96

13.12

5.2

5.3

380.88

369.57

umol/l

0.24

127

659

Other disorders of glucose regulation and pancreatic internal secretion

102

459

2.26

13.10

5.4

5.1

366.90

363.58

umol/l

0.08

405

Cluster headache, wide,, including avohilmo

277

2.66

13.08

3.2

6.0

322.45

369.30

umol/l

1.82

242

Iron deficiency anaemia

325

2071

1.56

13.04

4.6

4.7

353.88

359.54

umol/l

0.28

270

1742

Cardiac arrhythmias

542

2523

1.43

13.03

4.8

5.3

367.04

380.61

umol/l

1.21

487

2196

Other diseases of lip and oral mucosa

135

678

2.01

12.97

5.3

4.5

353.32

360.47

umol/l

0.26

117

578

Hyperfunction of pituitary gland

244

2.76

12.95

7.0

5.8

388.89

376.87

umol/l

0.29

210

Deposits [accretions] on teeth

310

2.50

12.69

6.5

4.9

393.68

386.62

umol/l

0.15

274

Cluster headache, strict, including avohilmo

264

2.67

12.69

3.2

6.1

321.24

370.87

umol/l

1.89

231

Inflammatory diseases of female pelvic organs

469

2447

1.45

12.68

5.2

376.90

375.02

umol/l

0.10

405

2130

Optic atrophy

4.29

12.64

4.6

5.2

461.23

373.76

umol/l

1.90

Acute sinusitis

473

3078

1.44

12.63

5.5

5.3

359.16

376.52

umol/l

1.71

415

2690

Parodontitis, under 40 years and operation codes

115

553

2.11

12.51

5.9

392.65

373.48

umol/l

0.68

100

482

Pyothorax

188

3.00

12.49

6.8

5.1

372.18

354.71

umol/l

0.38

169

Any operation in hilmo

3.24

12.47

5.5

6.3

355.25

417.18

umol/l

2.03

Parodontitis, operation under 40 years and operation codes

115

554

2.11

12.45

5.9

392.65

373.37

umol/l

0.68

100

483

Fungal Sepsis

142

3.32

12.39

5.2

4.7

311.81

363.09

umol/l

1.16

127

Abnormal findings on diagnostic imaging of central nervous system

211

2.86

12.35

3.3

6.0

370.27

370.74

umol/l

0.01

185

Diseases of salivary glands

159

859

1.87

12.31

5.1

4.7

346.95

365.63

umol/l

0.80

131

731

Benign neoplasm: Brain, supratentorial

4.53

12.29

5.2

4.8

373.72

384.92

umol/l

0.14

Pulmonary heart disease

231

1390

1.67

12.28

5.4

4.6

354.76

352.69

umol/l

0.08

201

1167

Pulmonary embolism

231

1391

1.67

12.25

5.4

4.6

354.76

352.21

umol/l

0.10

201

1167

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

506

3334

1.41

12.19

5.1

4.8

360.48

359.64

umol/l

0.04

436

2834

Toxic effect of alcohol

105

3.75

12.17

4.1

5.5

437.13

358.29

umol/l

2.06

Burns and corrosions of external body surface, specified by site

126

634

2.02

12.13

5.7

5.4

375.55

369.48

umol/l

0.18

120

562

Asthma, hospital admissions , main diagnosis only

752

5097

1.33

12.12

4.8

5.2

353.48

372.41

umol/l

3.03

653

4425

ILD medications: immunosuppressive drugs

290

4273

0.65

12.07

4.5

5.4

348.31

374.83

umol/l

2.61

245

3773

Open wound of hip and thigh

166

3.09

11.98

4.7

6.1

358.13

383.54

umol/l

0.60

148

Noninfectious colitis NAS

136

706

1.95

11.95

4.7

5.2

362.63

369.81

umol/l

0.23

121

611

Excessive, frequent and irregular menstruation

342

1237

1.55

11.91

5.3

5.1

357.85

378.67

umol/l

1.66

277

1072

Diseases of arteries, arterioles and capillaries (FINNGEN)

216

886

1.72

11.89

4.8

5.3

346.48

377.14

umol/l

1.55

188

753

Benign neoplasm: Brain, supratentorial

4.40

11.87

5.2

4.7

373.72

386.15

umol/l

0.16

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

493

3501

1.41

11.84

5.3

4.9

344.73

364.88

umol/l

2.44

425

3001

Other acute viral hepatitis

4.81

11.81

5.3

6.7

315.05

369.18

umol/l

0.95

Open wound of ankle and foot

111

539

2.09

11.79

5.2

5.3

340.31

368.78

umol/l

1.43

467

Fitting and adjustment of other devices

254

1469

1.62

11.75

4.7

4.2

375.32

344.76

umol/l

2.47

209

1198

Pilonidal cyst

110

535

2.09

11.65

6.0

371.83

376.84

umol/l

0.15

100

476

Elevated blood glucose level

405

2.26

11.61

5.3

5.4

381.08

362.32

umol/l

0.52

355

Other viral diseases, not elsewhere classified

189

1094

1.74

11.56

5.1

5.2

379.89

374.20

umol/l

0.24

172

956

Parodontitis, under 40 years

116

579

2.03

11.44

5.9

392.95

372.79

umol/l

0.74

101

506

Postpartum haemorrhage

1319

0.42

11.41

5.3

5.7

375.49

384.32

umol/l

0.19

1148

Assault by unspecified means

130

3.36

11.37

6.7

6.0

364.53

362.47

umol/l

0.03

121

Explicit bacterial Sepsis

409

2.23

11.30

4.8

370.82

352.33

umol/l

0.64

353

Inflammatory disease of uterus

116

581

2.02

11.30

5.2

5.3

383.12

371.53

umol/l

0.32

492

Ulcer of lower limb, not elsewhere classified

118

595

2.00

11.29

5.0

4.6

339.39

351.74

umol/l

0.46

511

Otitis externa

196

1157

1.71

11.28

5.3

5.0

368.94

365.71

umol/l

0.12

175

1002

Parodontitis, under 40 years, or operation codes

116

583

2.02

11.23

5.9

392.95

372.14

umol/l

0.77

101

510

Second line medication for Crohn's disease

240

3773

0.63

11.20

4.6

5.3

351.05

372.40

umol/l

1.56

201

3299

Implicit fungal Sepsis

131

3.28

11.16

5.4

4.5

324.84

365.13

umol/l

0.74

116

L04AX Other immunosuppressants

230

3647

0.63

11.16

4.7

5.3

352.74

371.97

umol/l

1.28

192

3185

Restless leg syndrome

110

544

2.05

11.13

6.1

5.1

377.96

360.18

umol/l

0.75

473

Myalgia

199

1185

1.69

11.09

5.8

5.4

353.65

375.01

umol/l

1.24

170

1026

Acute pharyngitis

157

870

1.81

11.02

5.8

5.4

355.56

378.03

umol/l

1.23

142

769

Ill-defined and unknown causes of mortality

259

2.55

11.01

4.2

4.5

335.96

348.46

umol/l

0.31

225

Embolic stroke

132

3.23

10.96

3.7

4.0

333.00

341.06

umol/l

0.14

119

Non-allergic asthma (mode)

148

804

1.84

10.95

4.4

4.7

365.95

372.34

umol/l

0.20

133

675

Disorders of lens

561

2584

1.37

10.94

4.9

5.0

361.85

368.79

umol/l

0.52

482

2216

Cerebral aneurysm, nonruptured

339

2.33

10.93

3.6

5.5

356.98

363.38

umol/l

0.13

302

Atrial fibrillation and flutter

286

1199

1.57

10.92

5.2

5.5

354.58

385.97

umol/l

3.38

259

1029

Premature rupture of membranes

981

0.39

10.91

4.0

5.6

314.86

381.35

umol/l

2.31

847

Non-allergic asthma (mode), excluding more controls

148

806

1.83

10.87

4.4

4.6

365.95

371.51

umol/l

0.17

133

673

Pulmonary heart disease, diseases of pulmonary circulation

241

1514

1.60

10.84

5.5

4.6

354.85

352.02

umol/l

0.11

209

1271

Use of galantamine

209

2.72

10.81

2.7

3.2

311.69

333.43

umol/l

0.60

174

Dermatitis

502

3653

1.38

10.73

5.0

5.1

363.54

366.83

umol/l

0.19

430

3158

Myopia

126

664

1.92

10.64

6.5

5.3

408.84

366.35

umol/l

2.66

112

577

Chronic periodontitis

120

622

1.95

10.63

4.8

4.6

349.96

359.99

umol/l

0.30

100

523

Scabies

241

2.59

10.58

6.1

6.0

357.89

377.99

umol/l

0.43

215

Dental caries 3 and operation codes, only avohilmo

320

1054

1.53

10.58

5.5

4.9

362.12

380.30

umol/l

1.38

283

904

Erosion of teeth, including avohilmo

193

1115

1.69

10.56

6.2

5.3

351.15

370.21

umol/l

1.10

178

962

Diaphragmatic hernia

281

1841

1.54

10.54

5.0

4.8

337.52

365.89

umol/l

2.67

248

1567

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

453

3250

1.40

10.53

5.2

4.9

345.23

364.21

umol/l

2.04

391

2798

Soft tissue disorders

1039

4297

1.26

10.46

4.8

5.3

355.98

374.08

umol/l

3.23

886

3767

Single delivery by caesarean section

875

0.44

10.42

5.3

6.0

348.17

392.60

umol/l

2.06

769

Candidiasis

117

606

1.95

10.40

6.1

5.3

341.09

364.94

umol/l

0.90

101

529

Other noninfective gastroenteritis and colitis

216

1336

1.63

10.38

5.0

4.9

359.82

370.97

umol/l

0.54

185

1154

Chromosomal abnormalities, not elsewhere classified

127

3.25

10.36

4.3

5.7

423.00

396.36

umol/l

0.50

116

Parkinson's disease, strict definition

108

545

2.00

10.35

5.4

3.9

366.33

342.18

umol/l

0.93

100

453

Unspecified kidney failure

393

2.19

10.29

5.9

4.3

351.03

338.99

umol/l

0.32

329

Symptoms and signs involving the skin and subcutaneous tissue

571

4250

1.34

10.24

5.1

5.0

350.13

368.65

umol/l

2.42

510

3672

Attention to artificial openings

149

3.02

10.21

5.0

4.0

350.71

346.97

umol/l

0.05

128

Fracture of forearm

447

3016

1.39

10.10

4.7

5.1

359.75

370.39

umol/l

0.82

377

2630

Other gastritis (incl. Duodenitis)

184

1102

1.68

10.08

4.5

4.8

322.93

363.70

umol/l

3.57

165

934

Otalgia

371

2.21

10.07

5.3

372.25

371.84

umol/l

0.01

319

Familial hypercholesterolemia

116

606

1.93

10.06

4.9

4.3

357.59

348.74

umol/l

0.30

502

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

163

2.64

9.97

3.7

6.0

340.54

396.92

umol/l

1.78

139

Congenital malformations, deformations and chromosomal abnormalities

548

3918

1.35

9.95

5.0

5.4

377.66

374.48

umol/l

0.21

491

3430

Injuries to unspecified part of trunk, limb or body region

100

499

2.03

9.94

6.1

5.2

364.83

367.19

umol/l

0.03

436

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

144

1935

0.58

9.75

3.8

4.7

329.41

357.15

umol/l

1.39

119

1634

Pain in joint

516

2516

1.36

9.69

4.7

5.2

354.44

377.53

umol/l

2.96

448

2182

Single spontaneous delivery

171

1508

0.60

9.62

4.7

5.4

355.90

378.23

umol/l

1.27

144

1312

Other heart diseases, wide

879

4319

1.27

9.60

5.1

5.4

366.51

375.38

umol/l

0.98

776

3770

Delivery

173

1511

0.60

9.59

4.8

5.4

357.94

378.46

umol/l

1.11

145

1314

Other and unspecified local infections of skin and subcutaneous tissue

447

2.06

9.46

6.4

5.4

365.19

366.01

umol/l

0.02

393

Peripheral artery disease

314

1724

1.47

9.44

4.5

4.3

334.97

342.32

umol/l

0.31

263

1435

Other ill-defined and unspecified causes of mortality

225

2.53

9.39

4.3

4.4

325.90

353.25

umol/l

0.85

195

Streptococcal septicaemia

312

2.27

9.31

4.8

4.4

365.10

349.66

umol/l

0.44

269

Senile cataract

489

2227

1.37

9.28

4.8

4.9

357.97

364.43

umol/l

0.44

419

1901

Mouth breathing

357

2519

1.42

9.22

5.1

5.2

373.80

372.81

umol/l

0.05

318

2184

Disorders of skin appendages

413

2988

1.39

9.22

5.5

5.3

360.18

372.77

umol/l

0.90

364

2610

Superficial injury of shoulder and upper arm

112

597

1.90

9.21

5.1

5.3

374.93

371.77

umol/l

0.08

100

516

Dental caries 1 and operation codes, only avohilmo

276

910

1.53

9.20

5.6

5.0

367.96

377.09

umol/l

0.46

239

779

Use of levodopa decarboxylase inhibitor

102

527

1.95

9.20

4.7

3.9

367.47

341.86

umol/l

0.89

439

Car occupant injured in other and unspecified transport accidents

178

1085

1.65

9.18

4.9

5.4

336.06

369.19

umol/l

2.27

149

950

Antenatal screening

873

0.48

9.13

4.6

5.9

328.96

386.27

umol/l

3.21

763

Cholecystitis

110

585

1.90

9.09

5.1

4.6

352.46

349.70

umol/l

0.08

496

Unspecified haematuria

313

1847

1.46

9.06

4.4

4.5

323.46

352.95

umol/l

3.12

258

1576

Insulin, intermediate and long-acting

461

3341

1.36

9.03

5.2

5.0

340.61

364.14

umol/l

3.05

405

2856

Delivery, wide proxy

147

1322

0.59

9.01

4.9

5.4

359.04

375.29

umol/l

0.70

119

1150

Atrial fibrillation and flutter with reimbursement

216

873

1.59

9.00

4.8

5.1

359.14

377.23

umol/l

1.11

196

739

Other and unspecified injuries of wrist and hand

195

2.62

8.97

5.4

5.9

370.00

373.59

umol/l

0.07

174

Other disorders of bladder

463

2.01

8.95

4.9

4.6

343.57

347.14

umol/l

0.08

395

Other symptoms and signs involving the circulatory and respiratory systems

286

2.30

8.93

5.3

5.1

332.67

360.19

umol/l

0.84

245

Pediculosis, acariasis and other infestations

312

2.25

8.92

5.8

374.29

372.08

umol/l

0.03

278

Supervision of normal pregnancy

854

0.48

8.90

5.5

5.9

352.87

385.49

umol/l

1.23

747

Other local infections of skin and subcutaneous tissue

479

1.98

8.86

6.4

5.3

366.84

365.98

umol/l

0.02

423

Examination and encounter for administrative purposes

134

2.96

8.84

5.8

5.2

337.41

344.24

umol/l

0.10

117

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

124

693

1.80

8.76

6.4

5.1

391.42

368.19

umol/l

0.94

108

591

Asthma/COPD (KELA code 203)

851

4800

1.25

8.73

4.9

5.1

359.58

372.80

umol/l

1.89

743

4165

Cardiac arrest

219

2.39

8.73

4.4

4.7

350.31

366.93

umol/l

0.38

177

Maternal care for known or suspected malpresentation of fetus

860

0.42

8.69

4.2

5.8

323.55

384.94

umol/l

2.35

746

Insulin medication

491

3143

1.34

8.68

5.2

4.9

340.74

366.48

umol/l

3.64

430

2691

Other disorders of eye and adnexa

121

674

1.81

8.67

5.6

5.3

375.78

371.71

umol/l

0.11

108

586

Conjunctivitis (acute, non atopic)

242

1603

1.51

8.60

5.2

5.5

376.56

375.24

umol/l

0.05

210

1406

Perineal laceration during delivery

849

0.38

8.51

5.4

5.6

347.63

373.78

umol/l

0.48

727

Sciatica+with lumbago

430

3014

1.36

8.47

4.9

5.3

343.13

373.83

umol/l

4.59

385

2622

Hypothyroidism due to medicaments and other exogenous substances

4.83

8.44

5.1

4.2

365.36

364.22

umol/l

0.01

Other and unspecified injuries of ankle and foot

202

2.52

8.35

6.9

5.6

380.56

378.33

umol/l

0.03

179

Postpartum hemorraghe, all women as controls

1330

0.48

8.35

5.3

5.5

375.49

379.66

umol/l

0.08

1153

Rheumatoid arthritis

107

1731

0.56

8.34

3.6

4.9

336.46

370.68

umol/l

1.56

1466

Oral leukoplakia and related diseases, including avohilmo

401

2.05

8.31

5.9

5.1

358.52

361.12

umol/l

0.06

349

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

395

1813

1.39

8.30

5.5

5.6

358.49

384.28

umol/l

2.31

349

1575

Post-traumatic wound infection, not elsewhere classified

118

3.04

8.27

3.7

6.0

339.48

377.03

umol/l

0.58

105

Dentofacial anomalies [including malocclusion]

209

1344

1.55

8.23

4.7

5.1

365.77

380.84

umol/l

0.78

186

1173

Toxic effect of carbon monoxide

3.67

8.20

4.1

5.0

363.85

353.12

umol/l

0.15

Gastric ulcer

135

789

1.72

8.20

4.3

4.5

356.64

352.73

umol/l

0.10

108

662

Other and unspecified visual disturbances

425

2.00

8.12

3.8

5.3

331.86

362.67

umol/l

1.25

367

Car occupant injured in noncollision transport accident

200

2.50

8.04

4.9

5.7

368.42

373.50

umol/l

0.08

176

Chronic ulcer of skin, not elsewhere classified

294

2.21

7.99

4.5

5.0

366.49

356.79

umol/l

0.19

256

Phakomatoses, not elsewhere classified

4.09

7.98

4.3

5.6

422.02

366.08

umol/l

0.76

Pedal cyclist injured in transport accident

197

1275

1.56

7.97

4.9

5.3

362.32

370.11

umol/l

0.31

170

1108

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

262

1800

1.46

7.94

6.0

5.2

372.25

370.95

umol/l

0.05

231

1564

Embolic stroke with flimmer

3.76

7.93

3.8

3.7

338.00

334.15

umol/l

0.04

Other disorders of skin and subcutaneous tissue

523

3677

1.31

7.88

5.1

4.9

349.41

364.18

umol/l

1.47

441

3172

Benign neoplasm: Colon

372

2664

1.37

7.86

4.9

4.6

351.93

355.92

umol/l

0.21

322

2257

Pain associated with micturition

521

1.88

7.86

5.4

5.0

348.87

365.13

umol/l

0.43

453

Complications of labour and delivery

272

2179

0.69

7.85

4.6

5.4

367.31

381.24

umol/l

0.93

231

1905

Cough

314

2143

1.41

7.82

4.6

5.0

352.71

371.34

umol/l

1.53

274

1838

Heterophoria

390

2.02

7.81

5.1

5.3

387.20

370.13

umol/l

0.41

345

Gastro-oesophageal reflux disease

555

3806

1.30

7.80

4.7

5.1

348.64

370.77

umol/l

3.13

490

3289

Speech therapy

207

1363

1.53

7.75

5.5

4.8

359.25

365.24

umol/l

0.25

185

1159

Exposure to smoke, fire and flames

134

2.84

7.72

5.6

6.1

386.40

359.42

umol/l

0.51

120

Medical treatment for female infertility

1103

0.45

7.70

4.6

5.7

319.31

379.78

umol/l

2.08

961

Amputation

392

2.01

7.68

4.3

4.4

325.39

334.91

umol/l

0.22

332

Disturbances of skin sensation

221

1480

1.50

7.64

4.9

5.3

364.54

372.55

umol/l

0.33

195

1276

Viral infections of the central nervous system

387

2.02

7.62

4.3

5.5

349.10

375.59

umol/l

0.86

338

Other diseases of anus and rectum

222

1487

1.50

7.62

5.1

4.5

344.09

361.55

umol/l

0.97

187

1247

Heart failure and bmi 25plus

284

1364

1.44

7.58

4.8

5.1

342.63

355.27

umol/l

0.78

240

1151

Abnormal findings on examination of blood, without diagnosis

353

2411

1.38

7.53

5.0

4.7

355.19

355.75

umol/l

0.02

311

2029

Obstructed labour due to malposition and malpresentation of fetus

1298

0.51

7.49

4.3

5.8

341.00

385.86

umol/l

2.29

1141

Pain and other conditions associated with female genital organs and menstrual cycle

157

937

1.62

7.48

5.1

5.4

358.81

387.75

umol/l

1.77

139

822

Other disorders of optic [2nd] nerve and visual pathways

296

2.16

7.47

5.0

5.4

422.49

368.10

umol/l

2.03

259

Need for other prophylactic measures

297

2.16

7.42

7.7

5.5

365.47

365.10

umol/l

0.01

264

Adverse effects, not elsewhere classified

162

1020

1.60

7.42

5.3

358.04

372.35

umol/l

0.69

136

883

Labour and delivery complicated by fetal stress [distress]

1035

0.54

7.38

4.5

5.8

346.74

380.26

umol/l

1.20

892

Other/unspecified seropositive rheumatoid arthritis

1290

0.50

7.37

3.0

4.9

334.08

361.16

umol/l

0.94

1099

Seropositive rheumatoid arthritis

1313

0.51

7.36

3.0

4.9

332.05

365.95

umol/l

1.36

1130

Otitis externa, unspecified

100

555

1.82

7.34

6.4

5.4

363.65

366.97

umol/l

0.10

484

Malignant neoplasm of digestive organs

106

1789

0.58

7.29

3.5

4.2

323.54

342.46

umol/l

0.60

1479

Sulfasalazine

101

1753

0.57

7.29

3.5

5.3

345.36

369.06

umol/l

1.00

1520

DVT of lower extremities

148

916

1.63

7.29

5.0

4.8

337.05

358.41

umol/l

0.91

122

779

Haemorrhage from respiratory passages

249

1599

1.45

7.22

4.7

4.6

348.30

357.27

umol/l

0.47

209

1351

Other disorders of penis

104

588

1.79

7.20

5.9

5.3

349.69

361.65

umol/l

0.33

511

Other viral diseases

266

1864

1.43

7.20

5.0

5.4

371.44

374.09

umol/l

0.12

240

1645

Seropositive rheumatoid arthritis, wide

1304

0.51

7.16

3.0

4.9

332.05

361.21

umol/l

1.09

1110

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1276

0.51

7.14

3.0

5.0

334.08

361.93

umol/l

0.97

1088

Vitamin deficiency

218

2.33

7.12

6.7

5.1

344.40

363.07

umol/l

0.36

190

Vitamin deficiency, wide

218

2.33

7.12

6.7

5.1

344.40

363.07

umol/l

0.36

190

Biological medication for rheuma

930

0.43

7.08

4.0

5.5

347.25

372.98

umol/l

0.82

818

Fracture of neck

257

2.21

7.06

3.4

5.1

355.82

356.96

umol/l

0.02

226

Benign neoplasm of colon, rectum, anus and anal canal

442

3040

1.32

7.06

4.7

350.48

359.11

umol/l

0.63

379

2575

Combinations of oral blood glucose lowering drugs

206

1384

1.50

7.05

5.3

4.6

354.77

358.78

umol/l

0.16

180

1164

Other follicular disorders

364

2.00

7.04

5.6

5.7

336.96

376.50

umol/l

1.78

317

Maternal care related to the fetus and amniotic cavity and possible delivery problems

188

1663

0.66

7.00

4.8

5.6

358.44

389.04

umol/l

2.27

165

1462

Dermatophytosis

110

638

1.74

6.97

4.8

5.0

347.26

359.02

umol/l

0.36

552

Other and unspecified tonsillitis

319

1968

1.38

6.92

5.3

5.5

367.20

380.04

umol/l

0.77

286

1732

Disorders of gallbladder, biliary tract and pancreas

810

4263

1.23

6.92

5.0

357.24

366.29

umol/l

1.04

708

3671

Stomatitis and related lesions

346

2.01

6.89

6.2

4.9

336.53

362.49

umol/l

0.67

292

Triptan medication for migraine, min. 3 purchases

459

2779

1.31

6.88

4.2

5.6

345.33

382.72

umol/l

6.32

393

2450

Abnormal results of function studies

430

1.91

6.88

6.6

5.2

391.00

365.77

umol/l

0.76

377

Acute laryngitis and tracheitis

130

779

1.66

6.86

6.4

5.4

380.21

380.59

umol/l

0.01

117

691

Dorsopathies

987

4184

1.21

6.85

4.9

5.2

357.23

373.58

umol/l

2.96

856

3636

Rheumatoid arthritis, including avohilmo

127

2047

0.62

6.84

3.7

5.0

341.52

364.33

umol/l

0.97

101

1754

Acute suppurative otitis media

262

1732

1.42

6.77

6.0

5.6

393.56

376.24

umol/l

0.87

235

1542

Other disturbances of cerebral status of newborn

17.93

6.77

5.1

4.1

455.50

437.86

umol/l

—

Sequelae with surgical and medical care as external cause

148

934

1.60

6.76

5.7

4.9

357.84

360.56

umol/l

0.08

132

804

Malnutrition

3.29

6.75

5.0

4.2

391.09

379.56

umol/l

0.12

Other and unspecified dermatitis

391

2956

1.33

6.73

5.0

5.1

357.13

370.11

umol/l

0.93

332

2546

Oligomenorrhoea

144

2.61

6.73

5.0

5.5

366.16

380.96

umol/l

0.25

122

Gastroduodenal ulcer

185

1226

1.51

6.70

4.3

4.4

348.25

348.83

umol/l

0.02

151

1013

Early complications of trauma

218

2.29

6.69

4.0

5.6

351.87

377.50

umol/l

0.48

194

!Aliquae complicationes praecoces traumatis

218

2.29

6.69

4.0

5.6

351.87

377.50

umol/l

0.48

194

D07AA Corticosteroids, weak (group I)

142

890

1.61

6.66

5.3

5.4

356.62

373.11

umol/l

0.70

121

784

Astigmatism

310

2.06

6.65

6.4

5.1

395.07

370.31

umol/l

0.70

273

Fibromyalgia

386

1.94

6.62

4.6

5.6

371.64

387.59

umol/l

0.43

334

Superficial injury of neck

3.02

6.60

5.9

5.7

347.09

378.00

umol/l

0.50

Tumor necrosis factor alpha inhibitors

832

0.42

6.58

4.2

5.5

345.67

374.06

umol/l

0.86

731

Suppurative and unspecified otitis media

341

2243

1.35

6.58

5.5

5.4

395.90

372.78

umol/l

1.56

300

1982

Dental caries 2 and operation codes

673

4325

1.24

6.54

5.9

5.3

379.61

375.49

umol/l

0.32

601

3791

Pedestrian injured in transport accident

361

1.96

6.51

6.4

5.5

374.02

371.68

umol/l

0.05

313

Phlebitis and thrombophlebitis (not including DVT)

174

1150

1.52

6.49

5.6

5.0

359.55

368.95

umol/l

0.24

142

985

Heartburn

467

1.84

6.49

6.0

4.9

366.47

367.87

umol/l

0.03

405

Childhood asthma (age<16)

131

638

1.64

6.49

4.7

5.6

357.78

384.05

umol/l

1.15

114

569

Allergic asthma (mode), excluding more controls

183

1199

1.50

6.48

4.8

5.1

344.92

378.58

umol/l

2.15

152

1041

Enlarged lymph nodes

540

1.77

6.46

5.9

4.8

359.88

371.36

umol/l

0.31

447

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

154

2064

0.65

6.45

4.1

4.7

334.62

361.77

umol/l

1.68

135

1744

Sulfonylureas

239

1335

1.43

6.45

4.4

3.9

335.82

340.06

umol/l

0.18

207

1084

Acute posthaemorrhagic anaemia

124

2.70

6.44

4.3

4.1

337.72

357.34

umol/l

0.29

108

Childhood asthma (age<16), excluding more controls

131

639

1.64

6.44

4.7

5.6

357.78

383.95

umol/l

1.14

114

569

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

124

1218

0.62

6.44

3.4

4.8

323.30

351.86

umol/l

1.53

1024

Other medical care

275

1941

1.39

6.35

4.4

4.6

339.85

353.11

umol/l

0.75

233

1608

Other infective otitis externa

289

2.07

6.34

5.4

5.8

346.31

363.92

umol/l

0.46

255

Chronic gastritis

191

1294

1.48

6.32

3.9

4.6

332.06

357.23

umol/l

1.87

158

1081

Dental caries 2

684

4372

1.23

6.32

5.9

5.3

378.35

375.71

umol/l

0.19

611

3835

Corns and callosities

317

2.01

6.29

6.9

5.4

364.63

368.87

umol/l

0.08

273

Dermatitis due to substances taken internally

264

2.11

6.24

5.2

374.11

369.65

umol/l

0.08

230

Diseases of the ear and mastoid process

1093

4682

1.18

6.18

5.2

376.07

366.84

umol/l

1.16

947

4087

Faecal incontinence

326

1.98

6.16

5.4

4.8

349.48

369.29

umol/l

0.52

281

Persons encountering health services in circumstances related to reproduction

368

3270

0.76

6.14

4.9

5.7

384.15

383.52

umol/l

0.03

326

2912

Superficial injury of ankle and foot

108

647

1.68

6.13

5.4

365.28

372.04

umol/l

0.20

569

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

113

1101

0.61

6.13

3.5

4.7

324.54

350.36

umol/l

1.24

922

Hyperlipidaemia, other/unspecified

251

1703

1.40

6.08

4.2

4.5

347.45

352.84

umol/l

0.24

212

1423

Opening and dilatation of root channel of tooth

328

1.98

6.08

5.4

5.9

348.95

376.29

umol/l

0.75

288

Flat foot [pes planus] (acquired)

463

1.81

6.07

6.5

5.4

395.74

377.35

umol/l

0.56

403

Allergic asthma (mode)

183

1217

1.48

6.06

4.8

5.1

344.92

378.95

umol/l

2.20

152

1058

Diseases of arteries, arterioles and capillaries

478

2800

1.28

6.01

4.4

4.7

343.20

356.34

umol/l

0.96

406

2369

Disorders of parathyroid gland

138

871

1.57

6.01

7.1

4.5

375.86

348.76

umol/l

1.45

115

748

Infections with a predominantly sexual mode of transmission

261

1890

1.39

5.99

5.7

5.5

355.59

376.18

umol/l

1.37

224

1654

Other blood glucose lowering drugs, excl. Insulins

116

714

1.63

5.93

5.3

4.3

349.26

351.02

umol/l

0.05

107

590

Persons with potential health hazards related to communicable diseases

334

2502

1.33

5.86

6.3

5.3

373.33

377.40

umol/l

0.21

299

2200

Other shoulder lesions

461

1.79

5.86

4.7

5.4

352.51

381.65

umol/l

1.01

393

Insulin, combination of fast acting with intermediate-acting or long-acting

491

3591

1.26

5.84

5.2

5.0

340.74

363.22

umol/l

2.94

430

3063

Fentanyl

418

1.83

5.81

3.3

4.6

315.95

352.96

umol/l

1.33

340

Alcohol-induced chronic pancreatitis

341

1.93

5.80

5.8

5.3

368.75

364.13

umol/l

0.09

303

Outcome of delivery

703

0.53

5.79

4.5

5.9

347.26

383.43

umol/l

1.24

615

Osteoporosis with pathological fracture (FG)

245

2.10

5.79

4.0

4.3

327.81

363.09

umol/l

0.96

208

Disorders of eyelid, lacrimal system and orbit

662

4251

1.22

5.79

4.7

5.1

359.11

365.56

umol/l

0.53

565

3672

Hyperparathyroidism

122

756

1.60

5.78

6.8

4.6

379.01

347.14

umol/l

1.85

103

649

Seborrhoeic dermatitis

463

1.79

5.78

6.1

5.3

375.25

365.47

umol/l

0.23

408

Conduction disorders

211

1228

1.43

5.78

4.2

4.6

334.28

352.66

umol/l

1.06

173

1013

Other disorders of skin and subcutaneous tissue, not elsewhere classified

108

659

1.65

5.74

5.0

4.9

359.64

359.04

umol/l

0.01

571

Melanocytic naevi

102

1654

0.61

5.74

5.0

5.2

377.13

370.43

umol/l

0.18

1416

Generalized skin eruption due to drugs and medicaments

169

2.34

5.70

4.7

5.2

382.63

375.87

umol/l

0.10

149

Pedal cyclist injured in other and unspecified transport accidents

103

623

1.67

5.68

5.3

5.2

371.72

367.27

umol/l

0.12

547

Other congenital malformations

468

1.77

5.58

4.5

5.5

400.18

380.28

umol/l

0.60

420

Pustular psoriasis

216

2.16

5.57

6.1

5.7

391.78

370.49

umol/l

0.42

194

Carpal tunnel syndrome

284

3420

0.75

5.56

4.0

5.3

356.81

369.78

umol/l

0.61

247

2954

Dental caries 2, only avohilmo

665

4323

1.22

5.48

5.9

5.3

378.14

375.84

umol/l

0.16

594

3793

Ulcer of oesophagus

300

1.95

5.41

5.1

4.6

360.33

347.90

umol/l

0.27

254

Use of pramipexole

147

980

1.51

5.35

5.4

4.8

339.54

357.13

umol/l

0.93

129

842

Artificial joint operation, meniscal resection

516

4248

0.81

5.35

4.4

5.1

348.15

366.54

umol/l

2.34

420

3686

Long labour

1269

0.60

5.34

4.7

5.7

355.77

385.53

umol/l

1.04

1101

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

238

1735

1.38

5.34

4.9

5.5

359.49

369.03

umol/l

0.47

205

1518

Other inflammation of eyelid

603

1.65

5.33

4.4

5.4

375.44

363.36

umol/l

0.33

525

Cholelithiasis, broad definition with cholecystitis

669

3785

1.21

5.32

4.9

5.0

352.72

365.87

umol/l

1.64

581

3247

Misadventures to patients during surgical and medical care

604

1.65

5.30

4.8

5.0

345.01

365.30

umol/l

0.72

522

Diseases of the musculoskeletal system and connective tissue

595

2424

1.23

5.29

5.1

5.4

356.69

384.96

umol/l

4.78

516

2137

Recurring oral aphthae, including avohilmo

108

674

1.61

5.29

6.0

5.0

350.66

370.94

umol/l

0.77

584

Pregnancy, childbirth and the puerperium

143

1119

0.67

5.28

4.7

5.3

358.62

372.10

umol/l

0.54

115

973

Injury of eye and orbit

114

721

1.59

5.27

5.5

5.2

381.31

372.24

umol/l

0.19

629

Mental and behavioural disorders due to cocaine

15.12

5.24

4.5

4.2

416.25

277.17

umol/l

—

Female infertility, cervigal, vaginal, other or unspecified origin

1013

0.61

5.20

4.6

5.4

348.47

386.57

umol/l

1.84

886

Pacemaker

205

1422

1.41

5.20

3.3

4.1

323.85

339.39

umol/l

0.79

169

1177

Other disorders of lacrimal gland

240

1761

1.37

5.18

4.8

5.1

364.77

369.46

umol/l

0.18

209

1513

Maternal care for other known or suspected fetal problems

984

0.62

5.14

4.0

5.7

336.09

382.44

umol/l

2.57

854

Malignant neoplasm

554

4020

0.82

5.10

4.7

5.3

357.02

371.67

umol/l

1.61

475

3507

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

185

2.20

5.06

4.2

6.3

349.25

377.83

umol/l

0.65

165

Melanocytic naevi

102

1601

0.63

5.04

5.0

5.2

377.13

366.08

umol/l

0.32

1375

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1309

0.60

5.02

3.8

4.4

335.65

351.93

umol/l

0.50

1076

Other congenital malformations of circulatory system

129

2.45

5.01

3.9

5.2

371.88

373.36

umol/l

0.02

117

Pustulosis palmaris et plantaris

199

2.14

5.01

5.9

5.6

390.70

375.07

umol/l

0.26

177

Infective dermatitis

545

1.66

4.99

5.2

388.96

362.56

umol/l

0.98

466

Pruritus

447

1.73

4.98

4.4

5.1

366.30

364.40

umol/l

0.04

387

Trochanteric bursitis

599

1.63

4.98

4.8

5.2

342.23

376.42

umol/l

1.62

519

Presence of other devices

151

1028

1.47

4.97

4.3

4.2

370.27

338.83

umol/l

1.84

129

857

Leiomyoma of uterus

279

2099

0.75

4.97

5.3

5.2

374.17

377.86

umol/l

0.16

238

1837

Polyneuropathies and other disorders of the peripheral nervous system

153

1046

1.47

4.96

4.8

4.7

346.00

352.60

umol/l

0.24

136

885

Redundant prepuce, phimosis and paraphimosis

212

1531

1.39

4.95

5.6

5.5

370.09

371.36

umol/l

0.05

194

1357

Effects of foreign body entering through natural orifice

210

1521

1.39

4.94

5.9

5.4

367.61

368.50

umol/l

0.03

184

1335

Later onset COPD

161

868

1.46

4.92

4.4

3.4

317.77

325.06

umol/l

0.29

137

697

Disorders of lacrimal system

291

2216

1.32

4.91

4.7

5.1

366.72

369.01

umol/l

0.09

252

1900

Acute generalized exanthematous pustulosis

201

2.12

4.89

4.5

5.4

382.17

369.47

umol/l

0.22

178

Temporomandibular joint disorders

114

736

1.56

4.85

4.6

5.4

361.02

380.87

umol/l

0.81

650

Benign neoplasm: Colon

366

2196

1.28

4.84

4.9

352.85

366.18

umol/l

0.99

316

1875

Maternal care for known or suspected abnormality of pelvic organs

100

1083

0.63

4.84

4.0

5.7

331.66

384.98

umol/l

3.02

945

malignant neoplasm of male genital organs

164

1486

0.70

4.84

3.3

4.5

314.53

342.06

umol/l

1.97

125

1249

Other and unspecified polyneuropathies, also in other diseases

132

884

1.50

4.76

4.4

4.7

347.13

352.23

umol/l

0.16

118

741

Oesophagitis

237

2.01

4.76

4.3

5.2

372.91

363.61

umol/l

0.15

205

Amputation of thigh

2.74

4.69

3.9

3.8

312.07

329.82

umol/l

0.20

Idiopathic gout

374

1.78

4.68

5.9

4.5

341.26

343.66

umol/l

0.05

320

Cholelithiasis

633

3697

1.20

4.68

4.8

5.0

351.72

365.78

umol/l

1.73

547

3173

Prolonged pregnancy

819

0.53

4.68

4.9

5.7

377.40

380.64

umol/l

0.05

705

Benign neoplasm of colon, rectum, anus and anal canal

424

2422

1.25

4.67

4.8

5.0

354.10

368.64

umol/l

1.26

361

2082

Female infertility

110

1037

0.65

4.63

4.5

5.3

349.73

386.36

umol/l

2.00

906

Impingement syndrome of shoulder

1409

0.63

4.61

3.5

5.4

358.76

374.90

umol/l

0.49

1226

Atherosclerosis, excluding cerebral and coronary sclerosis

259

1559

1.33

4.61

4.4

4.1

323.73

340.80

umol/l

1.12

215

1284

AV-block

118

704

1.53

4.60

3.7

4.1

327.67

336.77

umol/l

0.31

574

Other cataract

297

1766

1.31

4.59

4.9

4.7

358.65

357.37

umol/l

0.05

254

1484

Leiomyoma of uterus

220

1674

0.74

4.57

5.5

5.4

371.78

383.45

umol/l

0.58

191

1475

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

787

4558

1.18

4.47

5.0

5.2

366.74

369.61

umol/l

0.21

666

3984

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

572

0.43

4.42

3.6

4.5

313.12

352.07

umol/l

0.60

481

Nonalcoholic fatty liver disease

480

1.66

4.39

6.5

5.7

359.63

371.76

umol/l

0.30

422

Paracetamol of NSAID medication

205

748

1.39

4.36

4.9

5.7

364.08

391.20

umol/l

1.91

183

674

Other and unspecified injuries of shoulder and upper arm

138

2.28

4.34

5.3

5.6

360.77

377.23

umol/l

0.21

124

Other symptoms and signs involving the digestive system and abdomen

111

732

1.52

4.34

5.1

4.9

361.39

368.74

umol/l

0.20

642

Dialysis, with operation codes

104

677

1.55

4.33

6.6

5.0

352.28

361.78

umol/l

0.27

585

Urticaria and erythema

276

2128

1.30

4.31

4.9

5.3

341.73

374.54

umol/l

3.15

240

1857

Diseases of middle ear and mastoid

493

3320

1.22

4.31

5.4

5.2

384.39

369.08

umol/l

1.29

425

2906

Missing teeth due to accident, extraction or parodontitis

448

1.66

4.17

5.6

4.5

367.55

356.39

umol/l

0.26

373

Disorders of optic nerve and visual pathways

464

1.65

4.16

5.0

5.4

416.12

370.66

umol/l

1.85

405

Other complications of labour and delivery, not elsewhere classified

577

0.46

4.15

5.7

355.61

368.83

umol/l

0.18

489

Localized swelling, mass and lump of skin and subcutaneous tissue

225

1698

1.33

4.13

5.2

5.0

343.13

367.37

umol/l

1.88

196

1457

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

450

1.66

4.12

6.3

5.2

324.31

357.90

umol/l

1.26

395

2.90

4.08

3.8

5.9

336.97

401.17

umol/l

1.02

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

832

0.55

4.08

3.7

4.6

321.24

358.20

umol/l

0.94

697

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

229

0.26

4.06

7.8

5.6

378.67

372.11

umol/l

—

199

Other embolism and thrombosis

584

1.57

4.06

5.1

5.0

333.72

362.67

umol/l

1.21

507

Postpartum care and examination

616

0.58

4.05

4.0

6.0

365.19

382.81

umol/l

0.35

534

Oral leukoplakia, including avohilmo

117

2.35

4.04

5.1

4.9

386.86

371.87

umol/l

0.23

102

Postmenopausal osteoporosis with pathological fracture

189

2.03

4.04

4.1

4.2

342.52

360.18

umol/l

0.34

161

Chronic kidney disease

189

1388

1.36

4.04

5.3

4.2

327.58

347.26

umol/l

1.12

158

1146

Cervicalgia

148

1049

1.42

4.04

4.8

5.3

342.54

372.66

umol/l

1.67

127

901

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

880

0.57

4.03

4.2

338.00

350.55

umol/l

0.26

727

Abnormal findings on diagnostic imaging of lung

311

2393

1.27

4.02

5.1

4.6

354.00

355.24

umol/l

0.05

265

2015

Otitis media, unspecified

101

611

1.53

4.01

5.2

422.81

379.00

umol/l

1.56

539

Lifestyle-related condition

3.10

4.01

5.1

5.5

482.44

351.37

umol/l

0.60

Coxarthrosis, primary, with hip surgery

169

2184

0.73

3.99

3.8

4.3

322.96

347.24

umol/l

1.66

142

1830

Soft tissue disorders related to use, overuse and pressure

192

1424

1.35

3.98

4.8

5.3

352.56

374.19

umol/l

1.38

169

1236

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

576

4045

0.84

3.98

4.6

5.3

356.48

372.92

umol/l

2.02

495

3531

Oral leukoplakia and related diseases

232

1.92

3.98

5.3

4.8

353.78

359.94

umol/l

0.11

199

Malignant neoplasm of prostate

156

1366

0.72

3.97

3.4

4.3

316.12

338.90

umol/l

1.44

121

1140

Diseases of male genital organs

535

2247

1.21

3.96

5.3

372.46

368.50

umol/l

0.25

471

1970

Complications of internal orthopaedic prosthetic devices, implants and grafts

138

970

1.43

3.95

4.1

4.5

341.03

354.87

umol/l

0.55

117

814

Disorder of lipoprotein metabolism, unspecified

533

1.58

3.94

5.1

4.4

336.13

349.52

umol/l

0.41

444

Inflammatory disorders of breast

254

1.87

3.94

6.1

5.5

401.99

369.33

umol/l

0.90

219

Benign neoplasm: Colon, unspecified

153

1096

1.40

3.94

4.6

4.5

339.48

351.24

umol/l

0.49

136

924

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

577

4045

0.84

3.92

4.6

5.3

356.38

372.96

umol/l

2.06

496

3531

Malignant neoplasm, wide definition for exclusion

577

4045

0.84

3.92

4.6

5.3

356.38

372.96

umol/l

2.06

496

3531

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

225

0.26

3.92

7.8

5.9

378.67

365.91

umol/l

—

202

Meniscus derangement

336

2867

0.80

3.90

4.1

5.3

345.90

371.82

umol/l

2.82

282

2475

Viral pneumonia (unknown virus, not influenza)

343

1.74

3.90

6.3

5.5

400.76

373.08

umol/l

0.83

297

Other predominantly sexually transmitted diseases, not elsewhere classified

137

966

1.43

3.87

6.0

5.6

360.24

373.10

umol/l

0.45

116

840

Acne vulgaris

497

1.60

3.87

5.0

5.7

376.71

379.65

umol/l

0.07

435

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

190

1661

0.74

3.85

5.0

5.3

367.66

381.31

umol/l

0.65

162

1458

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

190

1661

0.74

3.85

5.0

5.3

367.66

381.31

umol/l

0.65

162

1458

Burn and corrosion of hip and lower limb, except ankle and foot

120

2.29

3.84

6.0

5.5

369.11

376.59

umol/l

0.08

104

L04AA Selective immunosuppressants

1189

0.64

3.82

3.9

5.4

322.96

370.74

umol/l

2.49

1036

Fissure and fistula of anal and rectal regions

179

1323

1.36

3.82

4.3

5.0

357.84

369.35

umol/l

0.56

153

1137

Orchitis and epididymitis

530

1.58

3.82

5.6

5.0

377.22

352.90

umol/l

0.86

456

Atopic dermatitis

466

3297

1.21

3.80

4.7

5.5

365.70

379.38

umol/l

1.27

409

2912

Rheumatism, unspecified

634

1.52

3.79

4.3

5.4

340.27

381.88

umol/l

2.00

554

Other and unspecified psoriasis

324

1.74

3.78

5.4

5.6

356.98

363.67

umol/l

0.13

288

Hypertensive heart and/or renal disease

155

864

1.40

3.77

4.7

4.4

328.65

354.27

umol/l

1.27

134

698

Colorectal adenocarcinoma

863

0.58

3.77

4.2

4.4

338.00

346.92

umol/l

0.18

730

Benign neoplasm: Rectum, anus and anal canal

128

897

1.43

3.75

3.7

4.7

345.08

351.98

umol/l

0.20

101

765

Benign neoplasm of brain and other parts of central nervous system

310

1.76

3.75

5.7

5.2

372.81

367.17

umol/l

0.11

265

Pleural effusion

660

1.51

3.74

4.8

4.3

342.25

344.34

umol/l

0.05

556

Ocular pain

386

1.67

3.71

5.3

5.5

336.09

371.96

umol/l

1.22

335

Other diseases of intestine

519

1.57

3.68

4.8

4.7

365.77

360.78

umol/l

0.12

446

Other disorders of the musculoskeletal system and connective tissue

100

672

1.50

3.65

5.1

350.18

361.90

umol/l

0.33

581

Benign neoplasm of brain and other parts of central nervous system

313

1.74

3.63

5.7

5.2

372.81

365.87

umol/l

0.14

271

Paralytic strabismus

306

1.75

3.61

4.5

5.1

342.26

352.92

umol/l

0.20

269

Other congenital malformations of ear

2.71

3.60

3.3

4.9

360.28

391.09

umol/l

0.40

Medical abortion

444

1992

1.21

3.58

4.7

5.3

368.67

374.88

umol/l

0.38

373

1731

Artificial opening status

234

1.86

3.57

6.3

4.8

355.45

345.37

umol/l

0.14

205

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

455

0.44

3.57

4.0

4.3

340.87

348.78

umol/l

0.08

386

Neurofibromatosis, type 2

10.80

3.57

3.0

3.3

382.50

317.67

umol/l

—

Disorders of calcium metabolism

234

1.85

3.56

5.6

5.1

335.33

360.84

umol/l

0.47

201

Gout, idiopatic and unspecified

155

1134

1.37

3.56

5.4

4.3

348.28

347.21

umol/l

0.03

129

952

Malignant neoplasm of breast

202

1906

0.76

3.54

4.8

5.2

364.57

376.38

umol/l

0.57

174

1659

Iron deficiency anaemia secondary to blood loss (chronic)

101

686

1.48

3.51

5.0

4.7

355.36

355.20

umol/l

0.00

583

Postpartum hemorraghe, parous women as controls

894

0.62

3.51

5.3

5.0

375.49

371.70

umol/l

0.07

762

Thyrotoxicosis, other and/or unspecified

121

851

1.43

3.50

5.5

4.8

380.57

361.64

umol/l

0.84

102

738

Contact with sharp glass

236

1.85

3.49

5.3

5.8

319.14

374.26

umol/l

1.62

207

Sensorineural hearing loss

545

3230

1.18

3.48

4.5

4.9

362.65

361.95

umol/l

0.04

456

2775

Hypopituitarism

456

1.59

3.47

5.5

377.84

382.90

umol/l

0.10

406

Other otitis externa (chronic)

295

1.74

3.47

4.5

5.6

376.11

365.92

umol/l

0.19

260

Disorders of mineral metabolism

325

1.70

3.46

5.8

5.3

330.87

358.79

umol/l

0.67

282

Nonsuppurative otitis media

198

1302

1.32

3.45

5.3

378.62

373.02

umol/l

0.21

174

1148

Dislocation, sprain and strain of joints and ligaments of thorax

146

2.08

3.44

3.5

5.2

325.68

370.88

umol/l

0.78

127

Injury of unspecified body region

364

1.66

3.43

6.0

5.3

351.22

366.81

umol/l

0.17

317

Disorders of continuity of bone

481

1.57

3.43

5.7

5.4

336.96

376.74

umol/l

1.57

417

Lesion of ulnar nerve

105

724

1.46

3.40

5.1

5.4

370.97

365.46

umol/l

0.16

617

Acute pancreatitis

139

1008

1.39

3.39

5.3

4.9

354.05

360.27

umol/l

0.18

121

858

Acne

610

1.50

3.39

5.0

5.6

374.40

377.99

umol/l

0.09

533

Diseases of liver

240

1883

1.28

3.38

4.9

5.1

353.67

365.78

umol/l

0.68

207

1630

Inflammatory bowel disease, strict (require KELA)

103

1476

0.70

3.38

4.4

5.4

335.80

370.57

umol/l

1.56

1284

Certain conditions originating in the perinatal period

504

1.52

3.38

5.2

390.99

385.82

umol/l

0.11

461

Menorrhagia

255

1103

1.28

3.38

5.5

5.2

359.18

379.59

umol/l

1.37

216

966

Psoriasis

209

1612

1.30

3.37

4.9

5.3

350.08

369.43

umol/l

1.09

172

1396

Other factor of the environment

2.77

3.35

5.1

5.0

482.44

360.43

umol/l

0.54

Contact with other sharp object(s)

390

1.63

3.35

4.1

5.6

361.92

373.20

umol/l

0.21

341

Coxarthrosis, primary

257

2804

0.79

3.35

3.8

4.6

326.34

355.25

umol/l

2.86

215

2376

Other diseases of oesophagus

429

1.59

3.33

3.2

4.8

335.65

355.82

umol/l

0.53

361

Contusion of other and unspecified parts of foot

262

1.77

3.32

5.3

5.5

381.41

374.42

umol/l

0.11

232

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

441

0.45

3.32

4.0

4.3

340.87

348.64

umol/l

0.08

373

Ovarian cyst

262

1194

1.27

3.30

5.0

5.1

353.22

378.36

umol/l

2.07

232

1038

Hypertensive Heart Disease

134

790

1.39

3.30

4.4

4.3

325.43

350.65

umol/l

1.12

115

633

Coagulation defects, purpura and other haemorrhagic conditions

132

955

1.39

3.28

4.8

4.9

383.54

364.16

umol/l

0.77

115

821

Convulsions of newborn

9.61

3.27

6.2

4.9

553.33

454.38

umol/l

—

Zoster [herpes zoster]

111

780

1.43

3.26

4.3

4.9

346.17

355.26

umol/l

0.29

666

Benign neoplasm: Colon, unspecified

153

1130

1.35

3.24

4.6

4.5

339.48

355.64

umol/l

0.75

136

934

Contusion of ankle

206

1.87

3.23

6.3

5.8

393.36

379.14

umol/l

0.26

182

Malignant neoplasm of breast, HER2-negative

197

1872

0.77

3.22

4.7

5.1

364.76

375.34

umol/l

0.47

169

1629

Colorectal cancer

1032

0.65

3.20

3.6

4.3

329.47

349.86

umol/l

0.55

865

Diabetic retinopathy

173

1437

0.76

3.20

5.0

5.5

338.75

357.20

umol/l

0.91

140

1269

Atopic dermatitis, strict definition with reimbursement

242

1857

1.27

3.19

4.7

5.5

370.56

381.30

umol/l

0.56

215

1644

Female genital prolapse

117

944

0.71

3.18

5.1

5.2

374.79

380.43

umol/l

0.18

107

824

Chondrocostal junction syndrome [Tietze]

172

1.94

3.16

6.8

5.6

390.39

374.24

umol/l

0.21

152

Acute gastritis

350

1.64

3.14

4.8

5.0

341.51

357.24

umol/l

0.43

302

Conductive and sensorineural hearing loss

578

3439

1.17

3.13

4.6

4.9

366.47

363.25

umol/l

0.19

486

2962

Supervision of high-risk pregnancy

835

0.69

3.12

4.4

5.9

362.35

386.84

umol/l

0.86

732

Cellulitis of external ear

2.86

3.11

3.6

5.5

329.64

364.84

umol/l

0.37

Osteonecrosis

260

1.75

3.11

5.0

5.2

333.57

366.89

umol/l

0.79

230

Personal history of other diseases and conditions

563

1.49

3.10

4.4

5.1

366.09

379.41

umol/l

0.32

493

Sexual assault by bodily force

7.92

3.10

7.5

4.6

427.00

393.25

umol/l

—

IBD patients in KELA-register

103

1451

0.71

3.10

4.4

5.4

335.80

372.23

umol/l

1.67

1265

Excessive attrition of teeth

327

1447

1.23

3.06

5.3

5.2

360.35

370.36

umol/l

0.62

288

1253

Complications of other internal prosthetic devices, implants and grafts

167

1.94

3.06

5.1

4.6

374.81

358.79

umol/l

0.21

145

Other disorders of kidney and ureter

568

1.49

3.05

5.6

4.9

372.35

352.96

umol/l

0.60

494

Neuralgia and neuritis, unspecified

240

1.77

3.03

5.4

5.8

337.49

370.05

umol/l

0.83

205

Pain in thoracic spine

108

767

1.41

3.02

3.8

5.4

332.30

373.75

umol/l

2.41

667

Other female pelvic inflammatory diseases

693

1.43

3.00

4.3

5.3

368.57

373.53

umol/l

0.13

595

Other maternal disorders predominantly related to pregnancy

278

2156

0.81

3.00

4.8

5.5

363.15

384.80

umol/l

1.68

244

1888

Colitis, primary sclerosing

0.00

2.98

0.0

6.1

—

390.47

—

Rotator cuff syndrome

336

3012

0.83

2.97

3.6

5.2

351.75

370.87

umol/l

1.67

292

2619

Benign neoplasm: Rectum

110

787

1.40

2.96

3.7

4.7

348.32

353.14

umol/l

0.12

674

Other disorders of ear

717

4187

1.14

2.95

4.6

5.1

365.54

366.29

umol/l

0.05

610

3635

Fenamates

147

738

1.35

2.94

5.3

6.0

354.57

382.41

umol/l

1.33

117

660

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.36

2.94

6.3

5.1

418.49

379.45

umol/l

0.88

Other disorders of white blood cells

250

1.74

2.93

5.2

5.3

411.26

356.54

umol/l

1.44

221

Benign neoplasm: Rectum, anus and anal canal

128

942

1.36

2.91

3.7

4.5

345.08

356.31

umol/l

0.37

101

789

Cholecystectomy

489

3701

1.17

2.89

4.9

352.85

364.73

umol/l

1.19

438

3167

Acute pancreatitis (for exclusion)

139

1038

1.34

2.88

5.3

5.0

354.05

360.60

umol/l

0.19

121

882

Benign neoplasm: Sigmoid colon

111

800

1.39

2.87

5.5

4.7

368.22

352.84

umol/l

0.48

684

Crohn's disease of small intestine

387

0.46

2.84

8.7

5.7

320.67

379.20

umol/l

0.79

337

Hernia of abdominal wall, postoperative

120

879

1.37

2.82

4.5

4.9

317.57

374.63

umol/l

3.87

103

755

Peripheral arterial reconstruction

677

1.42

2.82

3.8

3.9

327.18

338.76

umol/l

0.34

569

Simple and mucopurulent chronic bronchitis

165

1.89

2.81

4.2

366.88

351.46

umol/l

0.24

145

Trigger finger

696

0.60

2.81

3.6

5.4

361.43

376.61

umol/l

0.33

598

Bronchitis, not specified as acute or chronic

409

1.55

2.79

6.9

5.1

354.24

370.59

umol/l

0.42

350

Viral infections characterized by skin and mucous membrane lesions

304

2510

1.21

2.76

4.9

5.2

365.99

367.22

umol/l

0.05

273

2169

Primary open-angle glaucoma, strict

145

1095

1.33

2.76

4.7

4.1

351.29

343.39

umol/l

0.26

120

901

Meningitis

255

1.70

2.75

4.5

5.5

358.09

373.27

umol/l

0.31

224

Other and unspecified disorders of white blood cells

181

1.84

2.75

5.1

419.56

364.43

umol/l

1.30

161

Polyarthropathies

430

3362

0.85

2.74

4.8

5.3

346.31

372.61

umol/l

3.28

361

2914

Any event in cancer register

614

4165

0.87

2.73

4.6

5.3

360.58

370.92

umol/l

1.05

528

3625

Amputation of toe

286

1.66

2.73

3.8

4.4

311.44

340.22

umol/l

0.74

249

Follicular cysts of skin and subcutaneous tissue

130

971

1.34

2.72

6.5

5.2

359.89

368.81

umol/l

0.31

115

836

Coxarthrosis

274

2266

0.82

2.71

4.3

4.9

324.19

366.85

umol/l

5.38

232

1936

Other spirochaetal diseases

1343

0.72

2.69

4.5

5.1

362.77

366.22

umol/l

0.09

1161

Procreative management

206

2175

0.80

2.68

4.8

5.8

383.00

383.56

umol/l

0.02

186

1947

Pedal cyclist injured in noncollision transport accidents

643

1.42

2.67

4.5

5.4

333.36

368.94

umol/l

1.45

565

Osteomyelitis

288

1.64

2.67

3.8

4.9

342.67

356.44

umol/l

0.25

254

Chronic pancreatitis

635

1.43

2.67

5.6

5.1

368.34

357.33

umol/l

0.26

547

Sequelae of other external causes

250

1.69

2.66

3.7

5.5

335.31

370.03

umol/l

0.63

221

Striking against or struck by other objects

268

2196

1.22

2.66

5.4

361.72

371.72

umol/l

0.53

226

1935

Pregnancy hypertension

182

2079

0.79

2.65

4.3

5.5

350.19

381.95

umol/l

2.29

159

1822

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

403

0.49

2.64

4.0

4.5

340.87

339.35

umol/l

0.01

345

Gout, unspecified

123

916

1.35

2.63

5.1

4.3

349.04

348.30

umol/l

0.02

768

Other disorders of cornea

472

1.49

2.63

5.2

5.5

333.52

365.97

umol/l

1.18

409

Hypermetropia

328

1.60

2.63

5.6

5.2

431.96

370.40

umol/l

1.89

290

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

129

1386

0.75

2.62

5.3

5.2

362.28

379.75

umol/l

0.67

109

1213

Gestational [pregnancy-induced] hypertension

1334

0.72

2.62

4.3

5.6

339.42

380.11

umol/l

2.26

1159

Salpingitis and oophoritis

110

806

1.37

2.61

4.5

5.5

348.32

383.96

umol/l

1.93

705

Primary open-angle glaucoma

176

1343

1.28

2.61

4.6

4.0

346.95

339.42

umol/l

0.28

145

1109

Other disorders of bone

145

1108

1.31

2.60

4.9

5.2

382.52

372.61

umol/l

0.33

125

961

Other menopausal disorders

111

869

0.73

2.60

5.0

5.4

367.07

387.70

umol/l

0.88

765

Intentional self-harm by other and unspecified firearm discharge

7.68

2.60

7.4

3.4

397.80

270.29

umol/l

—

Inflammatory diseases of prostate (prostatitis)

706

1.40

2.59

4.4

4.8

355.31

356.42

umol/l

0.02

596

Azathioprine

898

0.67

2.58

5.0

5.4

312.42

373.60

umol/l

2.68

787

ILD medications: azathioprine

898

0.67

2.58

5.0

5.4

312.42

373.88

umol/l

2.70

790

Functional dyspepsia

175

1373

1.28

2.57

5.4

5.1

359.98

372.37

umol/l

0.54

155

1173

Scoliosis

394

1.53

2.56

5.0

5.2

347.91

379.82

umol/l

0.88

341

Peripheral artery operations in Hilmo

532

1.45

2.55

4.3

4.1

324.79

335.42

umol/l

0.28

439

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

210

1087

1.26

2.55

5.0

5.5

350.16

378.09

umol/l

1.77

177

939

Lesion of lateral popliteal nerve

239

1.69

2.52

5.6

5.7

347.96

363.04

umol/l

0.27

207

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

208

2257

0.80

2.52

4.6

5.5

351.28

381.79

umol/l

2.47

184

1974

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1094

0.70

2.51

4.4

5.4

325.59

370.25

umol/l

1.88

954

Lyme disease

1325

0.73

2.50

4.5

5.1

362.77

366.93

umol/l

0.11

1145

Impacted cerumen

437

1.50

2.49

4.7

390.17

353.27

umol/l

0.93

380

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

276

2274

0.83

2.48

4.4

4.8

332.94

364.43

umol/l

2.97

229

1941

Type 1 diabetes, strict definition

570

0.59

2.46

3.3

5.7

367.98

387.09

umol/l

0.28

512

Adenocarcinoma and papilloma adenocarcinoma of rectum

392

0.51

2.46

4.0

4.6

340.87

339.50

umol/l

0.01

336

IBD (strict) with PSC

0.00

2.45

0.0

5.7

—

381.67

—

Colitis, primary sclerosing, strict definition

0.00

2.45

0.0

6.5

—

376.11

—

Other specified disorders of external ear

152

1.86

2.44

6.2

5.0

357.35

356.41

umol/l

0.01

135

Inflammatory disease of cervix uteri

257

1.65

2.42

4.5

5.2

367.70

377.15

umol/l

0.16

220

Malignant neoplasm of bronchus and lung

749

0.66

2.40

3.7

3.9

364.52

333.55

umol/l

0.69

617

Disorders of muscles

507

1.45

2.39

5.6

5.3

347.59

371.97

umol/l

0.81

438

Deforming dorsopathies

193

1548

1.25

2.39

4.7

5.3

346.41

375.00

umol/l

1.78

169

1340

Retinal breaks without detachment

714

0.64

2.38

4.5

5.0

366.74

355.37

umol/l

0.25

619

Noninfective enteritis and colitis

353

2999

1.18

2.38

5.2

359.47

370.23

umol/l

0.71

307

2619

Other specified/unspecified hearing loss

345

1.55

2.37

4.4

4.9

345.91

356.62

umol/l

0.17

293

Emergency coronary revascularization (for ACS)

246

2142

0.82

2.35

3.1

4.5

339.76

343.72

umol/l

0.16

197

1798

Abscess of anal and rectal regions

501

1.45

2.35

4.5

5.2

354.99

370.59

umol/l

0.40

437

Crushed, pushed or stepped on by crowd or human stampede

452

1.47

2.34

5.9

5.6

347.88

379.68

umol/l

1.10

398

Ulcerative colitis (strict definition, all Crohn cases excluded)

878

0.68

2.33

4.6

5.5

333.27

369.53

umol/l

1.08

769

Contact with other hot metals

2.34

2.33

6.8

6.0

405.27

367.71

umol/l

0.46

Trigeminal neuralgia

260

1.63

2.33

3.8

5.2

360.06

365.76

umol/l

0.08

220

Insulin, fast-acting

269

2238

1.20

2.33

5.1

342.18

368.21

umol/l

2.17

236

1933

387

1.51

2.32

4.8

5.9

348.44

372.14

umol/l

0.55

334

Noninflammatory disorders of female genital tract

302

1267

1.20

2.32

5.2

5.1

360.97

379.21

umol/l

1.31

256

1098

Recurrent dislocation of patella

276

1.61

2.32

4.9

5.6

380.13

384.13

umol/l

0.07

234

Other obstetric conditions, not elsewhere classified

214

1125

1.24

2.31

5.0

5.5

350.26

379.16

umol/l

1.92

180

973

Coronary revascularization (ANGIO or CABG)

212

1814

0.81

2.30

3.2

4.6

343.92

349.28

umol/l

0.20

174

1513

Medicines for HER+ breast cancer

133

1670

0.77

2.29

5.3

5.1

362.45

373.92

umol/l

0.40

113

1453

False labour

153

1223

0.78

2.29

4.6

5.7

381.35

385.64

umol/l

0.14

137

1069

Postprocedural musculoskeletal disorders, not elsewhere classified

285

1.59

2.28

4.4

5.0

320.74

359.06

umol/l

0.96

248

Nonspecific lymphadenitis

301

1.57

2.28

5.2

5.7

358.93

371.75

umol/l

0.25

268

Malignant neoplasm of rectum

394

0.53

2.27

3.6

4.5

319.66

342.09

umol/l

0.22

337

Intracranial nontraumatic haemorrhage of fetus and newborn

6.02

2.27

5.2

3.4

476.20

415.44

umol/l

—

Unspecified misadventure during surgical and medical care

255

1.62

2.25

4.4

5.3

357.34

358.54

umol/l

0.02

222

Other coagulation defects

326

1.54

2.24

4.1

5.4

364.07

367.87

umol/l

0.06

283

Coxarthrosis [arthrosis of hip](FG)

286

2459

0.84

2.24

4.2

4.9

322.81

364.97

umol/l

5.53

241

2107

Unspecified maternal hypertension

0.00

2.24

0.0

6.7

—

364.38

—

109

775

1.33

2.24

3.7

3.6

325.84

329.41

umol/l

0.09

630

Failed attempted abortion

0.00

2.24

0.0

6.5

—

357.86

—

Benign neoplasm: Rectum

110

829

1.33

2.23

3.7

4.6

348.32

356.42

umol/l

0.22

700

Diabetes mellitus in pregnancy

154

1265

0.79

2.23

4.2

5.6

341.98

382.28

umol/l

2.53

132

1096

Collagenous colitis

424

1.47

2.23

5.3

5.2

339.69

365.23

umol/l

0.61

367

Other skin changes

101

752

1.35

2.22

4.7

320.49

355.65

umol/l

1.74

647

Melanocytic naevi of trunk

604

0.63

2.22

3.9

5.2

369.00

367.50

umol/l

0.02

519

Atopic dermatitis, strict definition

230

1859

1.22

2.21

4.8

5.4

372.89

380.49

umol/l

0.34

206

1638

Other congenital malformations, not elsewhere classified

2.68

2.21

5.3

4.6

412.82

354.65

umol/l

0.75

Malignant neoplasm of respiratory system and intrathoracic organs

864

0.70

2.20

3.7

4.0

342.50

338.17

umol/l

0.08

713

Nail disorders

442

1.46

2.19

4.9

5.4

357.64

376.90

umol/l

0.51

384

Primary coxarthrosis, bilateral

1306

0.75

2.18

3.9

4.3

334.79

350.65

umol/l

0.55

1099

Dysplasia of cervi uteri

158

966

1.27

2.18

5.0

5.4

383.35

384.62

umol/l

0.04

140

851

Dipeptidyl peptidase 4 (DPP-4) inhibitors

484

1.43

2.17

4.5

4.1

339.89

353.85

umol/l

0.35

399

Seronegative rheumatoid arthritis

551

0.61

2.16

4.7

5.1

361.71

363.32

umol/l

0.02

481

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

205

1677

1.23

2.15

4.5

5.6

365.70

371.47

umol/l

0.22

170

1466

Alcoholic liver disease

477

1.43

2.15

4.5

5.1

356.93

356.22

umol/l

0.01

415

Arthropathic psoriasis

611

0.64

2.15

4.1

5.4

375.60

374.94

umol/l

0.01

530

Conjunctivitis

585

4528

1.13

2.14

4.9

5.3

363.69

376.23

umol/l

1.36

503

3983

Chronic laryngitis and laryngotracheitis

680

1.36

2.14

4.5

4.9

324.20

362.71

umol/l

1.52

592

Herpesviral [herpes simplex] infections

570

1.39

2.13

4.7

5.4

332.42

371.37

umol/l

1.57

493

Benign neoplasm: Caecum

420

1.46

2.13

4.0

4.6

343.24

345.80

umol/l

0.05

363

Appendectomy

511

4341

1.14

2.12

5.9

5.3

368.28

373.69

umol/l

0.38

447

3797

Type 1 diabetes, strict definition, subgroup 1

534

0.61

2.12

3.4

5.6

370.83

384.94

umol/l

0.19

480

Other (seronegative) rheumatoid arthritis, wide

883

0.70

2.11

3.9

5.0

369.83

357.76

umol/l

0.24

763

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

510

0.61

2.11

4.4

4.1

336.45

347.15

umol/l

0.17

427

Pregnancy examination and test

671

0.72

2.10

4.7

6.0

346.65

382.19

umol/l

1.67

583

Urticaria

206

1691

1.22

2.10

4.6

5.4

337.85

374.72

umol/l

2.96

179

1480

Nasal polyp

1102

0.73

2.09

4.2

4.9

351.89

362.40

umol/l

0.27

949

All dysplastic lesions of the cervix uteri, vagina or vulva

178

1430

1.24

2.09

4.8

5.5

374.32

378.40

umol/l

0.14

158

1246

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

986

0.72

2.09

4.1

5.4

323.00

366.65

umol/l

1.84

862

Ulcerative colitis (strict) with PSC

0.00

2.09

0.0

5.5

—

384.27

—

Chalazion

598

1.38

2.08

5.2

5.5

382.63

365.62

umol/l

0.48

522

Other pleural conditions

422

1.45

2.08

5.8

4.4

358.88

339.46

umol/l

0.53

352

Disorders of porphyrin and bilirubin metabolism

0.00

2.08

0.0

5.3

—

360.29

—

Nummular dermatitis

365

1.49

2.07

5.5

5.3

403.37

360.18

umol/l

1.47

321

Hernia

759

4643

1.11

2.07

4.8

5.2

347.89

371.45

umol/l

4.54

658

4036

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

867

0.70

2.06

3.8

4.3

346.00

350.62

umol/l

0.10

720

Disorders of globe

2.00

2.06

5.2

4.1

373.50

375.47

umol/l

0.02

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

685

1.35

2.06

4.2

5.0

343.70

355.55

umol/l

0.31

591

Gout, FINNGEN

173

1398

1.24

2.06

5.2

4.3

337.50

345.51

umol/l

0.34

145

1167

Disorders of conjunctiva

646

4846

1.12

2.05

4.8

5.2

361.42

374.18

umol/l

1.47

556

4240

Other abnormal products of conception

144

1209

0.79

2.04

5.3

5.8

366.05

387.84

umol/l

0.91

126

1061

Acute appendicitis, with complications

141

1115

1.27

2.03

6.1

5.0

357.28

366.97

umol/l

0.33

121

957

Other diseases of liver

117

904

1.30

2.02

5.6

5.1

366.70

367.04

umol/l

0.01

786

Psoriatic arthropathies, ICD10

565

0.63

2.02

4.1

5.5

371.38

371.01

umol/l

0.00

491

Ulcerative colitis (strict definition, require KELA)

1025

0.73

2.01

4.3

5.4

320.48

368.41

umol/l

2.06

897

Colonic or urogenital fistula

183

1493

1.23

2.00

4.3

5.1

359.38

366.29

umol/l

0.30

157

1286

Insulin, fast-acting or short human

272

2303

1.18

1.99

5.1

340.98

367.11

umol/l

2.20

238

1991

Cervicocranial syndrome

510

1.40

1.99

5.2

5.3

348.91

367.53

umol/l

0.52

449

All dysplastic lesions of the cervix uteri

156

1249

1.25

1.99

5.2

5.4

383.01

376.07

umol/l

0.23

140

1080

Shoulder lesions

481

3338

0.88

1.99

3.7

5.3

350.08

370.21

umol/l

2.33

403

2914

Other joint disorders

826

3990

1.10

1.97

4.7

5.4

356.42

375.53

umol/l

3.22

726

3465

Sequelae of injuries of neck and trunk

149

1.76

1.96

3.0

6.0

311.15

366.13

umol/l

0.69

134

Exposure to other and unspecified inanimate mechanical forces

387

1.46

1.95

4.5

5.7

327.35

378.29

umol/l

1.40

345

Sequelae of injuries of lower limb

521

1.39

1.94

6.4

5.5

334.66

370.89

umol/l

1.83

452

Acute epiglottitis

2.14

1.93

5.9

5.5

359.73

391.74

umol/l

0.51

Contact with machinery

631

0.66

1.93

5.2

326.72

364.37

umol/l

1.22

547

Other specified congenital malformation syndromes affecting multiple systems

106

1.92

5.5

5.0

431.60

392.52

umol/l

0.61

Psoriatic and enteropathic arthropathies

642

0.67

1.92

3.9

5.3

360.88

378.14

umol/l

0.28

559

Asthma and allergy

617

1.35

1.91

4.9

5.2

319.15

378.05

umol/l

3.21

538

Benign neoplasm: Sigmoid colon

111

860

1.30

1.90

5.5

4.6

368.22

356.91

umol/l

0.33

728

Malignant neoplasm of breast, HER-positive

127

1579

0.79

1.90

5.2

5.0

362.88

375.67

umol/l

0.43

107

1372

Nephropathy related operations

661

1.34

1.89

6.5

5.1

345.20

361.96

umol/l

0.48

574

Varicose veins

321

2809

0.86

1.88

4.6

4.8

357.54

365.06

umol/l

0.41

272

2412

Psoriatic arthropathies

567

0.65

1.88

4.0

5.5

371.38

378.93

umol/l

0.10

485

Purpura and other haemorrhagic conditions

653

1.34

1.87

5.2

5.1

395.03

362.91

umol/l

1.21

568

Diabetic retinopathy, strict definition

1059

0.76

1.87

5.9

5.7

348.14

360.99

umol/l

0.40

932

Benign neoplasm of other and unspecified endocrine glands

593

1.35

1.87

5.3

5.2

366.57

362.14

umol/l

0.11

516

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

778

0.71

1.87

5.1

4.7

350.17

368.48

umol/l

0.49

658

Secondary uncertain malignant neoplasm

554

0.65

1.87

6.2

4.8

330.00

349.65

umol/l

0.42

468

Melanocytic naevi of trunk

578

0.65

1.87

3.9

5.4

369.00

365.36

umol/l

0.04

501

Viral infections of central nervous system, not elsewhere classified/unspecified

2.43

1.86

2.9

5.5

327.84

379.75

umol/l

0.36

Other and unspecified corneal deformities and disorders

159

1.71

1.86

4.4

5.8

337.05

372.90

umol/l

0.61

143

L02BG Aromatase inhibitors

101

1306

0.77

1.86

5.8

5.0

378.26

373.88

umol/l

0.11

1130

Chronic periodontitis, complicated

441

1.41

1.86

5.8

5.2

346.93

360.92

umol/l

0.34

387

Other noninflammatory disorders of vulva and perineum

383

1.44

1.85

4.5

5.6

394.76

379.09

umol/l

0.37

330

Psoriasis vulgaris

132

1050

1.26

1.84

5.1

5.2

343.50

368.31

umol/l

1.15

112

906

Other abnormal uterine and vaginal bleeding

144

821

1.25

1.84

5.1

354.70

377.74

umol/l

1.06

124

715

Intestinal adhesions without obstruction

367

1.45

1.84

7.4

4.6

350.50

359.74

umol/l

0.17

316

Spontaneous abortion

214

1739

0.84

1.83

4.9

5.5

374.36

381.65

umol/l

0.35

190

1523

Temporomandibular joint disorders, including avohilmo

286

2450

1.17

1.83

5.1

5.4

377.84

374.35

umol/l

0.14

246

2150

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1110

0.75

1.83

3.3

4.5

330.56

355.17

umol/l

0.98

913

Asthma and allergy, excluding more controls

623

1.34

1.81

4.9

5.2

319.15

377.33

umol/l

3.15

546

Spondylopathies (FG)

821

0.72

1.81

4.8

5.3

337.67

371.93

umol/l

1.25

721

Glaucoma

338

2578

1.15

1.80

4.9

4.5

358.77

352.85

umol/l

0.30

284

2176

Melanocytic naevi of other and unspecified parts of face

287

0.52

1.79

6.8

5.5

412.33

368.21

umol/l

0.69

247

Sequelae of other and unspecified infectious and parasitic diseases

320

1.48

1.79

5.4

6.0

365.27

370.27

umol/l

0.09

274

Convergent concomitant strabismus

320

1.48

1.79

5.2

5.5

429.98

373.37

umol/l

1.64

280

Appendicitis, broad definition

583

4795

1.11

1.78

5.6

5.3

370.41

370.42

umol/l

0.00

513

4175

144

1028

1.24

1.78

3.6

318.33

328.51

umol/l

0.37

113

844

Dislocation, sprain and strain of joints and ligaments at neck level

110

861

1.28

1.77

4.6

5.6

357.15

369.83

umol/l

0.40

757

Gestational diabetes (for exclusion)

171

1469

0.82

1.76

4.6

5.5

354.53

381.64

umol/l

1.60

150

1272

Melanocytic naevi of other and unspecified parts of face

285

0.52

1.76

6.8

5.4

412.33

372.93

umol/l

0.59

242

Keratitis

247

2103

1.18

1.75

5.0

5.2

349.48

367.87

umol/l

1.28

213

1820

Diseases of appendix

586

4813

1.11

1.74

5.6

5.3

370.26

370.30

umol/l

0.00

516

4191

Adjustment and management of implanted device

749

1.30

1.73

3.6

4.1

317.78

337.89

umol/l

0.74

604

Chondropathies

109

855

1.28

1.73

5.3

402.32

369.34

umol/l

1.42

747

Foreign body on external eye

974

0.75

1.72

5.2

5.5

352.07

368.98

umol/l

0.58

856

Other disorders of amniotic fluid and membranes

783

0.72

1.72

5.1

5.8

364.13

381.82

umol/l

0.44

678

Use of dimethyl fumarate

0.00

1.72

0.0

5.7

—

373.78

—

Presence of cardiac and vascular implants and grafts

280

1821

1.17

1.71

3.2

4.6

332.75

345.66

umol/l

0.81

224

1538

Familial hypercholesterolemia, with ischemic heart disease

398

1.41

1.71

3.8

4.0

350.06

336.28

umol/l

0.34

328

Synovial cyst of popliteal space [Baker]

315

1.47

1.71

4.4

5.2

391.33

370.12

umol/l

0.43

273

Embedded teeth, including avohilmo

517

1.36

1.71

5.4

5.6

426.54

369.19

umol/l

2.76

448

Abrasion of teeth

192

1175

1.20

1.70

5.6

5.3

373.28

366.79

umol/l

0.24

167

1014

Coronary angioplasty

169

1568

0.83

1.69

3.0

4.5

349.93

344.80

umol/l

0.18

136

1301

Other arthrosis

321

2635

0.87

1.69

4.1

5.2

360.06

372.18

umol/l

0.84

278

2276

Postprocedural disorders of nervous system

349

1.44

1.69

4.6

6.0

347.44

380.47

umol/l

0.89

312

Disorders of synovium and tendon

300

3109

0.87

1.68

4.2

5.3

350.08

373.46

umol/l

2.17

254

2713

Graves disease, strict definition

455

0.63

1.67

6.4

5.6

399.47

371.52

umol/l

0.52

390

Malignant melanoma, excluding all cancers (controls excluding all cancers)

808

0.73

1.66

3.9

4.5

326.69

359.14

umol/l

0.94

680

Abnormal blood-pressure reading, without diagnosis

204

1.58

1.66

5.6

5.5

398.04

374.77

umol/l

0.34

170

Paroxysmal tachycardia

145

998

1.23

1.65

4.7

5.2

379.58

381.03

umol/l

0.04

129

857

Voice disturbances

155

1276

1.22

1.62

4.2

5.0

332.86

369.74

umol/l

2.38

129

1096

Sudden idiopathic hearing loss

450

0.64

1.61

4.1

5.0

344.00

356.83

umol/l

0.17

387

Colon adenocarcinoma

474

0.65

1.60

4.4

4.1

336.45

342.38

umol/l

0.09

406

Benign neoplasm: Caecum

446

1.37

1.60

4.0

4.6

343.24

356.75

umol/l

0.34

378

LSIL lesion of the cervix uteri

480

1.36

1.60

4.3

5.5

387.58

370.68

umol/l

0.36

411

Pyoderma

1.97

1.60

4.8

5.1

359.47

365.82

umol/l

0.06

Abnormal findings on diagnostic imaging of other body structures

558

1.33

1.59

4.7

4.8

350.22

359.02

umol/l

0.18

487

Presbyopia

279

1.48

1.59

5.9

5.5

401.22

357.82

umol/l

1.44

248

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

236

1896

0.85

1.59

4.1

4.7

327.89

358.70

umol/l

2.49

197

1598

Methotrexate

731

0.72

1.58

3.8

5.2

348.70

369.01

umol/l

0.48

642

Ventral hernia

144

1181

1.22

1.57

4.7

4.9

334.42

364.79

umol/l

1.83

124

1006

Diseases of peritoneum

465

1.36

1.56

4.9

5.1

335.14

355.45

umol/l

0.53

405

Lung cancer and mesothelioma

529

1.31

1.56

3.8

3.9

355.28

346.30

umol/l

0.22

425

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

330

1.43

1.56

3.6

4.6

341.54

348.98

umol/l

0.16

284

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

230

1852

0.86

1.55

4.1

4.7

328.56

358.32

umol/l

2.27

191

1561

Lichen planus, including avohilmo

854

0.75

1.54

3.1

5.1

346.43

361.20

umol/l

0.31

743

Syphilis

130

1.71

1.54

4.4

5.6

306.88

369.99

umol/l

0.87

115

Disorders of eyelid in diseases classified elsewhere

153

1.65

1.54

4.0

5.5

345.85

366.08

umol/l

0.29

133

Chronic respiratory disease originating in the perinatal period

3.46

1.54

2.4

4.2

349.40

414.00

umol/l

—

Other bursopathies

632

1.30

1.53

5.0

5.3

353.34

367.35

umol/l

0.40

543

Other and unspecified abdominal hernia

169

1.61

1.52

3.4

5.0

343.00

361.12

umol/l

0.21

150

Benign neoplasm: Bones of skull and face

0.00

1.52

0.0

5.8

—

380.79

—

Benign neoplasm of other and unspecified endocrine glands

615

1.31

1.52

5.3

5.1

366.57

366.44

umol/l

0.00

531

In situ neoplasms

148

1702

0.83

1.51

4.6

344.64

358.36

umol/l

0.58

136

1424

Separation of retinal layers (serosa)

205

0.48

1.51

3.8

5.8

411.30

361.80

umol/l

—

186

Ptosis of eyelid

451

1.36

1.51

4.3

5.0

323.16

354.60

umol/l

1.21

390

Other keratitis

607

1.31

1.51

4.5

5.5

358.27

369.50

umol/l

0.30

529

Other specific joint derangements/joint disorders

625

3817

1.10

1.50

4.8

5.4

358.73

375.55

umol/l

2.18

553

3321

Burn and corrosion of ankle and foot

2.03

1.50

6.5

5.6

449.54

361.43

umol/l

0.95

Other diseases of peritoneum

202

1.54

1.49

4.3

5.2

347.52

360.17

umol/l

0.21

176

Impotence

251

1.48

4.4

5.0

395.00

348.20

umol/l

0.80

213

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1062

0.78

1.46

4.0

4.9

365.28

374.13

umol/l

0.25

912

Coronary artery bypass grafting

115

1080

0.81

1.46

3.1

4.2

319.14

336.03

umol/l

0.56

882

Acute appendicitis

542

4643

1.10

1.46

5.6

5.3

367.08

371.15

umol/l

0.27

475

4046

LSIL lesion of the cervix uteri, vagina or vulva

619

1.30

1.46

4.0

5.5

379.32

374.65

umol/l

0.09

528

Cardiodefibrillation

151

1806

0.83

1.46

3.8

4.5

348.06

345.71

umol/l

0.08

129

1509

Type 1 diabetes

186

1574

1.18

1.46

4.8

5.2

343.73

374.87

umol/l

2.07

159

1366

Other and unspecified disorders of vitreous body

171

2014

0.84

1.45

3.7

4.9

344.76

365.21

umol/l

1.17

148

1717

Calculus of kidney and ureter

136

1642

0.83

1.43

4.4

4.8

342.55

360.29

umol/l

0.71

109

1397

Lichen planus

567

0.70

1.43

3.4

5.1

359.44

364.09

umol/l

0.06

498

Infections of breast associated with childbirth

154

0.45

1.43

3.6

6.1

384.00

386.07

umol/l

—

131

Degeneration of macula and posterior pole

247

1765

1.16

1.43

3.9

4.2

329.77

342.90

umol/l

0.68

200

1473

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

345

1.40

1.42

5.0

5.1

342.95

358.31

umol/l

0.28

298

Antepartum haemorrhage, not elsewhere classified

484

0.68

1.42

5.1

6.0

369.25

378.19

umol/l

0.16

417

Other congenital malformations of tongue, mouth and pharynx

1.83

1.40

3.3

5.0

417.25

393.69

umol/l

0.22

Postmenopausal atrophic vaginitis

110

817

0.81

1.38

5.1

5.2

388.38

381.78

umol/l

0.18

105

716

Coronary atherosclerosis

376

2713

0.89

1.38

4.3

4.9

338.72

359.58

umol/l

2.30

329

2297

Other and unspecified mononeuropathies of lower limb

121

0.41

1.38

3.6

5.1

280.60

352.31

umol/l

—

104

Disorders of sclera, cornea, iris and ciliary body

387

3469

1.12

1.37

4.8

5.2

356.35

368.72

umol/l

1.02

338

3006

Diabetic retinopathy, excluding more controls

142

961

0.83

1.36

5.6

5.7

353.72

365.60

umol/l

0.43

117

838

Lichen ruber planus, wide definition including periferal and oral lichen planus

1015

0.79

1.36

3.1

5.1

350.61

363.58

umol/l

0.30

875

Sequelae of infectious and parasitic diseases

400

1.36

1.35

5.1

5.4

364.88

361.38

umol/l

0.07

341

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

0.00

1.35

0.0

4.6

—

350.09

—

Artrosis, including avohilmo

714

3607

1.09

1.35

4.8

5.3

349.59

372.20

umol/l

4.05

613

3119

Bacterial, viral and other infectious agents

522

1.31

1.34

7.0

5.7

382.82

367.57

umol/l

0.43

458

Infliximab

0.00

1.33

0.0

5.4

—

376.15

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

674

0.74

1.33

3.8

4.6

339.05

357.26

umol/l

0.37

571

Golimumab

195

0.51

1.33

2.6

6.3

301.80

364.43

umol/l

—

172

Malignant neoplasm of colon

605

0.73

1.33

3.7

4.4

336.77

343.43

umol/l

0.12

513

Malignant neoplasm of other and unspecified parts of biliary tract

0.00

1.33

0.0

4.1

—

363.94

—

Retinal vascular occlusion

462

1.32

3.4

4.1

345.38

345.01

umol/l

0.01

388

Occupational exposure to risk-factors

146

0.48

1.32

3.9

5.3

267.86

371.04

umol/l

—

129

Perforation of tympanic membrane

497

1.31

1.32

4.8

5.0

386.71

366.38

umol/l

0.46

433

Other and unspecified urticaria

127

1052

1.21

1.31

5.0

5.4

341.98

375.07

umol/l

1.66

104

918

Other orthopaedic follow-up care

250

1.45

1.31

4.1

5.4

363.48

358.15

umol/l

0.07

214

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

834

0.79

1.31

3.8

4.1

358.87

346.47

umol/l

0.32

689

Injury of muscle and tendon at shoulder and upper arm level

168

1971

0.85

1.31

3.7

5.1

336.96

364.54

umol/l

1.78

148

1678

Hyperplasia of prostate

248

1232

1.15

1.30

4.2

4.7

346.63

350.57

umol/l

0.17

214

1037

Arterial embolism and thrombosis

234

1.46

1.29

2.5

4.1

375.44

347.31

umol/l

0.15

203

Entropion and trichiasis of eyelid

335

1.38

1.29

4.2

4.1

360.69

340.44

umol/l

0.51

282

Other and unspecified disease of Bartholin gland

114

1.68

1.29

4.7

5.4

348.71

379.95

umol/l

0.50

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

133

0.45

1.28

1.2

4.5

323.67

352.58

umol/l

—

118

Papulosquamous disorders

257

2260

1.14

1.27

4.7

5.2

354.10

370.51

umol/l

0.96

215

1956

HSIL lesion of the cervix uteri, vagina or vulva

114

939

1.22

1.26

5.2

5.4

369.00

375.44

umol/l

0.18

108

798

Thrombocytopenia, unspecified

320

1.38

1.25

5.6

5.1

405.33

360.36

umol/l

1.14

285

Atypical virus infections of central nervous system

2.25

1.25

2.9

3.7

327.25

376.00

umol/l

—

Hydronephrosis

467

1.31

1.24

7.3

4.6

361.86

352.10

umol/l

0.21

395

Other disorders of nervous system

270

1.41

1.23

4.2

5.6

338.30

367.44

umol/l

0.56

242

Mixed conductive and sensorineural hearing loss

529

1.29

1.23

3.8

4.8

390.43

353.49

umol/l

1.17

453

5-aminosalicylic acid

114

1375

0.83

1.23

4.7

5.5

348.92

370.05

umol/l

0.83

1199

163

1.53

1.23

5.7

4.6

431.58

430.86

umol/l

0.01

155

Demyelinating diseases of the central nervous system

442

1.32

1.23

4.2

5.8

384.83

369.92

umol/l

0.29

386

Other abnormalities of plasma proteins

1.99

1.23

5.6

4.3

298.36

360.07

umol/l

0.58

Retinal vascular disorders

469

1.30

1.21

3.4

4.1

345.38

344.33

umol/l

0.02

392

Crohn disease

764

0.77

1.21

6.4

5.4

353.78

371.62

umol/l

0.44

666

Unspecified nephritic syndrome

101

1.70

1.20

4.3

5.9

331.18

378.97

umol/l

0.98

Maternal care for known or suspected fetal abnormality and damage

828

0.79

1.19

5.2

5.8

309.97

381.99

umol/l

4.11

716

L02BA Anti-estrogens

706

0.76

1.19

4.0

5.3

338.66

375.54

umol/l

1.15

608

Gonarthrosis

528

2772

1.09

1.19

4.6

5.2

347.75

371.16

umol/l

3.26

452

2383

Congenital malformations of the circulatory system

107

854

1.22

1.19

4.0

5.3

374.63

384.61

umol/l

0.32

761

Other deformities of toe(s)

167

0.54

1.19

4.3

5.3

357.44

375.36

umol/l

—

145

Motorcycle rider injured in other and unspecified transport accidents

384

1.34

1.18

3.8

5.9

335.81

373.65

umol/l

0.89

341

Arterial embolism and thrombosis of lower extremity artery

117

1.63

1.18

2.5

4.1

274.42

350.19

umol/l

0.84

105

Bullous disorders

248

1.42

1.17

3.7

5.1

351.30

362.68

umol/l

0.11

218

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

250

1940

0.88

1.17

4.4

4.7

333.71

359.61

umol/l

1.99

209

1635

Cholinergic urticaria

2.54

1.16

3.8

5.5

367.80

360.93

umol/l

—

malignant neoplasm of female genital organs

589

0.75

1.16

5.3

4.8

342.62

362.11

umol/l

0.46

496

Abnormal spermatozoa

520

0.73

1.15

6.3

4.3

376.20

339.79

umol/l

0.75

440

HSIL lesion of the cervix uteri

103

849

1.22

1.15

5.4

5.6

376.43

374.46

umol/l

0.04

724

Gilbert syndrome

0.00

1.15

0.0

5.3

—

361.55

—

Haemorrhage in early pregnancy

129

1488

0.84

1.14

4.5

5.6

361.09

384.66

umol/l

1.02

113

1292

Malignant neoplasm of breast, HER-negative

878

0.79

1.13

3.8

4.9

368.02

368.00

umol/l

0.00

755

Mucosal proctocolitis

778

0.78

1.13

5.3

5.6

325.76

373.41

umol/l

1.73

684

Anterior Iridocyclitis

129

1089

1.19

1.13

4.4

5.2

364.77

364.24

umol/l

0.02

114

947

Gout, strict definition

779

1.22

1.12

5.5

4.3

354.51

345.09

umol/l

0.27

652

Injury of muscle and tendon at forearm level

1.72

1.12

5.5

5.7

302.40

370.51

umol/l

1.03

Additional codes for the location of defect, injury or illness

259

1.40

1.11

5.0

5.6

340.21

364.23

umol/l

0.43

228

Injury of muscle and tendon at hip and thigh level

470

0.72

1.11

3.5

5.4

341.37

369.33

umol/l

0.59

416

Unspecified jaundice

220

0.59

1.11

6.1

4.4

355.85

356.10

umol/l

0.00

195

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

975

0.82

1.10

3.8

4.3

340.20

347.74

umol/l

0.20

804

Benign neoplasm: Small intestine

168

1.50

1.10

5.1

4.6

356.60

358.00

umol/l

0.01

140

Pulmonary oedema

1.96

1.09

17.4

2.9

428.75

339.42

umol/l

—

Seborrhoeic keratosis

973

0.81

1.09

4.4

4.6

366.67

356.32

umol/l

0.24

825

Pneumonia due to other infectious organisms, not elsewhere classified

120

1.59

1.09

4.4

4.9

363.50

364.40

umol/l

0.01

102

Ethmoidectomy

695

0.77

1.09

5.0

5.4

343.02

370.15

umol/l

0.74

603

ILD, hospital admission 2, with pulmonary infections

303

1.36

1.08

3.2

4.0

299.44

350.94

umol/l

1.32

249

Gout

173

1368

1.15

1.08

5.2

4.7

337.50

352.50

umol/l

0.77

145

1152

Carcinoma in situ of skin

327

0.67

1.08

3.5

4.0

306.59

343.46

umol/l

0.79

272

Spondyloarthritis

1026

0.82

1.07

4.6

5.1

340.10

364.90

umol/l

1.00

889

Other disorders of veins

237

2103

1.13

1.06

5.6

5.1

371.83

372.09

umol/l

0.01

195

1818

Benign lipomatous neoplasm

141

1642

0.86

1.06

4.8

5.0

369.47

370.57

umol/l

0.03

122

1400

Other benign neoplasms of skin

181

2030

0.87

1.05

5.6

4.7

350.42

365.39

umol/l

0.89

160

1715

Macular hole

203

1.44

1.05

3.2

4.4

340.77

369.25

umol/l

0.35

174

Other disorders of conjunctiva

614

1.24

1.05

4.4

5.0

338.83

359.61

umol/l

0.58

534

Benign neoplasm: Small intestine

170

1.48

1.05

5.1

4.6

356.60

359.58

umol/l

0.03

149

Left bundle-branch block

288

1.36

1.05

5.7

4.6

355.53

354.02

umol/l

0.02

256

Ménière disease

430

0.72

1.05

3.7

4.9

361.57

355.87

umol/l

0.08

373

Hypermobility syndrome

246

1.39

1.03

5.2

6.1

326.03

378.25

umol/l

1.54

217

Injury of muscle and tendon at wrist and hand level

788

1.21

1.03

5.5

5.6

345.54

369.35

umol/l

0.89

683

Type 1 diabetes, strict (exclude DM2)

653

0.78

1.02

3.4

5.5

360.91

386.09

umol/l

0.47

585

Acute and subacute iridocyclitis

123

1046

1.18

1.01

4.5

5.2

363.55

364.71

umol/l

0.03

109

908

Other and unspecified mononeuropathies of upper limb

155

1.49

1.01

6.0

5.8

348.43

356.50

umol/l

0.11

133

Chronic suppurative otitis media, including avohilmo

439

1.28

1.01

4.1

5.2

396.70

369.92

umol/l

0.86

389

Impacted teeth

103

1140

0.84

1.01

5.5

5.6

378.09

373.39

umol/l

0.12

1000

Type 1 diabetes, definitions combined

661

0.78

0.99

3.3

5.5

359.29

385.86

umol/l

0.52

592

Benign lipomatous neoplasm of other sites/unspecified

402

0.72

0.99

5.9

5.0

339.09

357.67

umol/l

0.23

345

conjunctival haemorrhage

326

1.32

0.99

5.0

5.1

334.95

363.10

umol/l

0.57

278

Hodgkin lymphoma, hilmo

134

0.52

0.99

9.4

5.8

398.86

370.26

umol/l

—

118

Hodgkin lymphoma

134

0.52

0.99

9.4

5.8

398.86

369.66

umol/l

—

116

Intestinal malabsorption

223

1.40

0.98

5.7

5.5

394.58

361.68

umol/l

0.45

190

In situ neoplasms

148

1706

0.87

0.98

4.6

344.64

356.93

umol/l

0.50

136

1421

Other disorders of eyelid

245

2117

1.12

0.98

4.2

4.7

335.54

360.57

umol/l

2.16

202

1790

Pre-eclampsia or eclampsia

1091

0.83

0.98

5.0

5.6

370.55

381.68

umol/l

0.31

936

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

0.00

0.98

0.0

5.4

—

359.64

—

ILD, hospital admissions 3, with pneumonia sepsis

266

1.36

0.98

3.4

3.8

294.53

336.52

umol/l

0.93

226

Thyrotoxicosis

140

1208

1.16

0.97

5.3

5.2

381.48

365.64

umol/l

0.72

116

1050

Other and unspecified nerve root and plexus disorders, also in other diseases

119

1014

1.18

0.97

4.1

5.4

341.67

369.62

umol/l

1.31

868

Foreign body or object entering through skin

371

1.30

0.97

5.6

341.26

366.54

umol/l

0.53

331

152

1.48

0.97

5.8

4.5

432.83

436.58

umol/l

0.03

144

Preterm labour and delivery

124

1444

0.86

0.96

4.6

5.8

378.72

388.69

umol/l

0.32

108

1276

Blepharochalasis

112

1315

0.85

0.96

4.3

4.7

328.70

359.95

umol/l

1.62

1116

Oxicams

169

1099

0.87

0.96

3.9

5.8

335.46

378.92

umol/l

3.56

144

977

Hypoparathyroidism

149

1.48

0.95

8.3

4.8

344.44

358.73

umol/l

0.12

132

Benign lipomatous neoplasm of other sites/unspecified

399

0.72

0.95

5.9

4.8

339.09

357.56

umol/l

0.23

344

Polycystic ovarian syndrome

216

1.39

0.95

5.8

5.6

304.80

378.64

umol/l

2.66

179

All dysplastic lesions of the vagina

118

0.51

0.94

3.5

6.4

277.50

377.20

umol/l

—

103

Exposure to excessive heat of man-made origin

2.25

0.94

8.8

4.3

408.17

339.64

umol/l

—

Malignant melanoma of skin

489

0.75

0.94

4.1

4.9

325.42

347.77

umol/l

0.35

419

Inguinal hernia

407

2984

0.92

0.94

4.4

5.2

348.44

364.99

umol/l

1.50

345

2580

Delayed puberty

1.75

0.93

6.1

5.5

368.67

398.37

umol/l

—

Urethral stricture

226

1.38

0.92

4.3

4.7

324.92

337.45

umol/l

0.21

198

Hypertrophic disorders of skin

278

1.34

0.92

6.7

5.7

358.57

380.48

umol/l

0.50

238

Hypertrophy of breast in women and men

110

937

1.18

0.91

5.4

350.26

377.11

umol/l

1.44

815

Polyp of the female genital tract

154

1027

0.87

0.91

5.0

5.3

357.57

379.96

umol/l

1.09

140

897

Other contact dermatitis

393

1.28

0.90

3.6

5.4

349.59

369.37

umol/l

0.33

335

Covid-19 suspected case

135

1171

1.15

0.90

5.7

5.3

356.76

368.48

umol/l

0.43

116

1008

Other specified/unspecified soft tissue disorders

219

1.38

0.89

3.9

5.1

376.52

360.17

umol/l

0.16

187

Benign neoplasm: Pancreas

104

0.48

0.89

3.0

4.5

310.00

361.85

umol/l

—

Malignant melanoma

619

0.79

0.89

4.3

4.7

322.82

349.91

umol/l

0.61

536

Pre-eclampsia

992

0.84

0.89

5.1

5.7

366.51

381.10

umol/l

0.40

854

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

358

0.72

0.87

5.4

5.6

376.42

378.34

umol/l

0.02

307

Thyroiditis, ILD-related definition

539

1.23

0.87

5.6

5.3

372.47

375.09

umol/l

0.05

469

Vertical strabismus

161

1.44

0.87

3.7

5.3

419.78

364.99

umol/l

0.75

144

Chronic diseases of tonsils and adenoids

589

3982

0.94

0.86

5.4

5.5

371.48

378.74

umol/l

0.60

514

3520

Muscle wasting and atrophy, not elsewhere classified

1.96

0.85

4.7

4.5

386.67

362.83

umol/l

—

Hypertrophy of breast

760

1.19

0.85

4.5

5.5

342.14

384.05

umol/l

2.47

656

Pemphigoid

1.57

0.84

3.9

4.5

294.60

365.38

umol/l

—

Hernia of abdominal wall

287

2617

1.10

0.84

4.8

5.0

336.92

364.77

umol/l

2.65

251

2224

Vitamin B12 deficiency anaemia

451

1.24

0.84

2.7

4.5

324.80

348.90

umol/l

0.62

388

Arthropathies

834

4014

1.06

0.84

4.9

5.3

353.79

376.18

umol/l

4.37

725

3488

Carbimazole or st.post thyroidectomy, condition for graves disease

1006

0.84

0.83

5.8

5.3

373.77

368.69

umol/l

0.14

875

Postmenopausal bleeding

168

814

1.14

0.83

5.6

5.2

386.43

381.27

umol/l

0.18

147

711

Iridocyclitis

142

1245

1.14

0.83

4.3

5.1

363.64

365.68

umol/l

0.06

126

1078

Nonhereditary hypogammaglobulinemia

1.75

0.83

7.9

5.3

337.25

359.77

umol/l

—

Allergic rhinitis

183

2030

0.89

0.83

5.0

5.5

363.48

381.98

umol/l

1.08

160

1798

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

386

3494

1.08

0.83

5.0

5.4

356.64

374.02

umol/l

1.56

331

3066

Bitten or struck by other mammals

570

1.21

0.83

4.8

5.6

333.56

371.36

umol/l

1.29

494

Coeliac disease

570

1.21

0.82

5.9

5.3

394.08

366.72

umol/l

0.92

497

Oral lichen ruber planus, including avohilmo

261

0.69

0.82

3.1

5.4

345.50

374.89

umol/l

0.31

226

Traumatic amputation of wrist and hand

201

0.64

0.81

4.2

5.4

402.62

360.67

umol/l

0.61

182

Urolithiasis

157

1772

0.88

0.81

4.3

4.8

334.31

358.41

umol/l

1.25

124

1509

Varicose veins of other sites

375

0.74

0.81

3.6

5.4

352.48

373.51

umol/l

0.36

332

Angina pectoris

324

2382

0.92

0.81

4.3

4.8

342.40

353.92

umol/l

0.76

286

2017

FESS (DNB20)

665

0.81

5.0

5.5

343.02

369.97

umol/l

0.73

578

Benign neoplasm of major salivary glands

445

1.24

0.80

4.8

5.2

350.73

354.62

umol/l

0.07

388

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

3.6

—

334.32

—

Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

4.8

—

366.80

—

Other specified and unspecified disorders of conjunctiva

1.83

0.79

4.5

4.3

375.17

342.14

umol/l

—

Contact with venomous snakes and lizards

1.68

0.79

6.0

5.4

398.63

370.62

umol/l

—

Benign neoplasm: Bronchus and lung

1.68

0.79

6.9

5.2

381.25

347.29

umol/l

—

Inflammatory bowel disease

182

2031

0.89

0.78

5.5

5.4

354.79

368.50

umol/l

0.60

159

1771

Thyrotoxicosis with diffuse goitre

574

0.80

0.78

5.9

4.9

393.06

365.41

umol/l

0.74

494

Carcinoma in situ of skin of trunk

0.51

0.78

5.4

3.5

271.00

338.16

umol/l

—

Loose body in joint

124

0.56

0.78

3.3

5.7

342.00

371.01

umol/l

—

108

Contact with hypodermic needle

0.00

0.78

0.0

6.1

—

385.23

—

Tonsillectomy and adenotomy

414

3102

0.93

0.78

5.1

5.7

372.99

379.45

umol/l

0.38

355

2767

Benign neoplasm: Pancreas

100

0.50

0.77

3.0

4.5

310.00

364.56

umol/l

—

Coxibs

220

1297

0.90

0.77

4.4

5.8

339.79

381.82

umol/l

4.73

195

1157

Contact with and exposure to communicable diseases

230

2079

1.10

0.77

6.0

5.4

372.09

378.79

umol/l

0.32

209

1823

Other disorders of prostate

132

1.45

0.76

4.7

351.79

326.57

umol/l

0.24

113

Hydrocele

641

1.19

0.75

5.9

4.6

347.77

352.87

umol/l

0.11

541

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

493

0.79

0.75

4.4

3.5

337.03

334.04

umol/l

0.05

401

Tooth eruption problems

827

1.16

0.75

5.1

5.4

404.13

375.31

umol/l

1.24

724

Artificial joint re-operation

280

1.29

0.74

3.9

4.5

380.14

354.66

umol/l

0.49

240

Exfoliative dermatitis

1.86

0.74

4.7

3.9

363.71

316.44

umol/l

—

Congenital malformations and deformations of the musculoskeletal system

557

1.20

0.74

6.0

5.3

382.61

385.48

umol/l

0.05

496

Diverticular disease of intestine

448

2778

1.07

0.73

4.7

4.8

350.57

364.85

umol/l

1.31

391

2366

Mandibular retrognathia

367

0.76

0.73

4.8

5.5

429.39

384.12

umol/l

0.77

325

Carcinoma in situ of skin

300

0.73

3.5

4.2

306.59

342.19

umol/l

0.75

258

Congenital malformations of anterior segment of eye

1.81

0.73

4.4

4.8

406.86

377.19

umol/l

—

Family history of certain disabilities and chronic diseases leading to disablement

228

1.32

0.73

4.1

5.3

371.36

364.62

umol/l

0.09

195

Patellar tendinitis

109

0.55

0.72

6.7

5.6

456.33

383.09

umol/l

—

Congenital deformities of hip

1.53

0.72

8.6

5.2

439.14

393.27

umol/l

0.54

Primary_lymphoid and hematopoietic malignant neoplasms

106

1214

0.87

0.72

4.9

4.6

345.88

356.48

umol/l

0.32

1015

Necrobiosis lipoidica, not elsewhere classified

1.94

0.71

6.4

3.5

328.90

324.05

umol/l

—

Benign neoplasm of other and ill-defined parts of digestive system

775

1.16

0.71

5.8

4.9

350.61

357.02

umol/l

0.16

666

Chronic suppurative otitis media

363

1.24

0.70

3.8

5.2

401.01

368.64

umol/l

0.95

321

Glaucoma suspect

190

1719

1.11

0.70

5.1

4.6

375.79

357.75

umol/l

0.81

168

1452

Gonarthrosis [arthrosis of knee](FG)

582

3232

1.06

0.69

4.6

5.1

348.81

371.40

umol/l

3.43

503

2790

Endocarditis

152

1.39

0.69

3.9

4.5

314.07

349.66

umol/l

0.43

131

Cervicobrachial syndrome

135

1199

1.13

0.69

4.5

5.5

348.63

378.82

umol/l

1.49

119

1033

Benign neoplasm: Brain, infratentorial

1.87

0.69

4.0

3.9

385.00

370.59

umol/l

—

Androgenic alopecia

1.68

0.69

3.7

5.4

364.71

395.19

umol/l

—

Bullous pemphigoid

1.60

0.68

3.0

4.4

252.17

355.98

umol/l

—

Benign lipomatous neoplasm

141

1580

0.89

0.68

4.8

5.0

369.47

366.55

umol/l

0.08

122

1349

Non-follicular lymphoma, hilmo, excluding all cancers

431

0.79

0.68

3.4

4.5

304.37

355.98

umol/l

1.22

369

Other sexually transmitted chlamydial diseases

401

1.23

0.68

5.9

5.7

317.37

376.97

umol/l

2.07

343

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

485

0.80

0.67

3.7

4.3

310.59

352.56

umol/l

1.07

410

Other interventions on the root canals of the tooth

1.50

0.67

6.4

5.8

351.79

373.52

umol/l

0.21

Neovascular glaucoma

179

1.35

0.67

2.0

5.2

281.33

360.28

umol/l

2.24

156

Glaucoma secondary to other eye disorders

179

1.35

0.67

2.0

4.9

281.33

356.56

umol/l

2.10

155

Vestibular neuronitis

418

0.79

0.66

4.5

5.3

359.96

359.40

umol/l

0.01

363

Lichen simplex chronicus and prurigo

276

1.27

0.66

5.3

5.4

332.42

365.14

umol/l

0.53

241

Other/unspecified enthesopathies of lower limb, excluding foot

357

1.24

0.66

4.0

5.6

360.77

380.81

umol/l

0.44

310

Achalasia of cardia

1.55

0.66

7.0

4.5

384.00

360.05

umol/l

0.32

Conductive hearing loss, unspecified

403

1.22

0.65

4.9

5.3

381.69

366.92

umol/l

0.30

347

Disorders of vitreous body

235

2503

0.92

0.65

3.9

4.9

342.07

366.13

umol/l

1.87

202

2138

Other disorders involving the immune mechanism, not elsewhere classified

166

0.66

0.64

4.6

5.5

311.82

365.14

umol/l

0.79

149

Other retinal disorders

388

2916

1.07

0.64

4.5

4.8

342.59

356.49

umol/l

1.01

324

2495

Other interstitial pulmonary diseases

646

0.83

0.64

3.3

4.4

325.24

346.33

umol/l

0.45

548

Pollen allergy

107

1200

0.88

0.64

5.3

5.6

364.61

383.31

umol/l

0.80

1063

Adenomyosis (Endometriosis of uterus)

613

0.83

0.64

4.9

5.3

337.27

378.95

umol/l

1.29

532

Hypertrophic scar

260

1.27

0.64

6.3

5.8

350.69

382.51

umol/l

0.82

223

Pre-eclampsia or poor fetal growth

142

1577

0.90

0.63

4.4

5.5

363.61

379.54

umol/l

0.68

120

1368

Other acquired deformities of musculoskeletal system and connective tissue

216

1.30

0.63

4.8

5.9

389.82

367.52

umol/l

0.30

192

Benign neoplasm of mouth and pharynx

515

1.19

0.63

5.2

5.4

346.51

362.20

umol/l

0.42

454

Interstitial lung disease endpoints

644

0.84

0.63

3.3

4.4

325.24

346.29

umol/l

0.45

547

Interstitial lung disease

644

0.84

0.63

3.3

4.4

325.24

346.29

umol/l

0.45

547

Subacute thyroiditis

153

0.65

0.63

4.3

5.3

363.40

366.40

umol/l

—

130

Erythema nodosum

138

1.38

0.62

6.9

5.8

307.95

379.64

umol/l

1.19

122

Brachial plexus disorders

470

1.19

0.62

3.3

5.6

363.38

371.31

umol/l

0.16

410

Other necrotizing vasculopathies (FG)

253

1.27

0.61

3.6

4.9

291.37

370.03

umol/l

1.68

223

Arthrosis

594

3098

1.05

0.61

4.5

5.4

342.40

372.46

umol/l

5.67

511

2679

Benign neoplasm of major salivary glands

462

1.19

0.60

4.8

4.9

350.73

358.60

umol/l

0.16

399

Duodenal ulcer

462

1.19

0.60

4.5

4.4

332.21

349.68

umol/l

0.39

383

Chloasma

0.00

0.60

0.0

4.3

—

341.94

—

Other specified/unspecified inflammatory spondylopathies

244

0.74

0.60

4.9

6.0

340.72

386.73

umol/l

0.74

217

Inguinal or femoral hernia, bilateral

527

1.18

0.60

3.8

4.8

312.68

357.13

umol/l

1.76

455

Spirochaetal infections, other/unspecified

389

0.79

0.60

3.4

5.3

357.05

363.48

umol/l

0.08

334

Major coronary heart disease event excluding revascularizations

405

2627

1.06

0.59

4.4

4.8

340.48

353.48

umol/l

1.12

348

2223

Toxic effect of contact with venomous animals

183

1.32

0.59

6.5

5.8

381.75

373.72

umol/l

0.12

163

Panniculitis affecting regions of neck and back

183

1.32

0.59

2.5

5.7

364.33

378.34

umol/l

0.32

161

Calcific aortic valvular stenosis

142

1252

1.11

0.59

3.7

3.9

337.70

332.88

umol/l

0.18

124

1018

Calcific aortic valvular stenosis, operated

142

1252

1.11

0.59

3.7

3.9

337.70

332.88

umol/l

0.18

124

1018

Disorders of synovium and tendon in diseases classified elsewhere

1.45

0.59

6.4

5.3

292.21

377.40

umol/l

1.56

Acute mastoiditis

1.73

0.58

5.0

459.50

340.92

umol/l

—

Other superficial mycoses

106

1.42

0.58

4.5

5.8

340.13

363.05

umol/l

0.22

Caries in Clefts patients

1.49

0.57

2.9

5.0

358.00

370.29

umol/l

—

Vasomotor and allergic rhinitis

246

2614

0.93

0.57

4.6

5.6

360.74

382.19

umol/l

1.66

214

2333

Glomerular diseases

108

961

1.13

0.57

5.2

5.0

320.74

363.90

umol/l

2.80

822

Isolated proteinuria

132

1.37

0.57

6.6

6.0

364.78

379.58

umol/l

0.17

116

Disorders of breast

278

2398

1.08

0.57

5.1

5.2

368.10

375.62

umol/l

0.39

234

2106

Calculus of lower urinary tract

211

1.28

0.57

3.2

4.6

289.55

345.57

umol/l

1.83

186

Contact with nonpowered hand tool

247

1.26

0.57

3.3

5.8

291.69

372.78

umol/l

2.01

222

Other/unspecified rheumatoid arthritis

528

0.83

0.56

4.0

4.9

356.34

354.42

umol/l

0.03

464

Spondylosis

346

2784

1.07

0.56

4.4

5.1

334.43

369.66

umol/l

4.56

297

2397

Benign neoplasm: Skin of lip

1.46

0.56

5.6

5.2

351.75

348.35

umol/l

—

Benign neoplasm: Skin of lip

1.46

0.56

5.6

5.1

351.75

387.73

umol/l

—

Hypertrophic cardiomyopathy

172

0.70

0.56

3.1

5.1

313.64

363.29

umol/l

1.04

152

Calcific aortic valvular stenosis, diagnosis (helper)

141

1248

1.11

0.56

3.7

3.9

338.70

332.68

umol/l

0.23

123

1014

Operations 2 for CAVS

141

1248

1.11

0.56

3.7

3.9

338.70

332.68

umol/l

0.23

123

1014

Non-rheumatic valve diseases

248

1951

0.93

0.56

4.0

5.0

360.28

361.75

umol/l

0.06

219

1654

Colectomy operation

764

0.86

0.56

7.3

4.7

366.22

351.81

umol/l

0.39

647

Vasomotor rhinitis (mode)

338

1.22

0.56

3.6

5.6

345.44

369.45

umol/l

0.46

288

Primary ovarian failure

0.55

0.56

5.0

6.2

322.60

381.17

umol/l

—

Glaucoma, exfoliation

402

1.20

0.56

4.0

3.8

331.56

340.55

umol/l

0.16

331

Abnormal findings in nipple discharge synovial fluid wound secretions

1.55

0.56

6.2

4.9

371.10

386.03

umol/l

—

Carcinoma in situ of skin of trunk

0.55

0.56

5.4

3.2

271.00

329.02

umol/l

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

612

0.85

0.55

4.8

5.5

366.35

371.47

umol/l

0.11

548

ILD, hospital admissions

633

0.85

0.54

3.3

4.4

325.24

347.36

umol/l

0.48

538

Retinal detachment with retinal break

580

1.16

0.54

4.2

4.8

338.82

356.60

umol/l

0.49

495

Inguinal hernia, bilateral

515

1.17

0.54

3.6

4.8

309.41

356.43

umol/l

1.85

445

Other and unspecified vascular occlusions

349

1.21

0.53

3.7

4.1

330.03

346.65

umol/l

0.29

295

Benign neoplasm of mouth and pharynx

525

1.16

0.53

5.2

346.51

363.85

umol/l

0.48

457

Calcific aortic valvular stenosis, including rheumatic fever

141

1252

1.10

0.53

3.7

3.9

338.70

332.44

umol/l

0.24

123

1018

Valvular heart disease excluding rheumatic fever

252

1977

0.93

0.53

4.0

5.0

360.20

362.18

umol/l

0.08

223

1680

HSIL lesion of the vulva

1.52

0.53

4.7

5.5

323.00

393.93

umol/l

—

Injury of muscle and tendon at ankle and foot level

117

1.37

0.52

2.6

5.8

287.82

386.32

umol/l

1.87

103

Heart failure and coronary heart disease

163

1111

1.09

0.52

3.5

3.9

309.44

331.88

umol/l

1.36

135

900

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

157

0.70

0.51

4.6

5.5

311.82

363.10

umol/l

0.74

142

Non-follicular lymphoma

413

0.82

0.51

3.4

4.8

304.37

350.60

umol/l

1.04

360

Scar conditions and fibrosis of skin

197

1.27

0.51

5.4

5.7

302.12

382.24

umol/l

2.24

168

Lumbar disc prolapse

456

3442

1.05

0.51

4.4

5.3

342.66

373.88

umol/l

5.03

388

2990

Other hammer toe(s) (acquired)

785

1.12

0.50

3.9

4.8

351.85

363.91

umol/l

0.31

665

Other intervertebral disc disorders

626

3666

1.05

0.50

4.4

5.2

344.68

370.84

umol/l

4.69

538

3174

Amiodarone users

412

0.82

0.50

3.6

4.4

398.41

346.17

umol/l

1.23

357

Myeloproliferative diseases (CML excluded)

335

0.80

0.49

3.1

4.8

352.67

350.75

umol/l

0.02

290

MS-disease / Multiple Sclerosis

371

1.19

0.49

4.6

5.9

404.14

374.48

umol/l

0.57

325

Finngen Rheumatological endpoints

811

4449

1.04

0.49

4.8

5.3

350.71

372.96

umol/l

4.40

692

3876

Myocardial infarction, without ST-elevation

207

1772

1.08

0.49

4.2

4.3

343.86

338.97

umol/l

0.18

174

1467

Personal history of allergy to drugs, medicaments and biological substances

1.57

0.49

7.4

5.2

438.86

360.46

umol/l

—

Other specific arthropathies, wide

111

0.63

0.48

2.6

5.0

287.71

375.43

umol/l

—

Hallux valgus (acquired)

215

1446

1.08

0.48

5.0

5.1

368.78

374.07

umol/l

0.20

179

1241

Deviated nasal septum

202

2172

0.93

0.48

4.5

5.4

343.65

369.07

umol/l

1.80

174

1889

Primary gonarthrosis, bilateral

287

2360

1.06

0.47

4.4

4.7

344.47

359.38

umol/l

1.18

244

2002

Other benign neoplasms of skin

181

1955

0.93

0.47

5.6

4.8

350.41

363.50

umol/l

0.74

160

1661

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

645

0.87

0.47

4.6

4.7

303.85

356.88

umol/l

2.01

548

Glucosamine medication

266

1991

1.07

0.47

4.5

4.4

338.99

356.19

umol/l

1.29

220

1683

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

354

0.82

0.47

4.1

4.2

348.50

348.45

umol/l

0.00

295

Endometriosis ASRM stages 3,4

1078

0.90

0.47

3.9

5.3

354.36

372.11

umol/l

0.69

930

Primary_lymphoid and hematopoietic malignant neoplasms

106

1172

0.90

0.46

4.9

4.7

345.88

354.74

umol/l

0.25

1001

Peripheral retinal degeneration

142

0.70

0.46

6.9

5.9

318.20

374.12

umol/l

—

129

Spondylopathies

570

3314

1.04

0.46

4.4

5.2

343.50

370.27

umol/l

4.37

491

2860

Corneal ulcer

113

1025

1.10

0.46

5.1

5.2

347.30

367.18

umol/l

0.83

892

ILD, hospital admissions 1, main diag only

557

0.86

0.45

3.4

4.5

320.78

345.38

umol/l

0.48

473

Other peripheral vascular diseases

352

0.82

0.45

3.5

5.1

453.27

366.28

umol/l

0.54

300

Abnormal findings in secretions and smears from cervix uteri vagina vulva

283

2094

1.06

0.45

5.3

5.4

375.43

380.50

umol/l

0.22

248

1830

Other peripheral vertigo

394

1.17

0.44

4.7

5.2

334.54

360.55

umol/l

0.63

342

Diseases of inner ear

288

2987

0.94

0.44

4.7

4.9

361.91

361.69

umol/l

0.01

241

2558

Use of antiglaucoma preparations and miotics

311

1.19

0.44

2.9

4.0

357.76

345.47

umol/l

0.19

260

Degenerative macular diseases

469

1.15

0.44

4.6

4.3

320.40

346.14

umol/l

0.55

396

Suggestive for eosinophilic asthma

427

0.84

0.44

4.3

5.3

341.75

363.87

umol/l

0.44

371

Maternal care for other conditions predominantly related to pregnancy

123

1109

1.10

0.44

5.2

5.6

377.12

382.62

umol/l

0.15

109

960

Malignant neoplasm of kidney, except renal pelvis

383

0.83

0.43

3.3

4.5

285.38

343.33

umol/l

2.04

338

Endometriosis of pelvic peritoneum

771

1.11

0.43

4.0

5.6

342.64

392.06

umol/l

2.55

680

Contraceptive management

308

2288

0.95

0.43

5.1

6.0

386.43

384.37

umol/l

0.09

271

2037

Iliotibial band syndrome

1.44

0.42

1.9

5.3

329.88

385.37

umol/l

—

Benign neoplasm: Bronchus and lung

1.44

0.42

6.9

4.8

381.25

344.46

umol/l

—

Acute nasopharyngitis (common cold)

797

1.11

0.42

5.6

5.7

395.35

380.72

umol/l

0.49

700

Nerve, nerve root and plexus disorders

795

4825

1.04

0.42

4.4

5.2

359.81

366.68

umol/l

0.61

694

4170

Myeloproliferative diseases

371

0.83

0.42

3.0

4.9

364.63

349.48

umol/l

0.22

320

Squamous cell neoplasms and carcinomas of the skin

457

0.85

0.42

4.4

3.6

337.03

333.38

umol/l

0.06

372

Cleft palate

1.41

0.42

2.0

4.9

332.00

372.65

umol/l

—

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

0.63

0.42

5.7

5.6

410.33

355.04

umol/l

—

Malignant neoplasm of skin

308

2448

0.95

0.42

4.0

4.5

317.29

351.32

umol/l

3.72

252

2063

Glomerulonephritis

509

1.14

0.42

4.2

5.2

327.18

365.41

umol/l

1.34

449

Ankle and foot

1.52

0.41

7.4

4.9

389.80

376.11

umol/l

—

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

552

0.87

0.41

3.7

4.2

316.20

349.82

umol/l

0.97

463

Adhesive capsulitis of shoulder

837

0.90

0.41

3.7

5.3

332.14

372.34

umol/l

1.48

718

Achilles tendinitis

519

0.87

0.40

4.5

5.4

358.63

375.62

umol/l

0.31

447

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

1.48

0.40

4.6

4.1

313.60

344.48

umol/l

—

Melanoma of uvea

1.48

0.40

3.2

3.9

262.00

342.66

umol/l

—

Other or ill-defined heart diseases

278

1.19

0.40

6.7

5.0

358.67

360.26

umol/l

0.02

244

Lichen sclerosus et atrophicus

411

0.85

0.39

4.0

5.3

349.96

374.16

umol/l

0.36

359

Malignant neoplasm, without specification of site

101

0.69

0.39

3.4

4.4

294.71

339.34

umol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

698

4390

1.04

0.39

5.1

356.52

367.40

umol/l

1.04

597

3805

Systemic atrophies primarily affecting the central nervous system

178

1.24

0.39

5.2

5.1

380.61

358.77

umol/l

0.22

160

Bell's palsy

579

1.12

0.39

4.8

5.3

388.84

363.05

umol/l

0.73

495

Bacterial sepsis of newborn

1.40

0.38

2.4

4.0

508.80

420.64

umol/l

—

Myocardial infarction, unclassifiable

108

882

1.09

0.38

3.9

341.80

331.02

umol/l

0.30

720

Other arrhythmias

434

3184

1.04

0.38

4.2

5.3

351.00

371.50

umol/l

1.89

374

2748

Benign leiomyoma with endometriosis

727

0.89

0.38

4.4

4.9

342.60

373.48

umol/l

0.92

622

Rubella [German measles]

192

0.78

0.38

4.9

5.4

351.73

360.41

umol/l

0.10

168

Metatarsalgia

429

1.14

0.38

4.2

5.3

348.60

376.54

umol/l

0.75

371

Endometriosis ASRM stages 1,2

828

1.10

0.37

4.2

5.5

345.85

379.17

umol/l

1.45

712

Dislocation, sprain and strain of joints and ligaments of knee

428

3813

1.04

0.37

4.9

5.5

350.87

375.50

umol/l

3.39

367

3353

Spontaneous rupture of synovium and tendon

355

1.16

0.37

4.0

5.1

360.40

366.75

umol/l

0.10

307

Tuberculosis of other organs

1.39

0.37

6.4

4.6

352.30

349.11

umol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

402

1.15

0.37

4.8

5.3

352.14

356.20

umol/l

0.07

350

Ovarian dysfunction

318

1.17

0.36

5.6

5.7

313.13

373.55

umol/l

2.17

269

Other enthesopathies

159

1701

0.93

0.36

3.7

5.5

338.40

379.62

umol/l

3.00

135

1490

Disorders of vitreous body and globe

251

2581

0.95

0.36

4.0

4.9

344.28

364.99

umol/l

1.56

214

2206

Benign neoplasm: Connective and other soft tissue, unspecified

1.47

0.36

4.2

4.6

327.83

348.47

umol/l

—

Benign neoplasm: Ascending colon

535

1.12

0.36

4.5

4.7

373.98

349.28

umol/l

0.65

462

Slow fetal growth and fetal malnutrition

1.43

0.35

3.0

4.8

451.33

440.17

umol/l

—

Aortic aneurysm

1059

0.92

0.35

3.8

4.2

329.18

341.47

umol/l

0.38

866

Pregnancy with abortive outcome

369

2017

0.96

0.35

4.6

5.2

360.48

374.21

umol/l

1.09

310

1753

Other systemic involvement of connective tissue

139

1295

1.07

0.34

4.0

4.8

344.33

360.42

umol/l

0.65

113

1108

Pulmonary eosinophilia, not elsewhere classified

1.37

0.34

7.3

5.6

383.83

375.30

umol/l

—

Other diseases of upper respiratory tract

907

4600

1.03

0.34

4.8

5.2

352.57

370.91

umol/l

3.17

778

4009

Follow-up care involving plastic surgery

154

1.24

0.34

4.9

5.4

385.23

367.84

umol/l

0.22

134

Unequal limb length (acquired)

1.34

0.34

3.0

5.4

368.00

411.88

umol/l

—

Other specified disorders of kidney and ureter

145

1.25

0.34

4.4

4.9

373.62

361.12

umol/l

0.09

128

Fibrosis and cirrhosis of liver

318

0.85

0.33

4.1

4.8

327.82

357.04

umol/l

0.72

279

Normotensive glaucoma

312

1.16

0.33

6.4

4.1

371.93

350.17

umol/l

0.54

270

Oter anti-inflammatory and antirheumatic agents, non-steroids

181

944

1.06

0.33

4.2

5.5

362.89

373.01

umol/l

0.45

150

832

Conotruncal defects

0.67

0.33

1.7

5.0

415.50

390.72

umol/l

—

Aortic valve malfunction, age under 60 years

551

0.89

0.33

4.5

5.5

367.49

368.48

umol/l

0.02

490

Other necrotizing vasculopathies

303

1.16

0.33

3.5

4.9

302.38

363.39

umol/l

1.24

261

Myocardial infarction, strict

258

1977

0.95

0.32

4.2

4.7

345.69

351.89

umol/l

0.29

217

1651

Other specified/unspecified arthritis

149

1589

0.94

0.32

4.4

5.2

350.64

373.47

umol/l

1.08

129

1364

Immunodeficiency with predominantly antibody defects

137

1.25

0.32

4.9

5.3

352.24

364.02

umol/l

0.12

124

Abdominal aortic aneurysm (AAA)

398

0.87

0.31

2.7

3.6

314.66

324.76

umol/l

0.15

324

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

685

0.90

0.31

4.5

5.2

367.81

365.70

umol/l

0.04

592

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.35

0.31

3.1

4.8

310.57

364.70

umol/l

—

Acute lymphadenitis

314

1.15

0.31

4.6

5.7

352.81

375.68

umol/l

0.54

276

Myocardial infarction

304

2088

1.05

0.31

4.4

4.7

344.77

351.55

umol/l

0.36

257

1753

Benign neoplasm of other and ill-defined parts of digestive system

829

1.09

0.31

5.8

4.8

350.61

360.86

umol/l

0.27

708

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

1.33

0.31

5.3

6.5

305.71

377.22

umol/l

—

Other systemic involvement of connective tissue (FG)

136

1266

1.07

0.30

4.1

4.8

345.67

364.14

umol/l

0.83

110

1083

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

484

0.89

0.30

4.1

4.7

282.23

354.27

umol/l

2.96

403

Myocardial infarction, with ST-elevation

798

0.91

0.30

3.2

4.2

346.65

340.31

umol/l

0.15

660

Carcinoma in situ of other and unspecified genital organs

1.34

0.30

5.2

5.3

315.50

378.70

umol/l

—

Respiratory tuberculosis, confirmed

1.34

0.30

5.6

4.0

358.30

342.94

umol/l

—

Other disorders of patella

1057

0.93

0.30

4.1

5.8

358.28

382.60

umol/l

0.84

910

Chronic rhinitis, nasopharyngitis and pharyngitis

206

1957

1.05

0.30

4.3

5.4

343.93

374.56

umol/l

2.58

176

1726

Benign neoplasm of ovary

776

0.91

0.29

6.2

5.0

359.25

378.96

umol/l

0.49

667

Malignant neoplasm of urinary organs

409

0.88

0.29

3.3

4.5

301.60

343.08

umol/l

1.34

357

Ganglion

106

1137

0.93

0.28

4.2

5.4

359.68

378.71

umol/l

0.74

986

Gonarthrosis, primary, with knee surgery

288

2452

0.96

0.28

4.4

4.6

348.35

358.18

umol/l

0.59

238

2081

Carcinoma in situ of skin of other and unspecified parts of face

302

0.86

0.28

3.4

3.5

305.04

330.51

umol/l

0.46

242

Benign neoplasm: Parotid gland

364

1.13

0.28

4.8

5.1

352.36

359.75

umol/l

0.13

313

Cyst of Bartholin Gland

167

1.20

0.28

1.8

5.6

336.91

378.18

umol/l

0.46

145

Exclusion endpoint for supernumerary teeth

1.32

0.28

5.1

4.6

418.20

387.58

umol/l

—

Thyrotoxicosis with toxic multinodular goitre

248

0.85

0.28

5.9

4.9

378.38

364.62

umol/l

0.20

213

Other disorders of breast

517

1.10

0.28

5.5

5.1

387.45

371.94

umol/l

0.34

443

Other acute skin changes due to ultraviolet radiation

149

1.21

0.28

5.6

5.0

406.85

361.34

umol/l

0.55

132

Benign neoplasm: Parotid gland

365

1.12

0.27

4.8

5.3

352.36

356.27

umol/l

0.07

318

Sarcoidosis

689

0.91

0.27

4.3

5.3

342.87

364.67

umol/l

0.57

603

IgA nephropathy (IgA glomerulonephritis)

120

0.75

0.27

4.0

6.0

325.22

366.27

umol/l

—

107

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.23

0.27

5.9

5.4

335.88

377.29

umol/l

—

Tooth agenesis EXCLUDE clefts and syndromes

204

0.83

0.27

3.8

5.4

395.06

380.93

umol/l

0.19

178

Arthropod-borne viral fevers and viral haemorrhagic fevers

509

1.10

0.27

5.1

5.5

360.30

368.44

umol/l

0.19

450

Migraine, single triptan purchase ok & required. ICD-code if available is included

554

3858

0.97

0.27

4.1

5.6

347.61

381.16

umol/l

6.48

474

3413

Triptan medication for migraine, single purchase ok

554

3858

0.97

0.27

4.1

5.6

347.61

381.16

umol/l

6.48

474

3413

Central retinal artery occlusion

1.21

0.26

1.8

4.3

388.75

354.81

umol/l

—

Other/unspecified enthesopathies, not elsewhere classified

395

0.89

0.26

3.4

5.1

320.55

364.90

umol/l

0.83

339

Other arthritis (FG)

172

1810

0.95

0.26

4.6

5.2

352.01

372.68

umol/l

1.07

149

1567

Thoracic aortic aneurysm

625

0.91

0.26

4.2

4.6

329.02

349.48

umol/l

0.54

523

Hypersensitivity pneumonitis due to organic dust

1.20

0.26

8.6

5.0

374.25

362.97

umol/l

—

Crushing injury of wrist and hand

0.69

0.26

6.4

5.4

284.00

346.40

umol/l

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

0.68

0.26

6.0

4.3

385.60

365.15

umol/l

—

Congenital malformations of breast

0.67

0.26

2.0

5.9

294.40

383.05

umol/l

—

Other disorders of male genital organs

235

0.85

0.25

5.1

5.4

386.66

365.60

umol/l

0.39

210

Alopecia areata

127

0.79

0.25

7.5

6.2

396.20

382.90

umol/l

—

114

Type 1 diabetes, wide definition, subgroup 1

134

1266

1.06

0.25

4.8

5.2

352.33

373.55

umol/l

0.94

115

1102

Diabetic nephropathy

910

0.93

0.24

4.9

5.5

316.06

351.58

umol/l

1.68

784

ILD medications: prednisolone, methylprednisolone, prednisone

888

4912

1.02

0.24

4.3

5.3

349.01

371.46

umol/l

4.44

734

4304

Spermatocele

371

0.89

0.24

3.2

4.8

368.76

348.89

umol/l

0.39

311

Tuberculosis of other organs, strict

1.27

0.24

6.1

4.4

370.00

351.86

umol/l

0.19

Carcinoma in situ of other and unspecified genital organs

1.29

0.24

5.2

5.3

315.50

389.43

umol/l

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.29

0.24

5.6

4.3

358.30

343.75

umol/l

—

Other abnormal immunological findings in serum

0.72

0.24

3.2

5.7

400.18

379.82

umol/l

—

Bronchiectasis

297

0.87

0.24

3.2

4.5

348.50

358.35

umol/l

0.12

253

ILD medications

899

5036

0.98

0.24

4.4

5.3

350.96

372.95

umol/l

4.31

739

4417

Other aneurysm

227

1.15

0.23

5.8

4.4

381.76

345.48

umol/l

0.57

202

Sicca syndrome [Sjögren]

360

1.11

0.23

4.2

5.2

340.00

367.83

umol/l

0.58

317

Other disorders of the genitourinary system

506

0.91

0.23

4.2

5.0

324.47

360.61

umol/l

1.23

441

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.32

0.23

5.0

5.3

288.60

370.27

umol/l

—

Melanoma of uvea

1.32

0.23

3.2

3.9

262.00

360.64

umol/l

—

Endometriosis of ovary

824

0.93

0.23

4.1

5.4

346.86

383.31

umol/l

1.66

719

Endometriosis of fallopian tube

1.29

0.23

9.0

5.9

401.80

367.55

umol/l

—

Benign neoplasm: Skin of ear and external auricular canal

168

0.83

0.22

4.6

4.9

342.44

357.84

umol/l

—

148

Other deformity of hallux (acquired)

1.25

0.22

5.2

4.2

424.00

361.46

umol/l

—

Retinoschisis and retinal cysts

0.75

0.22

5.6

4.8

312.14

359.87

umol/l

—

Early lumbar disc prolapse, operated

612

1.08

0.22

5.5

6.1

332.41

381.70

umol/l

2.58

539

Inflammatory bowel disease treatment related agents

888

5142

0.98

0.22

4.4

5.3

352.12

371.56

umol/l

3.45

738

4493

Benign neoplasm: Scapula and long bones of upper limb

1.22

0.22

2.6

5.1

423.40

368.60

umol/l

—

Benign neoplasm: Conjunctiva

144

1.18

0.22

3.5

5.3

372.83

366.01

umol/l

0.05

128

Need for immunization against other single infectious diseases

0.00

0.22

0.0

4.8

—

336.20

—

Birth injury to skeleton

0.00

0.21

0.0

3.6

—

428.70

—

Pityriasis rubra pilaris

0.00

0.21

0.0

3.1

—

297.64

—

Benign neoplasm: Scapula and long bones of upper limb

1.19

0.21

2.6

4.9

423.40

361.44

umol/l

—

Gonarthrosis,primary

590

3625

1.02

0.21

4.6

4.9

348.54

364.35

umol/l

1.95

498

3112

Benign neoplasm: Parathyroid gland

1.17

0.21

3.0

4.9

325.60

365.70

umol/l

—

Mucocutaneous lymph node syndrome [Kawasaki]

0.00

0.21

0.0

4.2

—

377.31

—

Malignant neoplasm of hypopharynx

0.00

0.21

0.0

3.1

—

281.69

—

Non-allergic asthma

450

1.09

0.20

4.0

5.3

341.70

371.00

umol/l

0.80

397

Basal cell carcinoma

281

2166

1.03

0.20

3.9

4.3

316.37

348.17

umol/l

3.09

231

1812

Benign neoplasm: Conjunctiva

145

1.17

0.20

3.5

5.1

372.83

370.26

umol/l

0.02

125

Eustachian salpingitis and obstruction

489

1.09

0.20

5.7

6.5

384.54

381.57

umol/l

0.04

436

Acute appendicitis, no complications

401

3894

1.03

0.20

5.4

370.43

372.20

umol/l

0.09

354

3403

Benign neoplasm: Choroid

261

0.88

0.20

3.2

4.8

354.88

361.93

umol/l

0.06

222

Benign neoplasm: Connective and other soft tissue, unspecified

1.25

0.20

4.2

4.0

327.83

365.10

umol/l

—

Excessive vomiting in pregnancy

374

1.10

0.20

4.9

5.9

372.06

379.54

umol/l

0.13

320

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

115

0.78

0.20

6.4

5.4

387.78

368.92

umol/l

—

Palmar fascial fibromatosis [Dupuytren]

703

1.07

0.20

4.1

4.3

329.14

354.00

umol/l

0.72

584

Carcinoma in situ of skin of lower limb, including hip

1.20

0.19

5.0

3.7

294.00

353.22

umol/l

—

Benign neoplasm: Skin of ear and external auricular canal

165

0.85

0.19

4.6

4.5

342.44

351.88

umol/l

—

141

Vitreous haemorrhage

491

1.08

0.19

3.8

5.2

334.14

354.56

umol/l

0.48

427

Horner syndrome

1.16

0.19

9.7

4.6

402.00

340.60

umol/l

—

Plantar fascial fibromatosis

457

0.92

0.18

4.0

5.3

371.41

376.38

umol/l

0.09

395

Injury of muscle and tendon at lower leg level

807

0.94

0.18

4.3

5.3

348.61

369.85

umol/l

0.66

690

Budesonide

735

1.06

0.18

4.2

5.4

299.85

371.78

umol/l

5.04

640

Malignant neoplasm of oral cavity

128

1.17

0.18

2.8

4.5

283.90

364.43

umol/l

—

111

Other specified and unspecified disorders of eyelid

1.21

0.18

4.6

5.6

302.57

376.82

umol/l

—

Rosacea

518

0.93

0.18

3.7

5.3

336.23

370.00

umol/l

0.87

448

Chronic hepatitis NAS

1.19

0.18

4.6

4.7

361.57

360.43

umol/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.20

0.18

5.3

4.7

475.08

439.71

umol/l

0.28

Follow-up examination after treatment for malignant neoplasms

319

1.10

0.18

3.9

4.3

393.59

340.87

umol/l

1.32

266

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

107

986

1.05

0.18

4.2

5.3

367.61

379.45

umol/l

0.40

874

Systemic connective tissue disorders

185

1785

1.04

0.17

3.8

4.9

342.37

363.19

umol/l

1.15

148

1525

Inflammatory disorders of male genital organs, not elsewhere classified

1.15

0.17

6.0

5.0

236.43

340.54

umol/l

—

Autoimmune diseases related-to ILD

621

5359

1.02

0.17

5.0

5.2

354.80

368.99

umol/l

1.59

519

4669

Obstructed labour due to maternal pelvic abnormality

774

0.94

0.17

4.6

5.9

396.42

391.40

umol/l

0.11

678

Guillain-Barre syndrome

1.11

0.17

8.0

4.9

385.57

366.08

umol/l

—

Migraine without aura, drug-induced

0.74

0.17

5.6

5.8

413.40

363.71

umol/l

—

Myasthenia gravis

0.73

0.17

9.8

4.6

307.80

370.07

umol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

288

0.90

0.16

5.4

5.1

376.42

373.52

umol/l

0.03

241

Other congenital malformations of skin

215

1.12

0.16

4.0

5.8

375.61

385.43

umol/l

0.11

193

Other malignant neoplasms of skin (=non-melanoma skin cancer)

274

2104

1.03

0.16

4.0

4.3

315.91

347.92

umol/l

3.13

227

1755

Dental caries 2 and operation codes, only avohilmo

590

3594

1.02

0.16

5.7

5.4

377.85

372.69

umol/l

0.40

527

3153

Abscess of external ear

1.11

0.16

5.8

422.75

372.22

umol/l

—

Spinal stenosis

294

2245

1.03

0.16

3.9

4.8

329.45

362.33

umol/l

3.57

241

1903

Skin changes due to chronic exposure to nonionizing radiation

159

1558

0.96

0.16

3.5

4.0

312.70

340.38

umol/l

1.82

136

1293

Other/unspecified synovitis and tenosynovitis

574

1.06

0.15

4.6

5.0

344.61

372.46

umol/l

0.72

496

Atrophic disorders of skin

652

1.06

0.15

4.4

5.3

333.51

373.96

umol/l

1.33

568

Pyogenic granuloma

0.79

0.15

2.2

5.1

292.00

378.18

umol/l

—

Sub-endpoint used in defining T1D endpoints

198

1887

1.03

0.15

4.8

5.1

346.53

365.69

umol/l

1.08

171

1632

Benign neoplasm: Stomach

409

1.08

0.15

4.9

4.8

364.38

358.94

umol/l

0.10

351

Basal cell carcinoma, including avohilmo

288

2210

1.03

0.15

3.9

4.4

316.33

349.12

umol/l

3.37

238

1849

Allergic contact dermatitis

637

0.94

0.15

4.2

5.2

353.23

369.57

umol/l

0.38

546

Radial styloid tenosynovitis [de Quervain]

255

0.90

0.15

4.0

5.7

336.50

377.94

umol/l

0.74

219

Other, unspecified and serous retinal detachments

121

1.16

0.15

6.0

5.0

327.07

359.24

umol/l

0.50

110

Insulin, fast-acting (human)

918

1.05

0.15

4.9

5.6

351.93

368.04

umol/l

0.52

812

Anti-inflammatory and antirheumatic products, non-steroids

269

1387

0.97

0.14

5.0

5.7

362.51

382.55

umol/l

1.48

236

1243

Actinic keratosis

153

1501

0.97

0.14

3.5

3.9

309.87

338.85

umol/l

1.98

132

1240

Sequelae of injuries of upper limb

538

1.06

0.14

4.8

5.5

350.46

374.25

umol/l

0.71

467

Oral corticosteroids

821

4899

1.01

0.14

4.3

5.3

350.08

369.55

umol/l

3.26

685

4282

conjunctival degenerations and deposits

0.82

0.13

3.7

5.0

311.50

382.07

umol/l

—

Autoimmune diseases excluding thyroid diseases

775

4241

1.01

0.13

4.5

4.9

359.86

367.63

umol/l

0.74

645

3694

Nontoxic goitre/thyroid nodule

134

1387

0.97

0.13

4.9

358.18

362.40

umol/l

0.15

120

1193

Postprocedural endocrine and metabolic disorders, not elsewhere classified

480

1.06

0.13

4.7

5.2

339.82

372.51

umol/l

1.06

413

Presence of other functional implants

318

2203

1.02

0.13

4.5

4.6

356.14

353.11

umol/l

0.12

256

1880

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

653

0.95

0.13

4.5

5.3

367.81

367.99

umol/l

0.00

569

Anaemia in chronic diseases classified elsewhere

1.17

0.13

4.8

4.1

308.45

360.25

umol/l

0.65

Benign neoplasm: Ascending colon

569

1.06

0.13

4.5

373.98

354.66

umol/l

0.47

480

Benign neoplasm: Stomach

413

1.07

0.13

4.9

4.8

364.38

362.77

umol/l

0.03

352

Polymyalgia rheumatica

499

0.94

0.13

3.1

4.4

344.53

342.23

umol/l

0.04

428

Malignant neoplasm of head and neck

345

1.07

0.12

4.1

4.6

271.69

349.48

umol/l

2.78

304

TMD related operations

886

0.96

0.12

4.4

5.3

330.46

373.64

umol/l

2.26

766

Puerperal sepsis

570

1.05

0.12

5.1

5.5

331.22

382.04

umol/l

1.97

493

Hallux rigidus

682

0.95

0.12

4.2

5.0

331.23

366.49

umol/l

1.36

582

Other and unspecified mononeuropathies, also in other diseases

133

1.13

0.12

4.9

374.20

358.07

umol/l

0.23

112

Unspecified lump in breast

669

1.05

0.12

5.3

5.0

365.37

374.87

umol/l

0.22

574

Benign neoplasm: Choroid

251

0.92

0.12

3.2

4.9

354.88

353.78

umol/l

0.01

218

Macular pucker

571

1.05

0.12

5.0

4.4

338.02

347.61

umol/l

0.19

487

Cardiomyopathies, Primary/intrinsic

609

0.95

0.11

4.2

4.8

312.00

352.42

umol/l

1.47

513

Fibroblastic disorders

123

1192

1.03

0.11

4.0

4.9

340.55

364.10

umol/l

1.07

100

1003

Early lumbar disc prolapse operation

690

0.96

0.11

5.5

6.0

332.41

376.61

umol/l

2.19

603

Diabetic neuropathy

615

0.95

0.11

4.4

5.5

329.80

347.10

umol/l

0.42

534

Other hearing loss

130

1240

1.03

0.11

4.3

331.74

341.28

umol/l

0.27

106

1031

Retinal detachments and breaks

172

1764

0.97

0.11

3.9

4.6

339.78

356.40

umol/l

0.78

142

1480

Thyroiditis

328

1.07

0.11

4.8

5.3

350.10

367.76

umol/l

0.33

283

Ischaemic heart disease, wide definition

495

3142

0.99

0.11

4.8

5.1

349.35

366.87

umol/l

2.02

434

2690

Complications predominantly related to the puerperium

125

1288

0.97

0.11

5.3

5.5

354.50

382.26

umol/l

1.49

107

1113

Nonischemic cardiomyopathy

299

1.07

0.10

5.3

5.2

350.93

354.54

umol/l

0.05

265

Cardiomyopathy (excluding other)

638

0.96

0.10

4.1

4.7

322.75

352.90

umol/l

0.90

536

Embedded and impacted teeth

173

1506

0.98

0.10

5.7

5.5

395.43

372.74

umol/l

1.26

156

1327

Polypectomy (DHB20)

341

0.94

0.10

4.4

5.6

374.62

359.71

umol/l

0.23

305

Glomerular disorders in diseases classified elsewhere

594

1.04

0.10

5.7

5.0

304.67

359.52

umol/l

2.63

513

Isolated proteinuria with specified morphological lesion

1.11

0.10

1.2

4.6

269.20

357.15

umol/l

—

Mature T/NK-cell lymphomas, hilmo

1.09

0.09

1.8

4.7

324.60

356.51

umol/l

—

Propionic acid derivatives

281

1387

1.02

0.09

4.7

5.7

356.00

382.55

umol/l

2.38

248

1243

Other enthesopathy of foot (+metatarsalgia)

467

1.05

0.09

4.2

5.3

348.60

376.56

umol/l

0.76

403

Other metabolic disorders

526

1.05

0.09

4.6

5.3

340.94

372.39

umol/l

1.01

456

Open bite that required surgery (Lefort1 or BSSRO)

1.06

0.09

4.6

6.8

354.60

392.76

umol/l

—

Cleft lip, lip and palate or palate

1.15

0.09

2.6

6.1

358.70

397.31

umol/l

—

Neoplasms

693

3754

0.99

0.09

5.4

364.84

377.68

umol/l

1.60

606

3300

Benign neoplasm of eye and adnexa

438

1.05

0.09

3.7

5.0

356.47

355.76

umol/l

0.01

386

Disorders of vestibular function (Vertigo)

252

2459

1.02

0.09

4.9

4.7

357.65

362.36

umol/l

0.20

209

2099

Ulcerative colitis

153

1496

1.02

0.08

5.3

5.2

354.66

368.45

umol/l

0.54

134

1302

Spondylolisthesis/Spondylolysis

938

0.97

0.08

4.6

5.4

349.35

375.80

umol/l

0.87

800

Benign paroxysmal vertigo

143

1397

1.02

0.08

5.5

5.0

363.69

360.53

umol/l

0.09

115

1194

Tinnitus

121

1241

0.97

0.08

4.7

4.9

344.87

364.11

umol/l

0.76

101

1064

Benign neoplasms

658

3760

0.99

0.08

5.6

5.4

362.23

375.37

umol/l

1.58

563

3291

Allergic conjunctivitis

379

3681

1.01

0.08

4.8

5.4

354.65

376.07

umol/l

2.17

325

3243

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

253

1.07

0.08

3.8

4.0

356.14

339.41

umol/l

0.20

213

Presbycusis

496

1.04

0.08

3.9

3.5

313.93

320.18

umol/l

0.10

392

HSIL lesion of the vagina

0.82

0.08

3.8

6.3

274.20

396.24

umol/l

—

Lateral epicondylitis

714

0.97

0.08

3.5

5.7

348.00

382.19

umol/l

1.18

627

Carcinoma in situ of cervix uteri, endocervix

1.10

0.08

9.4

6.4

323.86

384.48

umol/l

—

Overexertion and strenuous or repetitive movements

578

1.04

0.08

4.5

5.7

327.30

377.73

umol/l

2.57

503

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.08

0.08

3.7

6.4

361.71

375.52

umol/l

—

Benign neoplasm of ovary

734

0.97

0.08

6.2

5.1

359.25

374.39

umol/l

0.35

631

Ulcerative colitis, NAS

815

1.03

0.08

4.7

5.5

341.11

372.17

umol/l

1.16

710

Carcinoma in situ of cervix uteri, endocervix

1.06

0.08

9.4

6.6

323.86

375.11

umol/l

—

Malignant neoplasm of cervix uteri

1.06

0.08

6.9

5.9

389.14

387.29

umol/l

—

Type 1 diabetes, wide definition

139

1358

1.02

0.08

4.8

5.2

353.07

375.23

umol/l

1.05

120

1181

Measles

1.05

0.08

6.1

5.8

386.29

370.76

umol/l

—

Pneumoconiosis due to asbestos and other mineral fibres

0.83

0.07

6.7

3.3

310.00

330.97

umol/l

—

Childhood allergy (age < 16)

105

887

0.97

0.07

5.1

5.0

382.84

386.06

umol/l

0.08

789

Fistulae involving female genital tract

0.80

0.07

4.8

5.7

335.17

394.35

umol/l

—

Endometriosis

199

1163

1.02

0.07

4.4

5.2

356.84

377.46

umol/l

1.22

169

1013

Benign neoplasm: Connective and other soft tissue of head, face and neck

1.05

0.07

5.9

5.3

335.88

379.23

umol/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

359

3487

1.01

0.07

4.7

5.4

351.44

376.50

umol/l

2.73

307

3070

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

334

2691

1.01

0.07

5.5

5.2

375.32

373.24

umol/l

0.09

286

2335

Cardiomyopathy, Hypertrophic obstructive

0.85

0.07

2.9

4.8

292.43

379.32

umol/l

—

Abnormal serum enzyme levels

155

1559

0.98

0.07

4.3

4.6

340.28

352.38

umol/l

0.53

135

1302

Peritonsillar abscess

139

1363

1.02

0.07

4.6

5.8

352.57

371.46

umol/l

0.80

121

1203

Congenital malformations of the respiratory system

0.89

0.07

2.9

4.6

473.00

394.62

umol/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

0.85

0.06

5.9

5.3

374.63

400.80

umol/l

—

Stenosis and insufficiency of lacrimal passages

407

0.96

0.06

4.7

5.1

382.00

363.94

umol/l

0.30

352

Ectopic pregnancy

838

1.03

0.06

5.4

5.8

380.75

385.70

umol/l

0.13

740

First line medication for Crohn's disease

909

4924

1.01

0.06

4.3

5.4

354.92

372.89

umol/l

3.06

764

4317

Chronic lymphocytic leukaemia, helper endpoint

100

0.90

0.06

3.4

4.3

371.11

343.78

umol/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

100

0.90

0.06

3.4

4.3

371.11

343.78

umol/l

—

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

203

0.93

0.06

2.7

4.9

291.08

356.93

umol/l

0.93

173

Poor fetal growth

547

0.97

0.05

3.4

5.6

353.43

373.55

umol/l

0.52

466

Temporal arteritis

129

1.09

0.05

2.9

4.4

275.78

351.13

umol/l

—

111

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

525

0.97

0.05

3.7

3.8

335.45

337.46

umol/l

0.04

427

Correction of physiology of bite - demanding therapy visit

324

0.96

0.05

3.8

5.8

318.13

375.51

umol/l

1.70

285

Benign leiomyoma with endometriosis

667

0.97

0.05

4.4

5.0

342.60

371.62

umol/l

0.84

574

Other noninflammatory disorders of uterus, except cervix

111

771

0.98

0.05

5.2

346.02

381.78

umol/l

2.22

672

Other diseases of pancreas

327

1.04

0.05

4.4

5.0

332.62

355.12

umol/l

0.40

283

Benign neoplasm of bone and articular cartilage

426

1.03

0.05

4.0

5.4

356.33

369.77

umol/l

0.33

375

Other diseases of gallbladder

191

0.94

0.04

6.1

4.5

345.56

347.35

umol/l

0.02

163

Other and unspecified disorders of skin and subcutaneous tissue

292

0.96

0.04

6.7

5.3

374.38

368.85

umol/l

0.06

253

Preparation and fitting of bite rail to mouth

725

0.98

0.04

4.5

5.5

335.92

371.25

umol/l

1.37

638

Maternal care for cervical incompetence

170

1.06

0.04

3.4

5.6

379.31

382.90

umol/l

0.04

142

Crowding of teeth, including avohilmo

465

0.98

0.04

3.9

5.5

388.40

389.34

umol/l

0.02

415

Valvular operations

703

0.98

0.03

3.9

4.5

342.80

350.89

umol/l

0.23

589

Anomalies of dental arch relationship, including avohilmo

118

1046

1.01

0.03

4.8

5.4

360.81

379.41

umol/l

0.87

110

915

Diabetic nephropathy, excluding more controls

729

0.98

0.03

4.9

5.6

316.06

359.71

umol/l

2.28

627

Venous complications and haemorrhoids in pregnancy

1.09

0.03

3.0

6.2

394.00

380.76

umol/l

—

178

1689

0.99

0.03

3.7

4.0

320.25

340.49

umol/l

1.17

150

1397

Cirrhosis of liver, NAS

211

1.04

0.03

3.3

4.9

331.53

359.97

umol/l

0.52

187

Major coronary heart disease event

423

2835

1.00

0.02

4.4

4.8

342.25

356.09

umol/l

1.27

368

2402

Umbilical hernia

151

1524

0.99

0.02

5.1

335.22

368.71

umol/l

2.18

135

1309

Giant cell arteritis with polymyalgia rheumatica

132

1.06

0.02

2.9

4.3

275.78

355.83

umol/l

—

113

Wet age-related macular degeneration

637

1.02

0.02

3.7

3.6

298.87

328.92

umol/l

1.00

512

Other respiratory diseases principally affecting the interstitium

771

0.99

0.02

5.3

4.3

349.25

347.02

umol/l

0.04

656

Other diseases of pericardium

198

0.96

0.02

4.7

5.2

379.68

352.39

umol/l

0.43

174

Acetic acid derivatives and related substances

245

1284

0.99

0.02

4.4

5.8

338.78

382.03

umol/l

3.08

209

1145

Chronic sinusitis

277

2783

0.99

0.02

4.6

5.5

346.47

376.28

umol/l

3.13

236

2435

Benign neoplasm of eye and adnexa

451

1.02

0.02

3.7

5.2

356.47

363.82

umol/l

0.12

389

Radiculopathy

810

1.01

0.02

4.8

4.9

345.41

359.16

umol/l

0.37

684

Papilloedema, unspecified

107

0.93

0.02

3.5

5.6

362.20

377.82

umol/l

—

Granulomatous disorders of skin and subcutaneous tissue

127

0.94

0.01

6.0

5.3

332.96

366.54

umol/l

0.33

109

Distal bite

206

0.96

0.01

3.3

4.9

387.05

393.10

umol/l

0.06

187

Nontoxic multinodular goitre

779

0.99

0.01

4.9

4.4

346.90

353.69

umol/l

0.19

674

Ischemic heart diseases

511

3190

1.00

0.01

4.8

5.1

351.84

366.61

umol/l

1.57

450

2729

Disorders of choroid and retina

507

3701

1.00

0.01

4.5

5.0

344.51

363.07

umol/l

1.97

424

3180

Polyarthrosis

938

0.99

0.01

4.0

4.8

359.54

366.21

umol/l

0.19

795

Autoimmune diseases excluding thyroid diseases, strict definition

741

4136

1.00

0.01

4.6

4.9

358.29

367.19

umol/l

0.86

617

3601

Other diseases of arteries and capillaries

393

1.02

0.01

4.6

5.0

404.61

352.17

umol/l

1.88

338

Benign neoplasm of bone and articular cartilage

433

1.02

0.01

4.0

5.4

356.33

374.09

umol/l

0.47

376

Unstable angina pectoris

195

1609

1.00

0.01

3.5

4.4

327.96

341.69

umol/l

0.69

165

1341

Congenital malformations of heart and great arteries

787

1.01

0.01

4.1

5.4

374.41

386.81

umol/l

0.38

705

Intussusception

1.06

0.01

4.0

5.5

351.70

364.49

umol/l

—

Lupus erythematosus

104

1.06

0.01

3.9

4.9

406.60

365.37

umol/l

—

Chronic hepatitis, not elsewhere classified

156

0.96

0.00

3.9

5.3

363.00

363.24

umol/l

0.00

140

Benign neoplasms

804

4493

1.00

0.00

5.3

5.1

360.96

369.21

umol/l

0.88

691

3886

Haemorrhoids and perianal venous thrombosis

143

1434

1.00

0.00

4.5

344.10

358.97

umol/l

0.64

118

1198

Internal derangement of knee

261

2599

1.00

0.00

4.5

5.4

344.09

374.19

umol/l

2.93

222

2242

Polycystic ovarian syndrome, broad definition

468

1.00

0.00

5.5

5.6

328.31

366.70

umol/l

1.37

392

Mixed connective tissue disease

295

1.02

0.00

3.6

5.3

379.26

364.99

umol/l

0.22

254

305

1.02

0.00

3.9

4.5

338.63

346.93

umol/l

0.10

271

Other specified/unspecified systemic involvement of connective tissue

265

0.98

0.00

3.5

5.4

366.65

366.64

umol/l

0.00

228

Congenital deformities of feet

136

1.03

0.00

6.8

5.9

412.21

390.06

umol/l

0.22

127

Femoral hernia, unilateral

112

0.98

0.00

5.7

4.7

377.45

369.19

umol/l

0.09

Inguinal hernia, unilateral

112

0.98

0.00

5.7

4.7

377.45

369.19

umol/l

0.09

Inguinal of femoral hernia, unilateral

112

0.98

0.00

5.7

4.7

377.45

369.19

umol/l

0.09

Cardiomyopathy

882

1.00

0.00

4.6

4.7

344.80

351.74

umol/l

0.17

735

Malignant neoplasm of bladder

262

0.99

0.00

3.8

3.9

366.35

328.48

umol/l

0.81

222

Carcinoma in situ of skin of other and unspecified parts of face

258

1.01

0.00

3.4

3.6

305.04

333.85

umol/l

0.54

218

Scissor bite

149

1.00

0.00

4.1

4.6

410.93

387.26

umol/l

0.32

135

Certain disorders involving the immune mechanism

104

1038

1.00

0.00

4.4

5.1

347.63

367.33

umol/l

0.72

901

Giant cell arteritis

151

0.99

0.00

2.8

4.5

275.78

350.67

umol/l

—

131

Enthesopathies of lower limb, excluding foot

124

1241

1.00

0.00

4.2

5.6

359.10

376.65

umol/l

0.69

106

1075

Other facial nerve disorders

127

1.02

0.00

3.5

5.4

358.85

370.10

umol/l

0.16

108

General- and plastic-surgery devices associated with adverse incidents

0.00

0.0

6.3

—

415.13

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.95

0.00

3.7

5.8

361.71

385.33

umol/l

—

Unspecified drowning and submersion

0.00

0.0

5.2

—

353.83

—

Tympanosclerosis

0.00

0.0

6.0

—

353.80

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

0.98

0.00

1.8

4.1

324.60

348.95

umol/l

—

Other retinal disorders in diseases classified elsewhere

0.00

0.0

2.8

—

300.80

—

Benign neoplasm: Vulva

0.93

0.00

4.6

4.7

360.11

372.21

umol/l

—

Other porphyria

0.00

0.0

2.3

—

321.78

—

Calcinosis cutis

0.00

0.0

3.6

—

253.63

—

Placental disorders

0.89

0.00

7.2

5.4

401.40

390.05

umol/l

—

Cystic fibrosis, other manifestations/unspecified

0.00

0.0

3.5

—

397.88

—

Corneal degeneration

0.97

0.00

3.5

4.7

353.00

374.15

umol/l

—

Carcinoma in situ of oral cavity

0.00

0.0

2.8

—

341.83

—

Conditions involving the integument and temperature regulation of fetus and newborn

0.00

0.0

5.1

—

452.14

—

Left hemicolectomy

1.00

0.00

5.2

4.4

303.11

358.32

umol/l

—

Haemolytic disease of fetus and newborn

0.00

0.0

5.6

—

457.33

—

Moyamoya

0.00

0.0

3.0

—

324.40

—

Cervical disc disorders

213

2130

1.00

0.00

4.2

5.3

346.31

373.95

umol/l

2.43

182

1834

Congenital absence, atresia and stenosis of small intestine

0.00

0.0

5.7

—

399.71

—

Severe bullous disorders, KELA reimbursement

0.00

0.0

1.4

—

293.80

—

Congenital musculoskeletal deformities of head, face, spine and chest

0.91

0.00

4.8

297.57

386.87

umol/l

—

Carcinoma in situ of skin of lower limb, including hip

0.98

0.00

5.0

3.4

294.00

339.34

umol/l

—

Abnormal findings on diagnostic imaging of breast

0.98

0.00

6.0

5.1

347.40

387.48

umol/l

—

Posteruptive colour changes of dental hard tissues

0.00

0.0

3.4

—

380.20

—

Carcinoma in situ of lip, excluding all cancers

0.00

0.0

3.6

—

364.60

—

Carcinoma in situ of oral cavity

0.00

0.0

3.5

—

338.00

—

Acquired ichthyosis

0.00

0.0

1.4

—

230.80

—

Other and unspecified immunodeficiencies with predominantly antibody defects

0.97

0.00

1.7

5.0

314.57

371.56

umol/l

—

Cystic fibrosis with intestinal manifestations

0.00

0.0

3.9

—

402.00

—

Drug-induced autoimmune haemolytic anaemia

0.00

0.0

2.9

—

234.00

—

Benign neoplasm: Vulva

0.96

0.00

4.6

4.9

360.11

374.13

umol/l

—

Use of cabergoline

1.02

0.00

7.8

4.8

302.00

355.36

umol/l

—

Traumatic amputation of shoulder and upper arm

0.00

0.0

3.4

—

268.00

—

Retinal haemorrhage

0.93

0.00

1.6

5.1

337.87

357.37

umol/l

—

Traumatic amputation of hip and thigh

0.00

0.0

3.0

—

328.83

—

Mandibular prognathia

0.90

0.00

5.3

439.29

378.44

umol/l

—

Granuloma annulare

0.92

0.00

5.5

5.8

335.67

379.56

umol/l

—

Benign neoplasm: Spinal cord

0.97

0.00

8.4

5.5

416.71

377.80

umol/l

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

0.95

0.00

3.0

4.0

240.17

355.38

umol/l

—

Other conditions of integument specific to fetus and newborn

0.00

0.0

4.8

—

453.50

—

Chronic lymphocytic leukaemia

0.91

0.00

3.4

4.7

371.11

354.22

umol/l

—

Benign neoplasm: Spinal cord

1.01

0.00

8.4

5.6

416.71

380.54

umol/l

—

Other accidental hanging and strangulation

0.00

0.0

6.7

—

311.17

—

Hyperchylomicronaemia

0.00

0.0

3.2

—

295.67

—

Disorder of bilirubin metabolism, other/unspecified

0.00

0.0

2.5

—

295.50

—

Spotted fever [tick-borne rickettsioses]

0.00

0.0

5.2

—

241.80

—

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

0.00

0.0

2.0

—

332.80

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

0.0

1.7

—

329.67

—

Other perinatal digestive system disorders

0.00

-0.00

0.0

2.5

—

437.33

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Valproate [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS